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The purpose of this study was to identify changes in gene transcription that occur 
in the soleus muscle of untrained, 10 week old rats following a single aerobic exercise 
bout of 2 hours.  Of particular interest were genes involved in the production or 
protection from RONS. Rats were either run (experimental) for 2 hours or were rested 
(controls) and were killed 1 hour post-exercise with controls killed at a matched time.
The soleus muscles from each animal were pooled and examined using DNA microarray 
technology.  The microarray identified 52 genes significantly different between the 
conditions.  The major gene families altered were metabolism (~10% of all genes 
altered), apoptosis (~8% of all genes altered), muscle contraction (~10% of all genes 
altered), transcription/cell signaling (~17%of all genes altered), tissue generation 
(~15.5% of all genes altered), and inflammation (~10% of all genes altered).
To confirm the findings of specific genes from the microarray, real time PCR was 
performed on 4 genes of interest (NFκB, TNFα, Atf3, and Mgst1).  The results from the 
PCR analysis on these 4 genes were consistent with the microarray results. NFκB and 
TNFα were not significantly altered on the microarray or PCR analysis, whereas Atf3
(up-regulated) and Mgst1 (down-regulated) were found to be significantly altered in 
exercised animals by both methods. Genes related to RONS protection were down-
regulated.
Western Blot analysis was used to check if protein level was correspondingly 
altered.  The process from gene transcription to protein translational is a complex process
that may not coincide.  NFκB protein level was not different between the 2 groups, 
matching the results obtained with NFκB gene level.  Atf-3 protein level was elevated in 
the exercise group, matching the results obtained with Atf-3 gene level.
These data suggest that one hour after a 2 hour run at ~65% of VO2 max, the 
soleus muscle undergoes changes in gene expression.  These significant changes occurred
in the areas of metabolism, apoptosis, muscle contraction, transcription/cell signaling, 
tissue generation, and inflammatory genes.  Transcription of many genes involved in 
production of RONS was elevated, while that of genes involved in RONS protection were
either depressed or unaltered.
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CHAPTER I
INTRODUCTION
The balance between prooxidants and antioxidants is critical for determining
whether a cell will live or die.  Oxidative stress can occur in all cells when the production 
of prooxidants exceeds the physiologic capacity of the antioxidant defense system to 
neutralize or inactivate these prooxidants.  Prooxidants can be countered by means of the 
body’s endogenous antioxidant defense system, in conjunction with exogenous 
antioxidants consumed through the diet 50. Most cellular oxidation is mediated by 
reactive oxygen/nitrogen species (RONS), which  are molecules with an unpaired electron 
that makes them unstable.  RONS seek to either donate or capture another electron to 
become stable, often at the expense of another molecule, causing “damage” to the 
molecules affected.   The effect of these pro-  and antioxidants on gene regulation is not 
fully understood.
Generation of RONS occurs as a result of normal cellular metabolism, but is often 
increased during periods of stress 194.  Therefore RONS are typically thought of as part of 
the stress response signal.  Some typical RONS found in the body include, but are not 
limited to, the following: singlet oxygen (·O), superoxide radical (O2
· -), hydroxyl radical 
(·OH) and peroxynitrite (ONOO-) 64.  While exercise does have many documented health 
benefits, it also can be an intense physical stress leading to increased RONS production
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96, 194, likely modifying several macromolecules, including proteins, lipids, and nucleic 
acids 64.
Damage to macromolecules can alter how the cell functions and performs.  In 
fact,  a single bout of aerobic exercise for as little 20 minutes increases blood and skeletal 
muscle markers of oxidative stress above baseline 4.
It is clear however, that although RONS production is increased, protection from 
RONS is also increased with exercise 49, 160.  In addition, trained individuals show less 
damage to the same exercise bout than untrained persons.  This training adaptation may 
help attenuate the rise in protein, lipid, and nucleic acid oxidation noted post-exercise85, 
167, 193.
The exact intracellular signals controlling the reduction/oxidation (redox) status 
of the cell following exercise have not been fully elucidated. Many transcription factors
are altered in response to exercise.  Several apoptotic and anti-apoptotic factors are also 
altered following an exercise bout 22, 107, 153, 233.  Identifying the genes that are activated or 
inhibited, along with how these interact with each other is of great importance for 
developing interventive strategies for controlling oxidative stress damage in a variety of 
settings. 
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Purpose of the Study
The purpose of this study was to examine the response of the rat transcriptome to 
a single bout of aerobic exercise.
Specific Aims
The specific Aims of this investigation are as follows:
Specific Aim 1- To identify the transcriptional response of prooxidant genes to a 
single session of aerobic exercise one hour after exercise.
It was hypothesized that genes involved in the production of prooxidants in the body (e.g. 
NfkappaB, activating transcription factor 3 (Atf3), Tumor Necrosis Factor (TNF-α)) will 
be activated less in the exercisers than the controls one hour after an aerobic exercise 
bout.  This aim will be tested using a DNA microarray, and select genes will also be 
tested using PCR analysis.
Specific Aim 2- To identify the transcriptional response of antioxidant genes to a 
single session of aerobic exercise one hour after exercise. 
It was hypothesized that genes involved in protecting the body from oxidative stress (e.g. 
superoxide dismutase, glutathione peroxidase, catalase, microsomal glutathione S 
transferase 1 (Mgst1)) will be activated more in the exercisers than in controls one hour 
after an aerobic exercise bout. This aim will be tested using a DNA microarray, and 
select genes will also be tested using PCR analysis.
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Specific Aim 3- To determine if reported gene transcription level will match protein 
level following a single session of exercise one hour after exercise.
It was hypothesized that since the process of gene transcription to protein translation is a 
complicated pathway, which often takes several hours to complete, that at the one hour 
post-exercise time point, gene and protein levels will not match for genes which have 
been reported altered. The protein level will be determined using a Western Blot analysis 
with specific antibodies for each protein of interest.
Significance of Study
Identifying the genes altered in response to exercise-induced stress will allow 
future research to focus on the role of these genes in altering the defense mechanisms 
(enzymes, cell signals, proteins etc.) activated by acute exercise. If transcriptional
changes reflect the changes in protein levels, future research may focus on intervention 
strategies related to enhancing antioxidant enzymes or various transcription factors.  This 
research will provide a snapshot of the activation/inhibition of the genes at the 1-hour 
post-exercise time point (many changes in proteins and inflammation are reported to 
increase at this time 94, 161).  It is possible that the changes in mRNA and protein levels 
will not mimic the altered genes meaning there are translational modifications.  These 
experiments will serve as the beginning of a time course experiment to see if these gene 
alterations are transient, or if there are transcription or translation alterations occurring in 
the muscle.  This could lead to identifying factors that may contribute to the dissociation 
of the transcriptional or translational efficiency of some genes and proteins.  By 
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understanding this complex process, we may begin to understand what redox signals 
influence cells to live or die, and how to better manipulate these signals in both normal 
and diseased cells in order for optimal cellular functions to occur.
Limitations
1. Currently, statistically significant differences between 2 groups is defined as a 1.5 
fold difference between genes 66, 182, 183.
2. mRNA from multiple animals will be pooled on each chip, instead of each animal 
having their own chip, this could cause one animal which is an outlier to alter the 
expression levels reported from that chip 14since only average gene alterations 
will be reported for each group.
3. Although a one hour time point will be used, the possibility that some of the genes 
involved in the inflammatory process and oxidative status of the cell will be 
altered before or after this 1 hour time is possible.
4. Some of the genes which are altered at this 1 hour time point may only be 
transiently altered or might have not been altered in the same manner at a 
different time point.
5. Changes in gene expression levels do not always reflect changes in protein levels, 
and therefore do not necessarily lead to a biological response.
6
Delimitations
1. Gene chips (or cDNA microarrays) will be used, allowing simultaneous viewing 
of the entire rat transcriptome instead of a single gene by gene analysis.
2. Rat muscles share over 90% homology with human skeletal muscles in regards to 
muscle fiber types and structure and are therefore the species of choice in skeletal 
muscle microarray studies.
3. The entire soleus muscle of the animal will be used as opposed to a muscle 
biopsy.  These samples will represent what is happening in the entire muscle as 
opposed to just a particular random point in the muscle, which is a more accurate 
assessment of the entire muscular response.  It has also been suggested that since 
muscle biopsies are a surgical procedure, that this could activate the inflammatory 
process and alter gene response.
4. Rats will be fasted for at least 12 hours prior to removal of their muscles, thus 
limiting the influence diet may have on oxidative stress levels reported.
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CHAPTER II
REVIEW OF LITERATURE
This chapter presents a review of recent related literature in the area of oxidative 
stress and exercise.  It is organized into the following sections: background of reactive 
oxygen and nitrogen species, cellular damage, cellular protection, aerobic exercise 
induced oxidative stress, aerobic exercise induced protection, and oxidative stress 
associated cell signaling.
Introduction
Oxidative stress is a condition in the body in which the cellular production of 
prooxidants exceeds the physiologic capacity of the body to render these prooxidants 
inactive.  The generation of reactive oxygen/nitrogen species (RONS) occurs under 
normal physiologic conditions due to normal cellular metabolism and other cellular 
processes such as immune function and cell signaling. RONS normally cause little 
damage in unstressed conditions due to the ability of endogenous antioxidants as well as 
exogenous antioxidants consumed through the diet to protect the body from RONS 
associated damage.  RONS may also be produced due to environmental (smoke, ozone) 
and physiological (exercise, mental stress) disruptions to homeostasis.
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In some cases, the antioxidant protection of the body may not be adequate to 
overcome the RONS accumulation.  This can lead to a situation in which cellular
components, such as proteins, lipids, and nucleic acids are damaged.  This process has 
been implicated in aging, disease progression, and exercise.  Although correlations have 
been made between oxidative stress markers and several diseases, it is unknown if RONS 
cause any particular disease, or are a consequence of the disease process.
Reactive Oxygen and Nitrogen Species
Oxidative stress, which occurs in all cells, ultimately may determine the life cycle 
of a cell.  RONS have been implicated in apoptosis 170, necrosis 9, aging 161, and other 
normal cellular functions 57.  Clearly, RONS can be produced under homeostatic 
conditions, but any stress, such as aerobic exercise, has the potential to increase RONS 
production, which might be above the antioxidant capacity and may lead to several 
biological problems.  
A brief review of RONS (or free radical) chemistry is needed at this point. RONS 
are molecules with unpaired electrons or that have electrons that are not in the most 
stable arrangement.  Electrons within compounds are typically kept in orbitals, with each 
orbital containing two paired electrons. Molecules or compounds that have two paired 
electrons in these orbitals are considered non-radicals.  If the orbital only contains one 
electron, it is said to be free and a radical (hence the term free radical) which is capable 
of independent existence 64.  This unpaired electron can become a free radical (also 
known as a reactive species) in one of three ways: by homolysizing a covalent bond, 
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adding a single electron to a neutral atom (donation), or losing a single electron from a 
neutral atom 96 (abstraction).  These free radicals are reactive because they seek to fill 
their orbital with an electron from another molecule.  This electron donation (or 
abstraction) can lead to the formation of additional free radicals (reactive species) until 
the free radical is reacted with an antioxidant or becomes balanced.
One of the most widely studied sources of free radical formation is the oxygen 
molecule (O2).  O2 has two unpaired electron, causing it to be classified as a radical.  
Under normal cellular conditions, O2 is reduced to water during the electron transport 
chain in the mitochondria by way of cytochrome oxidase. During this process O2 is 
broken down into two singlet oxygen molecules. It has been purported that 2-5% of the 
singlet oxygen produced leaks out of the respiratory chain and becomes free to react with 
other molecules (typically in the form of a superoxide molecule).  The site of this electron 
leakage is currently under debate, but ubiquinone has been suggested 141.  RONS are also 
produced through a variety of other pathways as well, and the most investigated RONS 
will be discussed.
Common Radicals
One of the major free radicals produced from oxygen is the superoxide radical 
(O2
.-).  Superoxide is formed when singlet oxygen (O-) binds to molecular oxygen 
typically in the electron transport chain, which is produced mainly from mitochondrial 
leakage seen during oxidative phosphorylation 50.  This is not the only source of 
superoxide production.  Sen et al. hypothesized that superoxides are also formed from 
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peroxyl radicals through the electron transport chain 194.  Additionally, respiratory bursts 
of phagocytic cells like neutrophils, monocytes, and macrophages can lead to superoxide 
formation 62.  One of the major reasons that superoxides are viewed as dangerous and 
harmful radicals is their ability to convert into other reactive molecules, such as hydrogen 
peroxide (H2O2).
Hydrogen peroxide itself is not considered a strong free radical.  However, 
hydrogen peroxide can be converted into the hydroxyl radical (.OH), through the Fenton 
reaction, and this .OH is the most reactive species in the body.  Using iron or any reduced 
transition metal, the Fenton reaction is as follows:
 Fe2+ +  H2O2 → Fe3+ + OH + .OH.  
Additionally, the Haber-Weiss reaction can form hydroxyl radicals as follows:
 O2
- + H2O2 →O2 + OH + .OH.  
 The hydroxyl radical is considered by many to be the most reactive molecule.  This 
radical will react with any molecule from which it can borrow an electron, whether it is
protein, lipid, or DNA 167.  The .OH radical is considered highly reactive because it will 
react with the first compound in close proximity and abstract an electron  from that 
molecule 64.
Some lesser reactive species can also play a role in oxidative modifications to 
macromolecules in the body.  These include the peroxyl radical (ROO.), which is the 
result of any carbon-centered free radical (R.), and can also alter proteins, lipids, or DNA, 
depending on where it is produced 64.  Nitrogen species can also be formed and act as free 
radicals, hence the transition from the term ROS to RONS.  Nitric oxide can react with 
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transition metals and a superoxide to form peroxynitrite (ONO2
-) and other nitrogen 
centered radicals.  A sample list of common free radicals is listed in Table 1.
Table 1: Common RONS
Name Symbol
Singlet Oxygen O-
Superoxide O2
.- 
 Hydroxyl OH.
Peroxyl RO2
.
Alkoxyl RO.
Hydroperoxyl HO2
.
Hydrogen Peroxide H2O2
Peroxynitrite ONOO-
Adapted from Halliwell and Gutteridge 64
RONS Production
RONS can be produced from several primary and secondary sources.  These will 
be discussed in full detail in a later section, but it warrants mentioning here as well.  
Primary sources of RONS production include: electron transport chain leakage, 
prostanoid metabolism, catecholamine autooxidation, xanthine oxidase, and NADPH 
oxidase formation.  Several secondary mechanisms also exist, and these include: 
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phagocytic cells, disruption of iron containing proteins, and excessive calcium 
accumulation (or loss of calcium regulation) 64. 
RONS and Cellular Damage
The extent and amount of cellular damage that occurs due to RONS is dependent 
on several factors. First, not all RONS molecules have the same potential to disrupt or 
interact with macromolecules.  Another factor is the macromolecule that is attacked, as 
well as the location of any prooxidants.  Still another factor is the frequency, and duration 
of the RONS, or how much and often the RONS is present in the tissue.   Finally, the 
amount and type of antioxidants within the area present to quench the RONS can affect 
the amount of damage seen.  
The major cellular targets of prooxidant attack appear to be proteins, lipids, and 
DNA.  When proteins are damaged, many enzymes undergo modifications, which have 
implications for normal cellular function.  Lipids may undergo lipid peroxidation, and 
cellular membranes seem to be a major site for lipid peroxidation 64.  When cell 
membrane lipids become peroxidized this can lead to changes in membrane integrity.  If 
sufficient membrane changes occur this can alter what enters and exits the cell and may 
lead to further damage to cellular components normally protected by the membrane.  
Genetic material (DNA and RNA) may be damaged as well.  Consequences of DNA 
damage are strand breakage and alterations in nucleotide bases.  Clearly, this has 
important implications as incorrect base pairs can lead to incorrect protein formation, and 
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perhaps lead to further mutagenesis.  DNA oxidation has been reported to occur in 
response to oxidative stress. 
Protein Oxidation
Many investigators in recent years have documented oxidative modification to 
proteins, and some of these proteins have been identified as enzymes.  RONS have the 
ability to directly alter protein structure, or may alter structure through secondary 
mechanisms.  A common mechanism for protein oxidation occurs when transition metal 
ions are present (iron, copper) as these tend to damage either peptide bonds or the protein 
side chains 64.  Oxidation of proteins leads to changes in structure and/or catalytic 
function and has been shown to make proteins more susceptible to proteolytic attack 
(likely by way of the ubiquitin 26S proteosome) and degradation 105.  Protein oxidation
seems to be especially prevalent in diseased tissue, where oxidized protein may account 
for up to half of the total protein content of the tissue 96.  Clearly, whether a cause or a 
consequence of a disease, altered proteins are significantly correlated to certain disease 63, 
96, 161
RONS normally affect proteins in one of three ways: fragmentation, aggregation, 
or proteolytic digestion 58.  Fragmentation by RONS causes the protein to breakdown into 
several smaller fragments.  Fragmentation problems can occur during protein synthesis 
and may alter translational events and result in formation of incomplete proteins 198.  
Albumin and collagen are two proteins highly susceptible to this type of attack 121, 223
because they each contain numerous proline residues.  Proline residues are highly 
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susceptible to hydroxyl radical oxidation 200.  Amino acids that are bound to transition 
metals are also highly susceptible to fragmentation since these metals serve as  catalysts
in hydroxyl radical formation 228.
During aggregation, RONS can cause proteins to denature and these fragments 
can aggregate together 228.  Squier hypothesized that RONS causes post-translational 
problems leading to an increase in the number of incorrectly folded proteins 198.  These 
incorrect proteins aggregate together, which often disrupts normal cellular functions, and 
can bind to chaperone proteins and proteases in a manner that leads to the formation of 
additional improperly folded proteins.
Oxidized proteins are more susceptible to proteolytic degradation.  Since 
fragmentation and aggregation usually cause gross deformities in proteins, they become 
more susceptible to proteolytic attack by various pathways (ATP-ubiquitin, calpains) 159.  
Furthermore, at sites of RONS production, there is evidence of increased proteolytic 
activity 228.
In terms of measuring protein oxidation in the cell, it appears as though the 
formation of protein carbonyls (PC) is the predominant measure used 20, 39, 52, 53, 84, 162, 196, 
230.  Carbonyls react with 2,4-dinitrophenylhydrazine (DNPH), which can be detected by 
absorbance spectrophotometry 35 and then quantified.
Lipid Peroxidation
Lipid alterations due to RONS damage has been termed lipid peroxidation.  In this 
situation, carbon is attacked by either hydroxyl radicals or other lipid radicals, causing a 
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carbon with an unpaired electron to be present.  This carbon can combine with oxygen 
leaked from mitochondrial respiration, forming the peroxyl radical 5.  Peroxyl radicals 
can then abstract hydrogens from other lipids, forming lipid hydroperoxides.  A 
particularly damaging feature of peroxyl radicals is their ability to travel through the 
bloodstream, thus allowing them to attack not only locally, but also at distant sites 64.  
Alessio defined three phases of lipid peroxidation; initiation, propagation, and 
termination 5.  During initiation, one or more hydrogens are removed from the 
polyunsaturated fatty acid contained in the membrane, forming a conjugated diene.  At 
this point, propagation starts as the carbon centered fatty acid radical combines with 
oxygen forming a peroxyl radical.  The peroxyl radical begins a  chain reaction attacking 
more polyunsaturated fatty acids.  Termination occurs as the peroxyl radicals are 
inactivated forming lipid hydroperoxides.  This lipid hydroperoxide, in the presence of 
transition metals, can produce RONS that can result in further damage.  The 
consequences of lipid peroxidation appear to occur mainly as alterations to cell or 
organelle membranes.  Some common alterations observed to occur include; loss of 
membrane fluidity, increased membrane permeability (likely altering enzyme function) 
and apoptosis 177.
Several measures of lipid peroxidation currently exist, however there is no single 
method that is universally used. Lipid hydroperoxides (LOOH) are often quantified using 
the ferrous orange assay (FOX).  The measurement of thiobarbituric acid reactive 
substances (TBARS) and malondialdehyde (MDA) have also been extensively used.
TBARS is a non-specific but sensitive marker of lipid peroxidation. TBARS has 
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therefore been used as an indicator of lipid peroxidation, but can also reflect non-lipid 
components. MDA is one end product of lipid peroxidation which can be translocated 
from one site to another 43. Therefore, MDA measurements may only reflect the balance 
of production, from both elimination and clearance.  MDA represents around 20% of all 
the lipid peroxidation that has occurred 43.   In addition, not all lipid hydroperoxides will 
produce MDA 80.  Other intermediates of lipid peroxidation have also been determined 
such as conjugated dienes 179.  It is important to note that most studies have had mixed 
responses determining changes in these intermediates of lipid peroxidation. Recently it 
has been proposed that 8-isoprostane (F2 isoprostanes) measured by HPLC is a good 
indicator of lipid peroxidation as an oxidative stress marker 134.
DNA Oxidation
DNA damage can be manifested in several different ways including oxidative 
damage.  It appears that most oxidative modification occurs due to damage to single base 
pairs, which in itself can have a variety of consequences.  Damage to a single base pair 
could lead to strand breaks, or heteroduplex DNA (incorrect base pairs) being formed.  
Incorrect base pairs could create a premature stop signal and lead to aberrant protein 
formation having a variety of consequences from apoptosis to tumor growth 64, 107.
Recent studies have used formation of the marker 8-hydroxy-2`-deoxyguanosine 
(8-OHdG) as an indicator of nucleic acid oxidative modification 21.  It has been reported 
that this measure may actually only account for about 10% of total DNA oxidation21.  
Nonetheless, high levels of 8-OhdG have been correlated with many disease states, as 
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well as aging 112. 8-OHdG increases have not always been reported in response to 
exercise 112, 221.
Measurement of Oxidative Stress Markers
Many methods are currently available for one to quantify oxidative stress.  
Although markers can be measured following a variety of conditions, this review will 
mainly focus on markers following exercise.  The literature has reported mixed results 
depending on the marker and type of exercise used.  A major obstacle in oxidative stress 
research is that any measurement taken is only a snapshot of what is occurring at that 
particular moment in that particular tissue.  Blood, serum or plasma levels are often 
assayed but the majority of the production of RONS appears to originate in the tissues. 
The balance between production and removal of these RONS in blood can result in an 
increase in oxidative stress in response to exercise of sufficient intensity and duration. 
However, in a recent report 227 the correlation between markers of oxidative stress in 
plasma and tissue was not high. Although makers of oxidative stress increased in both 
blood and skeletal muscles, the highest correlations for these increases were between 
muscles doing similar muscle actions.  It has also been reported that not all markers of 
RONS increase in a similar manner to a specific oxidative stress 43.  It has therefore been 
recommended that oxidative stress be measured using several markers of RONS.  In 
addition, there may be temporal variation in changes in the markers of RONS.  Therefore,
multiple time points should be determined to ascertain what is actually occurring in the 
body in response to this type of stress 80.  This list of measurements was not meant to be 
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all inclusive.  For an extensive list of RONS associated measurements, please see Figure 
1.
Figure 1: Methods for Determining RONS Associated Damage (adapted from 43)
Cellular Protection Against RONS
The balance or ratio of prooxidants to antioxidants determines whether or not
oxidative stress will occur in the cell.  The antioxidant defenses exist in order to minimize 
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oxidative stress, and to protect macromolecules from oxidative attack.  Table 2 lists some 
common antioxidants routinely studied in oxidative stress studies.
Table 2: Common Antioxidants
Name Type
Cooper Zinc SOD (Cu-Zn SOD) Antioxidant Enzyme
Manganese SOD (Mn SOD) Antioxidant Enzyme
Catalase (CAT) Antioxidant Enzyme
Glutathione Peroxidase (GPX)
Glutathione Reductase (GR)
Glutathione (GSH/GSSG)
Antioxidant Enzyme
Antioxidant Enzyme
Thiol – hydrogen ion donator or acceptor
Vitamin C (ascorbate) Antioxidant Scavenger
 hydrogen ion donator
Vitamin E (α-tocopherol) Antioxidant Scavenger
 hydrogen ion donator
Carotenoids Antioxidant Scavenger 
Adapted from Halliwell and Gutteridge 64
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Enzymatic Antioxidants 
One of the major antioxidant enzymes is superoxide dismutase (SOD) .  As the 
table indicates, SOD actually exists in two separate forms, copper-zinc SOD, which is 
also referred to as SOD I, and is mainly found in the cytoplasm, and manganese SOD 
(Mn SOD) which, is also referred to as SOD II and is found primarily in the 
mitochondria.  SOD is an enzyme that aids in the conversion of the highly reactive 
superoxide to hydrogen peroxide.  The reaction looks like this: 
O2
.- + 2H+→ H2O2.
The hydrogen peroxide that is produced has the ability, in the presence of 
transition metals, to convert into the hydroxyl radical.  The main function of glutathione 
peroxidase (GPx) and catalase (CAT) is to inactivate hydrogen peroxide before it can 
form the hydroxyl radical.  GPx exists as both a selenium independent and selenium 
dependent enzyme 194.  This explains why selenium is commonly added to antioxidant 
cocktails in the literature 50, 53.  If adequate reduced glutathione (GSH) is present, GPx 
aids in the conversion of hydrogen peroxide to water and oxidized glutathione (GSSG).  
The reaction is:
 H2O2 +2GSH → GSSG +2H2O
 For this reason, the amount of total glutathione (TGSH), GSSG, GSH, and the GSH to 
GSSG ratio have been measured to assay oxidative stress 20, 52, 53, 87.  The enzyme 
glutathione reductase (GR) is used to convert GSSG back to GSH in the presence of 
NADPH.
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Mgst1 is the gene believed to be of great importance in the glutathione defense 
system.  The Mgst1gene functions to code both  glutathione transferase (GST) and 
glutathione peroxidase (GPx) 104.  Clearly, GST and GPx levels are important in 
maintaining the protective abilities of the glutathione system.  It has been previously 
reported that Mgst1 plays a role in cancer defense 45, cell survival 116, and in response to 
RONS exposure 111.  This protein appears vital in proper glutathione pathway function 
and warrants further investigation.
The antioxidant enzyme CAT also functions to convert hydrogen peroxide into 
water and oxygen.  The reaction is as follows in the presence of CAT 64:  
H2O2 → H2O + O2.
Non-enzymatic Antioxidants
The most common types of antioxidants that are non-enzymatic come from the 
diet in the form of various vitamins (e.g. C and E), minerals (e.g. selenium, zinc, 
manganese), carotenoids (e.g. beta-carotene), and flavonoids.  The exact amount of 
dietary intake for these antioxidants is unknown and likely is dependent on the training 
and health status of the individual.  Several investigations have concluded that regular 
training increases endogenous antioxidants 38, 85, 160, 179.  However, oxidative 
stress/damage can still occur even with increased basal levels of endogenous protection.  
Several investigators have shown that antioxidant supplementation can cause additional 
protection to either reduce or prevent oxidative stress 49, 50, 53.
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The two most studied dietary antioxidants are vitamins C and E.  These vitamins 
work together to combat RONS. Vitamin C primarily works in the aqueous areas of the 
cell whereas vitamin E works on the lipid portions of the cell.  They can interact with 
each other as well.  Vitamin E (α-tocopherol) can help reduce lipid peroxidation, as it acts 
on peroxyl radicals, forming a vitamin E radical as a byproduct.  This vitamin E radical is 
less reactive than the peroxyl radical and then can be either quenched or reverted to a 
reduced state with a hydrogen ion donor. Ascorbate (vitamin C) can regenerate vitamin E 
by accepting an electron from the vitamin E radical (or donating a hydrogen ion), thus 
converting it back into active or reduced α-tocopherol.  Vitamin C radicals can either be 
converted back into ascorbate by GSH or excreted in the urine. In addition vitamin C can 
help to reduce oxidized glutathione (GSSG) to the reduced form of this thiol (GSH).  
Therefore, antioxidants are interrelated and can help reduce oxidative stress in both the 
lipid and aqueous portions of the cell 49, 50.
Many other non-enzymatic antioxidants function in the body as well.  Metal-
binding proteins bind to transition metals, denying them the opportunity to react with 
hydrogen peroxide to form the hydroxyl radical.  Dietary minerals can also be important 
in the antioxidant defense system due to their role as critical components of a reaction or 
compound such as manganese, copper, zinc, and selenium in the enzymes Mn SOD, Cu-
Zn SOD, and GPx, respectively.  The vitamin A precursor beta-carotene has recently 
been under investigation for its potential role as an antioxidant, as it appears to bind to 
singlet oxygen 40. These carotenoids can revert back to their normal antioxidant status by 
vibrational actions as well as being reduced with thiols.   Various flavonoids consumed 
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through the diet may play a role in antioxidant protection, however the exact compound 
and mechanism of action remains to be elucidated 19.  There are a great number of 
flavonoids and their role as antioxidants in vivo has not been adequately investigated.
Chaperone molecules also seem to play a role in antioxidant defenses as they may 
protect macromolecules from oxidative damage.  One of the most widely studied 
chaperone molecules are the heat shock proteins (HSP).  For example, HSP 72 helps to 
synthesize new proteins by allowing them to fold and function correctly 127.  Antioxidants 
therefore function to decrease the amount of radical formation, or limit the progression of 
RONS associated damage.
Aerobic Exercise Induced Oxidative Stress
Several primary and secondary sources of RONS production have been identified 
in response to exercise.  Primary sources are those that actually produce RONS in 
response to a particular stress (e.g. exercise).  Secondary sources are those in which there 
is a delay in RONS production due to the response of the stress often producing RONS 
through another mechanism.  This includes damage associated with muscle inflammation 
and infiltration of macrophages and neutrophils to help degrade damaged muscle.
Primary Sources of RONS Production
It appears as though the major source of radical production is the electron 
transport chain that uses molecular oxygen to produce ATP.  Most oxygen is converted to 
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water at the last step of the electron transport chain.  However, 3-4% of the oxygen used 
in the electron transport chain leaks out as singlet oxygen at rest 4, 79, 212.  It has been 
purported that as oxygen consumption increases, such as would occur during exercise 
that singlet oxygen leakage would increase proportionally.  During an exercise bout, 
oxygen uptake may increase by up to 15 fold above resting values.  Reid et al., provided 
evidence of this  when they reported increased markers of RONS in the interstitial fluid 
following repeated muscle contractions (similar to exercise) 172, 173. 
Another potential primary source of RONS production is prostanoid metabolism.  
Prostaglandins are released from cells within the muscle in response to a stress (i.e. 
exercise).  It was reported that skeletal muscles subjected to excessive contractile activity 
released prostaglandins 126, 176.  One of the intermediates produced during prostaglandin 
metabolism is a RONS.  In addition, arachidonic acid, a prostaglandin precursor, can be 
converted into active RONS via lipoxygenase and one of the products, 8-isoprostane, has 
been shown to increase with exercise 134.
During exercise, catecholamines (epinephrine and norepinephrine) are released in 
order to increase heart rate and control blood flow as well as to increase metabolism of 
lipids and carbohydrates.  These hormones help prepare the body for the “fight or flight” 
response.  It is currently believed that these catecholamines autooxidize, resulting in 
increased RONS formation 79, 83.
The enzyme xanthine oxidase has been reported to increase RONS levels 79, 96.  
As ATP is degraded (as would be the case during exercise) incidents of ischemia, 
followed by reperfusion (often termed I-R injury) leads to increased ADP formation.  
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ADP degradation leads to the conversion of xanthine dehydrogenase to xanthine oxidase, 
which is a superoxide producer 131.  This situation usually occurs in the presence of 
hypoxanthine, which can be a substrate for either xanthine dehydrogenase or xanthine 
oxidase. This situation usually manifests itself when calcium homeostasis is altered 125.  
This likely happens due to repeated skeletal muscle contractions.
NADPH oxidase, primarily found in neutrophils, can also be a RONS producer.  
Whether or not this happens in skeletal muscle appears to be speculative, as the presence 
of NADPH oxidase in skeletal muscle is undocumented.
Secondary Sources of RONS Production
As previously discussed, RONS can also be generated as byproducts of tissue 
injury-related processes. These RONS are likely key factors in determining the degree of 
secondary damage to the muscle, and may be a necessary component for muscle repair 
and remodeling 26. Secondary sources of RONS include phago cytic cells, disruption of 
iron-containing proteins, and excessive calcium accumulation (or loss of calcium 
regulation). Damaged fibers have been shown to have increased levels of phagocytic 
cells (e.g. neutrophils, monocytes, macrophages) within the affected muscle fibers 114.  
The phagocytic cells, such as neutrophils, can release superoxide radicals.  Neutrophils 
act in part by degrading material (by way of  superoxide radicals) and its activity is often 
determined by what is known as neutrophil burst activity. RONS production, in this case 
can serve a useful purpose at the level of damaged tissue, as these superoxide radicals 
help in degrading severely damaged tissue so that regeneration of new and healthy tissue 
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can occur.  However, these RONS have also been known to attack some of the 
surrounding healthy tissue causing damage where it is not intended 119.
Iron disruption from iron-containing proteins can increase free iron 62, 63, 81, 82.  
Excessive free iron can stimulate reactions that can result in protein and nucleic acid 
degradation as well as peroxidative damage to lipids.  The Fenton reaction can lead to 
hydroxyl radical formation.   The increase in free iron can stimulate the amount of 
hydrogen peroxide generated into the hydroxyl radical.  In addition, the iron catalyzed 
Haber-Weiss reaction can form the hydroxyl radical.  Certain exercises (primarily 
eccentric type actions) can cause muscle injury, which likely damages iron containing 
(and other transition metal) proteins within the muscle (e.g. myoglobin) and releases free 
iron 174, making it available for these reactions.  In addition, erythrocytes within the 
vasculature of these muscles could be damaged and release free iron. This could result in 
oxidative stress within the muscle and the blood. 
A third source for secondary production of RONS is likely due to an imbalance in 
calcium homeostasis 10, 125.  Calcium may directly activate calcium dependent proteases, 
such as the calpains, that stimulate protein degradation 10.  In addition, calcium overload 
can lead to the dissociation of ATP production within the mitochondria leading to 
increased superoxide levels through the ADP mechanism discussed previously 128.
Since secondary sources of RONS manifest themselves through the inflammatory 
process, Atf3 is believed to be of importance. Atf3 is an activating factor with several 
proposed functions.  However, its main functions appear to be in regard to cell cycle.  It 
appears as though this gene acts as both an apoptotic factor 137 and as a cell proliferation 
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factor 206.  It has been hypothesized that this gene is a stress response gene 206.  Atf3 is 
induced by a variety of different physiological stimuli including ischemia, reperfusion, 
wounding, and other stress signals 61.  It appears as though any time a stress is induced, 
the cell will respond with increased Atf3 levels 1, 29, 109, 148.  Therefore, it appears that At3 
levels may be an important factor in determining the extent of inflammatory injury 
present.  Further research is needed to confirm this finding.
In conclusion, RONS can be produced from both primary and secondary sources 
and lead to a variety of maladies that can ultimately lead to the production of muscle 
degradation and injury and often a loss of muscle function 130.  These systems can be 
stimulated during or following exercise depending on the type of exercise and the 
intensity of the exercise.  This stimulation is likely due to increased oxygen consumption 
with aerobic exercise, due primarily to ischemia-reperfusion and vascular factors with 
instances of repeated high intensity exercise and probably secondary sources during 
muscle damage.  Establishing the mechanism by which radicals are produced will be 
difficult.  It is likely that RONS production is due to the collective efforts of several 
pathways, simultaneously activated in response to exercise.
Markers of Aerobic Exercise Induced Oxidative Stress
Aerobic exercise has consistently shown increased markers of oxidative stress in 
both blood and muscle in numerous investigations 4, 5, 21, 51, 54.  The actual magnitude of 
the increase in the markers of RONS is dependent on several factors, including the 
exercise protocol, the measurement taken, the source of analysis, subject characteristics, 
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as well as the intensity and duration of the exercise and when the measures were 
obtained.  It appears that for significant increases in the markers of RONS to occur, the 
muscle must be sufficiently recruited (sufficient time and intensity) 49.  One difficulty in 
measuring oxidative stress after exercise is that varying degrees of activation of the 
markers of RONS can be noted.  For example the activation of glutathione from the 
reduced to the oxidized form is rapid 52. In contrast, the production of a lipid peroxidation 
end product such as MDA takes time 43.    Clearly, when one reads the oxidative stress 
literature this needs to be kept in mind.  Since most studies use an individually selected 
exercise protocol, cross study comparisons can prove problematic.
It has been well established that regular aerobic exercise is beneficial at reducing 
morbidity and mortality.  In fact, the American College of Sports Medicine has 
recommended that individuals should perform at least thirty minutes of mild intensity 
aerobic exercise on most days of the week 6.  However, it is also known that moderate to 
high intensity exercise (usually > 65% of VO2 max) will likely increase markers of 
oxidative stress 49, 50, 167.  Table 3 presents a brief summary of several findings related to 
exercise induced changes in markers of oxidative stress.
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Table 3: Sample of Reported Oxidative Stress Following Aerobic Exercise
Measure Exercise Change Reference
MDA 20 minute run at 
60% max
↑62% 4
PC 60 minute run at 
60% max
↑50% 52
8-OHdG 30 minutes cycling 
at 70% max
No change 21
8-OHdG 3 km run ↑ 21% 145
Lipid 
Hydroperoxides
45 minute run at 
75% max
↑ 30% 163
Isoprostanes 12 hour Triathlon at 
80% max
↑ 181% 140
GSSG/GSH 40 minutes cycling 
at 60% max
↑ 50% 98
It appears as though aerobic exercise can significantly increase PC generation.  A 
recent study by Alessio et al.5 reported PC increased 67% immediately after exercise with 
values returning to baseline by one hour post-exercise.  These findings have been 
supported by several authors, including Sen et al., who reported an ~85% increase in PC 
immediately after a treadmill run to exhaustion in rats 191.  Additionally, our lab has 
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reported increases in PC in both males and females at both 60% and 80% of VO2 max, 
with 80% having a greater increase in PC compared to 60% VO2 max 
54.  A common 
denominator reported in these studies was a return to baseline within one hour post-
exercise of the PC response.  The limited research in this measurement associated with 
acute aerobic exercise suggests that PC can be elevated by aerobic exercise of  > 60% of 
VO2 max. Also, PC values had returned to baseline within one hour post-exercise 
5, 52, 
191.  It is unclear if this is typical for all types of aerobic exercise.  Further research is 
needed to establish whether this increased PC content has any long term physiological 
effects.  In conclusion, it that in order to have significant changes in PC levels, one must 
exercise for at least 30 minutes at an intensity of at least 60% of max, and that this 
increase is transient and often returns to baseline within one hour post-exercise 21, 52-54.  
Clearly, diet and training status of the individual may alter these responses; however this 
does appear to be the minimum exercise prescription to consistently report PC increases.
Several investigators have reported findings dealing with lipid peroxidation 
following an acute bout of aerobic exercise. It should be noted that not all of these studies 
have determined the same marker and not all studies report increases in lipid 
peroxidation.  It should also be understood that the measurement of TBARS is 
nonspecific and caution should be used when interpreting changes in this marker. In 
addition, studies have involved both animals and humans.
In subjects who performed a treadmill run for 30 minutes at 80% VO2 max, a 33% 
increase in plasma TBARS was reported 30 minutes post-exercise 3.  Additionally, a 
maximal run to exhaustion elicited a 26% increase in plasma MDA compared to baseline 
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113. Kanter reported increases in serum MDA when the subjects ran for 35 min at 60-90% 
VO2 max 
92.  Subjects that ran at 75% of their HR max for 45 minutes also demonstrated 
increases in serum MDA 122.  In contrast, low intensity exercise has typically not
demonstrated increases in MDA in human 44, 113.
Some investigators have measured markers of lipid peroxidation in skeletal 
muscle. Most of these studies have utilized rats.  In the hind limb muscles of rats run to 
exhaustion, TBARS content was increased up to 30%, dependent on the tissue analyzed 
191.  Swimming increased MDA almost 100% in rat skeletal muscle 169, however, it 
should be noted that rat swimming may not be a good exercise model for humans, as rats 
don’t swim in a typical fashion.  When rats swim, they tend to bounce back and forth 
from the bottom to the top to keep their head above water.  Alessio et al. 4 reported that 
MDA content in rat hind limb muscles increased to moderate intensity exercise for 20 
minutes. The increase was modest and depended on the type of muscle. In a follow up 
study these authors reported that higher intensity exercise could increase MDA within 
muscle to a greater extent 2. Li and coworkers also reported increased MDA in rats to 
moderate intensity running for 20 minutes 86. Recently You et al. reported that 90 
minutes of downhill running increased MDA 2 hours after the exercise in specific 
muscles of the rat hind limb 227.
These studies support the fact that exercise can significantly increase markers of 
lipid peroxidation following an acute bout of aerobic exercise of sufficient intensity and 
duration.  The literature repeatedly has reported increases in markers of lipid peroxidation 
following as few as 20 minutes of exercise at a moderate intensity (at least 60% of max).  
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Again, these values typically returned to baseline within one hour (if this was measured).  
It is unclear if these increases in lipid peroxidation markers lead to a physiological 
response and this warrants further investigation.
Several published studies refute the aforementioned studies and have reported no 
changes in markers of lipid peroxidation after exercise.  It was reported that 45 minutes 
of treadmill running at 75% of age predicted max heart rate did not alter plasma MDA
content post-exercise 179.  In agreement with this study, two other studies have shown no 
changes in plasma MDA following one hour of step aerobics 124, or changes in TBARS 
following voluntary wheel running in rodents 188.
While many published studies do show increases in markers of lipid peroxidation 
following acute aerobic exercise, some studies have reported no changes.  The 
differences in the results to lipid peroxidation are probably due to several factors that 
include: subject status, assay utilized, and differences in intensity and duration of 
exercise.  Further studies are needed to establish at what minimum intensity and duration 
these markers will become elevated.  As previously mentioned, some studies report 
significant alterations in lipid peroxidation following as few as 20 minutes of exercise at 
intensities as low as 60% of VO2 max.  Diet, training status, and marker measured likely 
account for differences seen in this measure.  Similar to PC, these alterations appear to 
return to baseline within an hour.
Similar to lipid peroxidation research, the results of studies measuring DNA 
oxidation are mixed.  One major discrepancy is that some studies have measured 8-
OHdG in blood, while others have measured it in urine. In addition, some studies have 
33
measured DNA strand breaks using the comet assay.   This assay uses whole blood or 
isolated lymphocytes and examines the dispersion of DNA in agarose.  The migration 
appears as the shape of a comet.  The amount of DNA migration indicates the amount of 
DNA breakage in the cell. Using the comet assay several exercise studies have reported 
increases in DNA damage in human leukocytes 193. These studies have used incremental 
treadmill runs to exhaustion and half-marathons and triathlons as the exercise stimulus.  
In all these studies humans were the subjects and the increase in the DNA damage was 
detected several hours after the exercise.  For the triathlon study the peak increase was 72 
hours after the competition.  Another method is fluorometric analysis of DNA unwinding 
(FADU).  Sen and coworkers reported that a single bout of 30 minutes of exercise 
induced DNA strand breaks in leukocytes 194.  In contrast to the above assays, 8-OHdG as 
the marker has shown mostly negative results. No alterations in human lymphocytes was 
noted in 10 trained runners after an 8 day training camp 145 and decreases were reported 
in dogs run on a treadmill for 7 hours in lymphocytes 146.  It was noted that lymphocyte 
levels increased in response to the exercise and this might have led to the decrease.   
Following a 30 kilometer run, urinary 8-OHdG was increased 21% above baseline 145.  In 
agreement with the previous study, DNA oxidation was 33% higher post- exercise in men 
exercising approximately 10 hours per day 156.  Radak et al., reported increases in 8-
OHdG of approximately 30% following runs of either 56, 59, 93, or 120 kilometers 166. 
Several studies have not shown any changes in 8-OHdG in urine to multiple days of 
cycling, and distance running 193.  One should use caution when interpreting results of 
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urine changes in regards to DNA damage as it may only represent a small fraction of 
actual DNA damage 21.
In contrast to these extreme aerobic bout studies, several shorter duration studies 
have shown no alterations in 8-OHdG.  Two studies published by the same researchers 
reported no increases in 8-OHdG following either an incremental treadmill test or a20 
kilometer run 203, 204.  Our laboratory has also reported no changes in serum 8-OHdG 
following 30 minutes of cycling at 75% VO2 max
21 or 30 minutes of running at 75-80% 
VO2 max in either men and women 
19.
In conclusion, it appears that to consistently induce increases in DNA oxidation, 
exercise must be of a sufficient duration (a very long duration for 8-OHdG). Also, studies 
need to be completed linking the amount of 8-OHdG in the blood, muscle tissue and 
urine in order to properly evaluate these results. Leukocyte DNA damage in the blood 
may not reflect what damage if any is occurring within the muscle. It does appear that if 
one is using a sensitive measure of DNA oxidation (e.g. FADU, comet), as little as 30 
minutes of exercise at a moderate intensity may increase markers of DNA oxidation.  
However, the only studies to consistently show increases in DNA oxidation have been 
extremely long durations (marathons and longer).  No real time course for these 
measurements has been established.
Glutathione status has also been used as a marker of oxidative stress following 
aerobic exercise.  It appears as though alterations in glutathione status are directly related 
to the intensity of the exercise session 190.  Laakonsonen et al. reported an increase in 
GSSG by 50%, while also reporting a decrease in GSH by 13% following 40 minutes of 
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cycling at 60% of VO2 max 
98.  Similar results have been reported following 90 minutes 
of cycling at 65% of VO2 max 
218.  Both of the aforementioned studies showed immediate 
alterations in glutathione levels, with levels returning to baseline within 30 minutes post-
exercise.  Published studies have also reported no changes in glutathione status.  There 
were no reported changes in GSH or GSSG following 35 minutes of running at 60% of 
VO2 max 
27.  Also, it has been reported that trained subjects had no alterations in blood 
glutathione levels following a triathlon 120.  Clearly, these studies used different subjects, 
at different intensities, and different durations, which could explain the discrepancies 
seen in the data.
As seen with many other measures, glutathione exhibits mixed results as well.  It 
does appear that as little as 30 minutes of exercise at a moderate intensity (60% max) 
may alter this marker.  These changes appear to diminish as one approached 30 minutes 
post-exercise.  Again, diet and training status of the individual can alter these results.
Taking all measures into account, it does appear as though exercise will increase 
some markers of oxidative stress following exercise if the bout is of sufficient intensity 
and duration.  At present time, sufficient intensity and duration has not been defined and 
it likely to vary depending on the marker measured.  Differences in the literature can 
likely be attributed to different training regiments, diet, as well as different types of 
subjects.  Additionally, no study has ever measured every marker of oxidative stress.  The 
possibility that some measures may show no change, while other measures are altered, 
clearly exists.  However, most studies do seem to show increases in markers of oxidative 
stress in at least one measurement at one time point following aerobic exercise.
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Markers of Aerobic Exercise Induced Oxidative Stress Protection
The aim of this project is to study both the prooxidant response and the 
antioxidant response to a single bout of aerobic exercise.   Many studies have shown that 
exercise, while increasing oxidative stress, also increases the ability of the body to
subsequently combat these stresses 85, 160, 212.  If exercise is of sufficient intensity and 
duration, many positive changes in the levels of endogenous antioxidants are observed.
This is likely related to the exercise bout producing a sufficient amount of RONS.  It is 
believed that the amount of protection is directly related to the amount of RONS incurred 
stress 167 during the bout.  The more one undertakes aerobic exercise, the more protected 
the systems appear to be from subsequent RONS associated damage 85, 87, 160.  This could 
be due to either decreasing RONS production, or increasing enzymatic protection.  
Research seems to support the contention that aerobic exercise will induce an increase in 
SOD, GPx, and GSH, with mixed results in reporting alterations in CAT activity 160.  
This has been documented in changes in the blood, muscle, and some measurements in 
mRNA levels 38, 84, 85, 157, 160.  Also, some investigators have not measured the source of 
protection, yet have focused on reporting decreased markers of RONS damage in 
response to endurance training 85, 103, 158, 160, 165, 177.
Before viewing changes in actual antioxidants, a review of selected publications 
showing antioxidant protection following exercise is warranted.  These studies are often 
difficult to compare due to the differences in training intensities, durations, and exercise 
protocols.  This list is not meant to be exhaustive, only to highlight several key studies 
showing protection.  In elderly men run for 30 minutes, three times a week, for three 
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months.  They reported that plasma MDA had decreased by 9% at rest and by 16% post-
exercise, compared to controls 47.  In agreement with this, teenage soccer players who 
underwent normal sport training, had lower baseline and post-exercise blood MDA than 
age matched controls 132.  Radak et al. reported that  regular exercise training decreased 
PC levels post- exercise by 25% in rat muscle 167.  This same group also reported that
swim trained rats (nine weeks 60 minutes/day, five times/week) showed a decrease in 
both PC and 8-OHdG compared to age matched controls post-exercise 165.  Also, rats 
undergoing ischemia-reperfusion injury in the myocardium following a single session of 
aerobic exercise had significantly less I-R associated damage than untrained rats 161.  This 
study suggested that protection may be elevated with as little as one bout of exercise.
In conclusion, it appears as though regular aerobic exercise can decrease PC 
levels, lipid peroxidation measures and may decrease 8-OHdG levels as well.  Again, this 
measurement is dependent on the tissue involved and the time of measurement, as well as 
the training regimen and type of subject used.
It is generally believed that aerobic exercise training will result in an up-
regulation of SOD, GPx, and GSH, with little or no change in CAT (see Tables 4-6).  
This appears to be tissue and intensity specific.  For example, a recent study examining 
GPx levels following 10 weeks of treadmill training found increases in both GPx activity, 
as well as GPx mRNA, with no changes in CAT 222.  A similar study by Gore et al. 
reported increases in SOD activity and mRNA levels, with no changes in SOD protein 
levels following 10 weeks of treadmill training in the heart and some selected skeletal 
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muscles 55. This raises the possibility that some alterations are transcriptional in nature, 
while others may be translational or posttranslational.
Glutathione status may also be altered.  Aerobic training reportedly will increase 
resting GSH levels 190.  This increase in GSH may help lower oxidative stress associated 
measures, as it was reported that trained subjects had higher GSH at rest and this was 
correlated to lower lipid peroxidation levels post-exercise 98.  This suggests that subjects 
with elevated GSH at rest due to prior aerobic exercise bouts may be less prone to 
experience exercise induced oxidative stress.
The following three tables highlight much of the research in regards to activity of 
SOD (Table 4), GPx (Table 5), and CAT (Table 6) in response to training. Generally 
there is an increase in SOD and GPx activity in response to acute exercise in humans 160
and these findings have been observed in blood 143 as well as muscle 147.  These results 
have also been shown in rats, but are more mixed, likely because the type of muscle 
examined and the type of exercises used to induce the change were not standardized. In 
fact, studies have shown an increase in SOD activity following one acute aerobic exercise 
bout 101, as well as increases in SOD mRNA following a single aerobic bout 73, 74.  GPx 
activity has also been shown to be increased following a single aerobic exercise bout 89, 
102.  CAT results are inconclusive, as researchers have published findings showing 
increases 60, decreases 207, and no alterations 87.
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Table 4: Training Induced Alterations in SOD Activity
Training Muscle SOD Activity Reference
10 wk treadmill Vastus Lateralis Increase 103
12 wk treadmill Soleus Increase 38
10 wk treadmill Soleus Increase 158
18 wk treadmill Vastus Lateralis No Change 2
Adapted from Powers et al. 160, all the above results were in rats.
Table 5: Training Induced Alterations in GPx Activity
Training Muscle Activity Reference
5 wk treadmill Gastroc Increase 192
12 wk treadmill Soleus Increase 38
10 wk treadmill Soleus Increase 157
12 wk treadmill Soleus Increase 100
Adapted from Powers et al. 160, all the above results were in rats.
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Table 6: Training Induced Alterations in CAT Activity
Training Muscle Activity Reference
10 wk treadmill Soleus No Change 157
18 wk treadmill Vastus Lateralis Decrease 4
10 wk treadmill Soleus Decrease 103
8 wk treadmill Gastroc Increase 154
Adapted from Powers et al. 160, all the above results were in rats.
In summary, aerobic exercise, while increasing oxidative stress levels, can also 
increase protection from oxidative stress by either activating the antioxidant enzymes or 
possibly upregulating the concentration of some of these enzymes.  For any adaptation to 
occur, the muscle must be recruited at a sufficient intensity and duration.  Again, 
comparing studies often proves difficult since authors use different subjects, exercise 
protocols and measurements. It is unclear what the signals for the induction of these 
changes are within the muscle. Several redox signals have been suggested to activate
nuclear material (e.g. NFkappaB, JNK, etc.)  It is not known how acute exercise up-
regulates the antioxidant protection that lower s markers of oxidative stress and increases 
in the antioxidant enzymes.
RONS and Cell Signaling
RONS have been implicated in apoptosis 170, necrosis 9, aging 161, and other 
normal cellular functions 57.  RONS have been linked to several diseases as well.  
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Although nobody has directly been able to prove that RONS can cause a disease, the fact 
that several diseases have shown increased RONS levels does warrant further 
investigation into this topic.  For some diseases linked to RONS in humans, see Table 7.
Table 7: Sample of Diseases and Processes Linked to RONS
Disease Reference
Aging 161
Cancer 214
Diabetes 219
Arthritis 69
Coronary Artery Disease 32
Alzheimer’s Disease 186
Muscular Dystrophy 46
Chronic Obstructive Pulmonary Disease 56
Clearly, RONS can exert effects on cells through very complex signaling 
pathways.  The exact intracellular signals controlling the reduction/oxidation (redox) 
status of the cell following exercise has not been fully elucidated. Also, many 
transcription factors are altered in response to exercise 23, 68, 155. The transcription factor 
NFkappaB (NFκB), is an important factor in regulating the stress response.  Oxidative 
stress conditions activate NFκB 107.  This signal is important in the cell cycle as it 
42
modulates cell survival and appears to be a central transcription factor. Several other 
transcription factors including tumor necrosis factors (TNF-α, TNF-β), MEKK1 and 
MEKK3 all seem to play a role in activating NFκB 107.  C-Jun-terminal kinases (JNK) 
were reported to be activated during exercise 22.  It was purported that JNK can directly 
oppose NFκB 233.  Since JNK activation can lead to apoptosis 153, the balance between 
JNK and NFκB activity appears important for cell viability in response to oxidative 
stress. This is just a small sample of the numerous transcription factors that may be 
activated after an acute exercise bout.  Identifying the transcription factors that are 
activated/inhibited, along with how these potentially interact with each other is of great 
importance for developing interventive strategies to prevent oxidative damage.  
The role of NFκB and JNK were recently examined, and it was concluded that the 
two appear to be antagonists of each other 233.  Several studies have shown several areas 
of cross talk between NFκB and JNK that includes IL-1-RAK, MAP, ERKKK, and 
protein kinase C.  In addition, it appears as though NFκB activated TNF-α was necessary 
for JNK activation 233.  This study suggests that NFκB may also indirectly activate JNK. 
In contrast, the antagonistic role of JNK on NFκB is under investigation.  It has recently 
been shown that prolonged NFκB inhibition can lead to increased JNK activation 31, 
leading to increased apoptosis.   Specifically, it is believed that RONS production leads to 
an imbalance in the cross talk between NFκB and JNK.  It has been hypothesized that 
RONS may actually oxidize activated NFκB 133, thus leading to increased JNK 
expression.  This has been confirmed in recent studies in which prolonged hydrogen 
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peroxide exposure lead to prolonged JNK activation 30, 180.  The mechanism for how 
RONS alter JNK is currently under investigation.  
Antioxidant enzyme activity (concentration) has also been implicated in cell 
signaling. SOD levels were unchanged by NFκB inhibition 30, but GPx levels were 
decreased following NFκB inhibition 180. It is unclear if the increases in SOD with 
endurance training are a result of changes in cell signaling through either NFκB or 
through JNK or some other factors. If NFκB inhibition resulted in an increase 
concentration of GPx it is likely that JNK and other cell signaling factors are also 
involved.  
It has been well documented that NFκB inhibition increases apoptosis 233, 
however, the apoptotic activity of JNK is not well understood, as JNK can activate both 
apoptotic and antiapoptotic pathways.  These authors have suggested that further research 
is needed in order to determine the exact role of the signals 233. 
There are many factors which may alter NFκB or apoptosis as well.  It has been 
reported that inhibitor protein kinase beta (IKβ) must be present in adequate amounts, and 
phosphorylated by an IKK complex in order for NFκB to become activated and elicit its 
response 71.  The factor pBAD (Bcl-2/Bcl-XL-antagonist, causing cell death), when 
activated by calcium, can translocate from the cytosol to the mitochondria and cause 
cytochrome c release, thereby increasing RONS levels, eventually leading to cell death 
197.  This is not meant to be all inclusive, as there are several factors not mentioned that 
have the ability to alter NFκB or apoptosis not mentioned (i.e. p50, p65)
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As previously mentioned, NFκB plays a major role in the stress response to many 
events, such as exercise 107.  The role NFκB has in cell survival especially in relation to 
exercise has not been elucidated.  It has been established that NFκB can oppose apoptosis 
in most situations; however, several stimuli that activate NFκB also can lead to apoptosis.  
This is apparent with TNF activation.  TNF has repeatedly been shown to up-regulate
apoptosis, and activate NFκB.  However, the activation of NFκB leads to the activation of 
the antiapoptotic gene products such as TRAF1, TRAF2, and FLIP 107.  While NFκB may 
seem like it protects the cell, the over expression of NFκB , through the cell cycle 
progression regulators c-myc and cyclinD1 has been associated with cell proliferation 
and tumor progression 171.  Researchers have concluded that the balance between cell 
survival and cell death likely is dependent on NFκB working on several cell signaling 
factors 107.  
A recent study examining the relationship between cell signaling and exercise was 
completed by Boluyt et al. 22.  The investigators were specifically concerned with JNK 
protein activation in the heart by exercise.  Untrained rats were assigned to different 
exercise groups; low, medium, and high intensity, as well as a long duration group.  
Additionally, one group also underwent 6 weeks of aerobic exercise training.  In the 
untrained rats, the higher the intensity, the greater the JNK response, with the high 
intensity group showing an increase of 250% over untrained controls.  Chronic training 
down-regulated the JNK response as trained animals showed no differences above 
baseline in JNK activation.  JNK is activated in response to cellular stress events.  When 
JNK is activated, it leads to the activation of the following DNA binding proteins: c-Jun, 
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JunB, JunD, ATF2, and Elk1 202.  Contractile activity has also been shown to increase 
JNK levels 11, 24.  These authors believed that JNK was somewhat responsible for the 
protection seen after exercise as it has the ability to activate DNA by several different 
mechanisms 22.  It was hypothesized that JNK activation phosphorylates heat shock factor 
1, which activates various heat shock proteins 149.  However, JNK activation is a 
necessary step in mitochondrial apoptosis 22.  Further research is clearly needed to 
distinguish the extent to which JNK activation plays in both cell protection and cell 
death.
Another study showing the apoptotic effects of JNK was completed by Peng et al. 
153.  Parkinson’s disease has recently been characterized by high levels of JNK and 
phosphorylated c-Jun.  It appears as though prolonged activation of the JNK/c-Jun 
pathway results in apoptosis both in vivo and in vitro 153.  An interesting finding from this 
study was that antioxidants (using a specific manganese antioxidant) could lower JNK 
activation by 66% 153.  The authors noted that JNK was activated in response to stress. It 
is unclear which pathways are up-regulated and how these cell signaling pathways 
interact to result in better protection against stress.  
Nuclear Factor Kappa Beta and Aerobic Exercise
Several studies have identified alterations in NFκB protein levels.  Some of these 
studies have actually used exercise as a model to induce these changes, while others have 
simulated exercise through ischemia/reperfusion (I-R) or heat induction.  This review is 
not meant to be all inclusive, but to only highlight some published literature.
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It has been previously established that during the exercise response, the 
inflammatory process is activated.  Viedt et al. reported that NF κB activity increased 
125% when inflammatory processes are activated 217 as would be seen during exercise.  
Other experiments have used heating to induce NFκB.  It was reported that rats exposed 
to 41°C for 30 minutes not only demonstrated significantly altered muscular MDA 
content (by 200%) and GSH/GSSG ratio (by 50%),  but had almost a three fold increase 
in NFκB activity one hour post-heat exposure 231.
As previously mentioned, I-R is commonly used as a model in experiments which 
simulates exercise as well.  It has been reported that 90 minutes of I-R exposure will 
significantly increase NFκB protein activity levels by one hour post-exercise.  This same 
study also reported that levels had returned to baseline within 4 hours post I-R 224.  
Another group reported NFκB alterations following I-R injury.  Sung et al. reported that 
60 minutes of ischemia significantly elevated NFκB activity by 100% above baseline.  
Further, the activity remained elevated above baseline during reperfusion through one 
hour (increase of 150%), with the greatest increase seen 15 minutes into reperfusion 205.  
No measurements were made between one hour and two hours of reperfusion.
Some investigators have used exercise as their stress model to induce NFκB 
alterations.  Radak et al. reported that aerobic exercise not only significantly altered the 
GSH/GSSG ratio, but also significantly elevated NFκB levels and activity.  This study 
also reported that younger animals (18 month old) had significantly lower levels of NFκB 
compared to that that of aged rats matched for time and percent of maximal effort 164.  Ji 
et al. reported alterations in both NFκB activity and levels following a one hour run at 25 
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m/min at 5% grade in 4 month old rats (this corresponds to about 75% of max).  This 
group reported increase of 60% in NFκB activity and 250% in NFκB levels immediately 
post-exercise, suggesting a link between NFκB and oxidative stress 88.  In addition, this 
group has previously shown increase in NFκB binding to its DNA binding domain on the 
MnSOD gene 74.  Taken together, the authors speculate that this likely means that since 
MnSOD is a known antioxidant gene activated by RONS from a contracting muscle, that 
NFκB signaling is therefore directly related in the signal transduction process to increase 
antioxidant genes following exercise 88.  Finally, a recent study published by Atherton et 
al. studied whether a fiber type difference in NFκB levels existed. These researchers 
noted that NFκB levels were 300% higher in the type I soleus muscle over the type IIx 
and IIb extensor digitorum longus (EDL).  These authors concluded that type I fibers 
were more dependent on NFκB signaling in their signal transduction and alterations seen 
in this fiber type are more likely to involve NFκB dependent pathways 13.
In conclusion, clearly NFκB plays a major role in the response to various stresses.  
Exercise is a stress model, and many other models that have been used simulate stress 
contain an aspect which would occur during exercise (e.g. I-R during contraction, heat).  
Repeatedly, these stress models report increases in both NFκB levels and activity.
Conclusions
In conclusion, exercise can increase oxidative stress if the session is of sufficient 
intensity and duration. This exercise session also has the ability to increase protection 
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from oxidative stress.  It is unclear how this increase in production of RONS will 
influence the cells viability. There are many cell signaling processes that appear to be 
influenced by exercise. It is unclear how these cell signaling pathways act to activate 
certain genes or inhibit other genes. There is a need to determine the genetic factors that 
are activated and inhibited by exercise induced oxidative stress.  By understanding the 
signals affected, better therapies and treatments can be devised to help protect cells 
against oxidative stress.
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CHAPTER III
METHODS AND PROCEDURES
This chapter presents the methods and materials utilized for the completion of this 
dissertation.  It is organized into the following sections: Subjects, Experimental design 
and protocol, Genetic analysis, and Protein analysis.
Subjects
Sixteen 10 week old Sprague-Dawley female rats from the same litter (obtained 
from Charles River Laboratories, Wilmington, MA) were used in this experiment.  Rats 
from the same litter (from the same F1) were used in order to limit genetic variation 
between the animals at baseline.  All animals were individually housed and were fed and 
given water ad libitum in the animal facility in the Stone Building.  Additionally, rats 
were housed for 2 weeks prior to any intervention in order to eliminate the stress 
response of transport and a new housing environment.  All rats were handled daily and 
put on the rat treadmill daily for 10 min and run at a very mild intensity (10 m/min) in 
order to limit their apprehension due to these stresses.  This intensity of running was 
reported to have no training adaptations in oxidative capacity (unpublished observations).  
Rat cages were cleaned daily, and rat chow was replaced daily up until 12 hours prior to 
the experiment at which time the rats began fasting. The animals were housed (one per 
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cage) in a standard plastic cage using a 12:12 hour reverse light cycle in a temperature 
(21 + 1 ºC) and humidity (30-40%) controlled room. 
Experimental Design and Protocol
The exact protocol used was approved by the UNCG institutional animal care and 
use committee (IACUC).  On day 15, after 2 weeks of housing, rats were randomly 
assigned to an exercise (E) group (n=8), or a control (C) group (n=8).  The E group was
fasted for 12 hours and then ran on the motorized treadmill for 2 hours.  The 2 hour 
duration was selected based on work by Hildebrandt et al. who reported that 
transcriptional activation following exercise is intensity and duration dependent 68.  The 2 
hour run at 22 m/min was of sufficient intensity and duration according to these authors 
who reported many adaptations at times ranging from 45 minutes to 3 hours.  The 
treadmill contained a slight electrical shock at the rear of the treadmill for motivation 
which was only used if the animal stopped running.  All exercised animals were able to 
complete the 2 hour run.  Mild electrical shock at the back of the treadmill is commonly
used to induce or stimulate the rat to run.  The shock was calibrated to insure it was in the 
appropriate range for stimulating but not too intense.  During the treadmill run the rats 
may have had electrical shock (3.9 volts and 0-2 mA in a pulse manner) applied to their 
tails to stimulate them to run. The rats only got a shock if their tails came in contact with 
the grid in the back of the treadmill.  Typically, the rats learned to stay away from the 
grid.  The purpose of having the rats familiarized with the treadmill and running 2 times 
per week was to minimize contact with the electrical shock.  The rats ran at 22 m/min at
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0% grade, which is considered a mild exercise intensity that was been shown to increase 
protein carbonyls in blood and decrease reduced glutathione and increase oxidized 
glutathione from rats exercised in our lab 227.  
The one hour post-exercise time point was chosen as a result of personal 
communications with investigators who have recently completed similar experiments as 
well as previously published exercise data that found changes in gene expression at this 
time point 23, 41, 94, 155.  Rats were sacrificed by decapitation one hour post-exercise for the 
E group, and at a matched time for rats in the C group. Decapitation was used as previous 
experiments have shown that anesthesia can significantly alter the gene expression profile 
of a rat 17.  Upon sacrifice, the soleus muscles from both legs was rapidly removed from 
each animal and were placed in RNALater (Sigma-Aldrich R0901) and immediately 
frozen in liquid nitrogen between cooled aluminum blocks and stored at - 80ºC until 
assayed.  The soleus muscle was chosen because it primarily contains slow twitch muscle 
fibers and therefore will be sufficiently recruited during the run 102.
The experimental design is shown in Figure 2.
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Figure 2: Experimental Protocol
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RNA Isolation
RNA was isolated from the soleus muscles using a modified Chomczynski 
technique 36 by using the RNA Isolation Kit from Fluka (#83913 Sigma-Aldrich, St. 
Louis, MO).  All instructions were followed using a standard of 10mgof wet weight per 
soleus muscle (most muscles weighed ~10mg) and all solutions were supplied in the kit.
Fresh soleus muscles that had been clamped in precooled aluminum blocks were weighed 
and the muscle placed into solution D (solution D was made by mixing 10µl of β-
mercaptoethanol with 1.4 ml of denaturing solution). The soleus muscle was then
homogenized in Trizol using a Virtus Polytron homogenizer (Gardiner, NY).  
Approximately 10 mg of soleus muscle was used from each animal.  Once homogenized, 
samples were quickly frozen in liquid nitrogen and stored at -80°C until assayed.  
Samples were thawed and 100µl of 2M sodium acetate (pH 4.0) was added and 
the sample was mixed by inversion. Next, 1ml of phenol saturated with water was added 
and the sample was again, mixed by inversion.  200µl of chloroform:isoamylalcohol 
mixture (49:1) was then added and the sample was shaken vigorously for 10 seconds 
before being placed on ice for 15 minutes.  At this point all samples were centrifuged at 
10,000 g for 20 minutes at 4°C. The top aqueous layer was then transferred into a new 
tube as RNA is found in the upper aqueous phase.  In contrast, DNA and proteins are left 
in the interphase and phenol phase respectively. Roughly 1ml of isopropanol (equal 
volume to the aqueous layer) was added and the samples were well mixed.  The samples 
were then stored at -20°C for 60 minutes in order to precipitate the RNA.  These samples 
were again centrifuged at 10,000 g at 4°C for 20 minutes to recover the precipitated 
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RNA.  The supernatant was removed and the pellet was saved.  The pellet was then 
resuspended in 300µl of solution D and mildly mixed using a pipette.  300 µl of 
isopropanol was then added and the samples were mixed and placed at -20°C for 60 
minutes.  The samples were then centrifuged at 10,000g for 10 minutes at 4°C.  The 
supernatants were removed and 300µl of pre- cooled 75% ethanol was  added and mixed.
The samples were then sedimented by centrifugation at 10,000g and 4°C for 15 minutes.  
The samples were then centrifuged for 45 minutes at room temperature in a vacuumed 
centrifuge until the RNA pellet was dried.  RNAse free water (50µL) was added and the 
samples were incubated at 65°C for 10 minutes to resuspend the RNA.  At this point, 
approximately 45 µl of the RNA from each sample was frozen at -80 °C for further 
analysis, and 5 µl was used for the subsequent quality analysis. 
The concentration of nucleic acids to amino acids was measured in OD buffer by 
an optical density ratio (A260/A280) via an Eppendorf Biophotometer (Eppendorpf-
Brinkman; Westbury, NY). A ratio of 1.8 or better is acceptable for this ratio.  All 
samples were checked for RNA quality using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA).  This machine is now being used in place of running the 
samples on agarose gels 59, 77, 110, 187. A sample with 2 clear spikes at 28S an 18S on the 
Bioanalyzer readout is considered pure.  Briefly, this machine takes RNA samples (5 ng 
of total RNA) loaded on a chip (Agilent catalog #5067-1511) and over the course of 30 
minutes, electrophoretically separates the loaded components.  The machine then takes 
the fluorescence and translates them into gel like bands and electropherograms (peaks, 
see Figure 3).
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Figure 3: Sample Readout from Bioanalyzer
Statistical Analysis for RNA Concentration
Group means were analyzed using an independent T-test.  Significance was set a 
priori at p<0.05.
Microarray Analysis
For aminoallyl labeling, 10 µg of DNase I-treated and purified total RNA was 
combined with 2 µl of random DNA hexamers and RNase- free water for a final volume 
of 17µl.  The samples were then mixed well and incubated at 70oC for 10 minutes, and 
then at 4oC for 5 minutes.  13 µl of Master Mix (5x Buffer, 0.1M DTT, 20x dUTP, and 
18S
28S
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Superscript II RT transcriptase) was then added to each sample and each sample was then 
mixed and incubated at 42oC for 2 hours. To hydrolyze the RNA present, 1µl of RNase 
was added to each sample and each sample was incubated for 30 minutes at room 
temperature.
For reaction purification (removal of unincorporated aa-dUTP and free amines), 
the Qiagen QIAquick PCR purification kit was used (catalog # 28104) per manufacturers 
instructions. Each sample was mixed with 150 µl buffer PB and transferred to a 
QIAquick column.  The column was placed in a 2 ml collection tube (Qiagen supplied) 
and centrifuged at ~13,000 rpm for 1 minute. The column was then washed with 750 µl
of phosphate wash buffer and centrifuged at ~13,000 rpm for 1 minute. The collection 
tube was emptied and rewashed and recentrifuged.  The column was then transferred to a 
new 1.5 ml microcentrifuge tube marked with the appropriate dye color and 30 µl 
phosphate elution buffer was added to the center of the column membrane. This was then 
incubated for 10 minutes at room temperature.  The samples were then centrifuged at 
~13,000 rpm for 1 minute.  The samples were then dyed a second time by repeating the 
last 2 steps for a final volume of 60 µl and 1.5 µl from each sample was checked for 
purity using a spectrophotometer.  The sample was then dried in a speed vacuum 
centrifuge.
To couple the aa-cDNA to the Cy Dye Ester, the aminoallyl-labeled cDNA was 
resuspended in 5 µl 0.1 M sodium carbonate buffer (Na2CO3, pH 9.0) and 5 µl of the 
appropriate NHS-ester Cy dye was added (Cy3- or Cy5- ). Each sample was then 
incubated for 1 hour in the dark at room temperature. Each sample then had 5 µl of 4 M
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hydroxylamine added and each sample was then incubated for 15 minutes in the dark at 
room temperature.
For the second reaction purification (removal of uncoupled dye), 35 µL of 100
mM NaOAc (pH 5.2), and 250 µl (5X reaction volume) of Buffer PB was added to each 
reaction tube. A QIAquick spin column was placed in a 2 ml collection tube and the 
sample was applied to the column, and centrifuged at ~13,000 for 1 minute. The 
collection tube was then emptied and washed using 0.75 ml of Buffer PE to the column 
and centrifuging at ~13,000 for 1 minute.  The column was then placed in a clean 1.5 ml
microcentrifuge tube and 30 µl of Buffer EB was added to the center of the column 
membrane.  The column was then incubated for 10 minutes at room temperature. The 
column was centrifuged at ~13,000 rpm for 1 minute.  The last 2 steps were repeated 
twice until a final volume of ~60 µl was present. From each sample, 1.5 µl was checked 
for purity using with a spectrophotometer.  The sample was then dried in a speed vacuum 
centrifuge.
For hybridization, the pellet was resuspended in 190µl nuclease-free water, and 
then heated for 3 min at 98oC, and then cooled to room temperature.  The cDNA target 
hybridization solution was prepared with 215µl of cDNA, 35µl of 10x control targets and 
250µl of 2x hybridization buffer for a total volume per array of 450 µl (rat microarrays 
catalog # G4130A from Agilent in Palo Alto, California).  The samples were then mixed 
by pipetting and by mildly spinning.  The array slide was placed into the hybridization 
mix with the numeric barcode side up and hybridized at 60oC for 17 hours.  All slides 
were then washed with wash solution 1 for 10 minutes at room temperature, and then 
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finally washed in wash solution 2 for 5 minutes at 4°C.  All slides were then dried and 
analyzed using an Axon GenePix Pro 5.1 scanner (Union City, CA) with computer 
support for comparative and clustering analyses involving this array output.
Statistical Analysis for Microarray
Early experiments set the bar for significance in microarray data as any gene 
which had a 1.5 fold increase or decrease as being considered significant 14, 66, 182, 183.  
This criterion was used for this study.  In addition, to verify the results of the microarray, 
real time polymerase chain reactions (Q-PCR) was performed on 4 genes. For the arrays, 
the samples were split in half, as samples E1-E4 were run against C1-C4 on arrays 1 and 
2.  Samples E5-E8 were run against C5-C8 on arrays 3 and 4.  In order to make sure dye 
incorporation was not a factor is these experiments, dye swapping was performed.  On 
array 1 and array 3, the exercised soleus muscles were incorporated with Cy3- dye, and 
on array 2 and array 4, exercised soleus muscles were incorporated with Cy5- dye.  In 
order for a gene to be classified as significantly different between the 2 groups, the gene 
dye intensity had to be at least 1.5 fold different on all 4 arrays.
Real Time PCR
Q-PCR was used to validate the microarray because it allows for cycle by cycle 
comparisons of RNA levels.  Before this analysis could be completed, the RNA had to be 
converted to cDNA using reverse transcription (RT).  This was performed using the 
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purified RNA isolated from the soleus muscle of each animal.  The Qiagen Omniscript 
Reverse Transcription Kit (#205111, Valencia, CA) was used for this step based on the
kit instructions.  Briefly, 1µg of total RNA was added to RNase free water (#95284
Sigma Aldrich, St. Louis, MO) for a total volume of 6.5µl.  A total of 3.5µl of Master 
Mix (using supplied chemicals) was added to each sample.  The Master Mix contained 
1µl of 10x buffer, 1µl of 5mM DNTs, 1µl of 10 µM gene specific reverse primer, and 
0.5µl of reverse transcriptase.  All samples were then loaded into a PTC-100 
Thermocycler (#PTC-1196 Bio-Rad, Waltham, MA) for 60 minutes at 37° C.
For the PCR step, Taqman probe analysis was used.  Using a specific probe for 
the gene to be tested helps ensure that the signal intensity reported is from the gene in
question.  It helps to eliminate non-specific binding.  All samples were loaded onto an 
ABI 96 well plate (#436767, Foster City, CA) and the procedure followed the
manufacturer’s instructions.  Each well contained the following: 5µl of cDNA, 25µl of 
PCR master mix (10x buffer, MgCl2, dNTPs, Taq enzyme),   5µl of forward primer, 5µl
of reverse primer, 5µl of gene specific probe, and 5µl of RNase free water.  For exact 
primer and probe sequences, please see Table 8.  All primers were of known sequence 139.
All samples were run using the following conditions: 1) 95°C for 10 minutes 2)  95 °C for 
15 seconds 3) 60° for 1 minute 4) repeat steps 2 and 3 for 40 cycles.  The polymerase 
chain reaction serves to copy DNA. 
When the Taqman cleaves the probe as more double stranded DNA is formed, it
liberates the quenching molecule thus increasing the intensity of the fluorescent emission
increases. As more double strands are produced, the signal will increase.   This allow ed
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direct comparisons between the exercised and the control samples at any cycle.  All of 
these reactions took place in an ABI 7900 HT Fast Real Time PCR System (#4351405, 
Foster City, CA). 
 
Table 8: Primers and Probes used for Real Time PCR Analysis
Gene Genebank# Primer Probe
NFκB NM_199267 F-GTCTCAAACCAAACAGCCTCAC CCCCAAGCCAGCACCCCAGCCCTAT
R-CAGTGTCTTCCTCGACATGGAT
TNFα NM_012675 F-GTTTCAGTTCTCAGGGTCCTA AAAGGGATGAGAAGTTCCCAAATGG
R-CAGGATTCTGTGGCAATCTGG
Atf-3 NM_012912 F-CATCAGACCTGATTTCCGAGAGT CTGCAGAAGGAGTCAGAGAAACTGG
R- AACAGTTTGTAGCCAAGGACAGC
Mgst-1 NM_134349 F- AGGCCGGTCATGTTAAATGTCTA ACGCGTGCGAAGAGCCCACCTGAAT
R- ACCGTCACCCTCTGATTGATTTA
Statistical Analyses for Q-PCR
Group differences were analyzed by an independent T-test using the 2-∆∆CT
method.  This is the analysis most frequently cited in the literature 25, 150-152.  This analysis 
uses the difference between the housekeeping gene and the control sample as ∆1 and the 
difference between the experimental group and the control group as ∆2.  Significance was 
set a priori at p < 0.05.  In this experiment, GAPDH (glyceraldehydes-3-phospahte 
dehydrogenase) was used as the housekeeping gene.  GAPDH is commonly used as a 
housekeeping gene, and recent experiments by Mahoney et al. have confirmed that it is 
the housekeeping gene of choice for any experiment utilizing endurance exercise, as 
GAPDH remains unchanged through 48 hours post-exercise 117, 136.
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Protein Isolation
Muscle samples were homogenized in lysis buffer containing, 20 mM Tris (pH 
7.4), 150 mM sodium chloride, 1% triton X-100, 0.5% non idet P-40 (NP-40), 1 mM 
ethylene diamine-tetraacetate (EDTA), and 1mM ethylene glycol-tetraacetic acid 
(EGTA).  In addition, appropriate protease (0.3 µM aprotinin, 20 µM leupeptin, 1 µM 
pepstatin A, and 0.5 mM phenylmethylsulfonyl fluoride) and phosphatase inhibitors (2 
µM sodium vanadate, 10 mM sodium fluoride, and 20 mM β-glycerophosphate) were 
included.  Homogenates were then centrifuged at 10,000 rpm for 10 minutes at 4 °C to 
remove insoluble material.  The supernatant was then placed in microcentrifuge tubes and 
protein concentrations of each soleus muscle was determined using the Lowry et al. 115
method.  This method compares values to known protein standards determined on a 
spectrophotometer at a wavelength of 700 nm.  Each sample (20µl) was combined with 
1980 µl of distilled water and mixed to make a master mix for each sample.  An aliquot 
of the master mix (20µl) was then added to a cuvette and 500µl of Lowry reagent and 
480µl of distilled water were added. Each sample was then shaken and incubated at room 
temperature for 20 minutes.  Then, 250µl of Folin’s reagent was added to each sample, 
and the sample was shaken and incubated at room temperature for 30 minutes.  Each 
sample was then read at a wavelength of 700 and the sample was then compared against 
known protein standards from bovine serum albumin standards.  All samples were 
performed in duplicate.
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Western Blot Analysis
Western Blot analysis was performed using the previously published methods 99, 
142.  NuPAGE 4x lithium dodecyl sulfate sample buffer (#NP0008, Invitrogen, Carlsbad, 
CA) and NuPAGE 10x reducing agent (#NP0004, Invitrogen, Carlsbad, CA) were added 
to each sample.  A total protein of 8.3 µg per sample was loaded onto a NuPAGE Novex 
10% Bis-Tris polyacrylamide gel (#NP0307BOX, Invitrogen, Carlsbad, CA).  Gels were 
processed at 175 volts for four hours to separate proteins.  The gels were then transferred 
onto a nitrocellulous membrane at 200 mA overnight  at 4 °C in transfer buffer.  After 
transfer, the membrane was placed in blocking buffer (4% non-fat dry milk in PBST) for 
45 minutes followed by a serial wash with PBST (3 x 5 min).  The nitrocellulose 
membrane was then incubated for 2 hours at 4 °C with anti-NFκB P-65 (#sc-8008, Santa 
Cruz Biotechnology, Santa Cruz, CA) or anti-Atf3 C-terminus (#sc-188, Santa Cruz 
Biotechnology) antibody diluted 1:400 in non fat dried milk.  After incubation with the 
primary antibody, membranes underwent a serial wash (3 x 10 min) with blocking buffer 
(4% non-fat dry milk in PBST).  Membranes were probed with an anti-rabbit IgG 
secondary antibody (#sc-2372, Santa Cruz Biotechnology, Santa Cruz, CA) diluted 
1:2000in 2% non fat dried mile in TTBS for 1 hour in blocking buffer.  An enhanced 
chemiluminescence (ECL) reagent was used to detect protein content and was visualized 
when exposed to Kodak autoradiographic film.  Kodak densitometry software was used 
to quantify results based on band pixel intensity.   
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Statistical Analysis for Protein Concentration and Western Blot Analysis
Group means were normalized to the C group mean since optical density is an 
arbitrary unit and were analyzed using an independent T-test.  Significance was set a 
priori at p<0.05.  Band intensity was normalized to the control group band intensity so 
that all differences are in arbitrary units in relation to protein levels in the control soleus.
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CHAPTER IV
RESULTS
The results section is organized as follows: Animals, RNA Isolation, DNA 
Microarray, Real Time PCR, Protein Isolation, and Western Blot Analysis.  All values in 
this section are presented as the mean ± the standard error the mean (SEM).
Animals
Eighteen, two week old rats obtained from Charles River labs (originally 
weighing 100-120 g) were randomly assigned into either the exercise or the control 
group.  All rats were housed in a temperature controlled (21 + 1 Co) room, on a 12 hour 
dark-light cycle and at a relative humidity of 45%. Rats were provided food and water ad 
libitum.  All rats were familiarized to the treadmill and exercised for 10-15 minutes at 
least 5 days prior to the experiment.  There were no differences in the body weights of the 
animals at the time of the experiment (E =175.3 ± 6.6g, C =170.9 ± 6.7g), or the weights 
of the soleus muscle (E =86 ± 3 mg, C = 84 ± 3 mg). Rats that were randomly assigned to 
run for the two hours all successfully completed the 2 hour run at 22 m.min-1.  At one 
hour after the run the exercised animal and a control animal were killed by decapitation 
and the soleus muscles of both legs were rapidly removed. 
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RNA Isolation
All RNA isolates met the criteria for high quality RNA as measured by the OD at 
260/280, and as analyzed using an Agilent 2100 Bioanalyzer.  No significant differences 
existed between the 2 groups in regards to RNA quality as measure by the 260/280 ratio 
(E = 2.01±.045, C = 1.94±.029), or RNA concentration (E = 1524±177, C = 1617±160
ng/ul).  For a sample of the gel output by the Bioanalyzer, please see Figure 4.
Figure 4: Gel Output from Bioanalyzer
DNA Microarray
A total of 52 genes were at least 1.5 fold different between the exercise and 
control group on all 4 arrays.   The results are listed below in Table 9.  All genes are 
28S
18s
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listed by their Genbank Accension Number, the Gene Symbol (if one is known), their 
average fold change across all 4 arrays, as well as the SEM.  All genes shaded in red
showed greater expression in the E animals, while genes shaded in green showed greater 
expression in C animals.  All values are in fold change from control.  Please see 
Appendix A for a complete list of every gene altered on the arrays, and Appendix B for 
the complete gene list organized by family.
Table 9: DNA Microarray Results
Genbank 
Number Gene Symbol
Mean 
Change SEM
NM_012543 Dbp -1.66 0.02
XM_215375 LOC294337 -1.95 0.05
NM_021989 Timp2 -1.54 0.02
AW918612 -1.82 0.05
NM_012656 Sparc -1.78 0.05
NM_031628 Nr4a3 17.47 2.70
XM_227446 LOC310670 -1.60 0.05
XM_223124 Col9a1_predicted -2.20 0.13
NM_031347 Ppargc1a 2.11 0.14
NM_053356 Col1a2 -2.35 0.18
NM_024388 Nr4a1 5.26 0.90
XM_213440 Col1a1 -2.59 0.23
NM_138828 Apoe -2.12 0.15
XM_225173 Pfn3_predicted -2.01 0.15
NM_012912 Atf3 4.87 0.73
XM_346881 LOC360478 -2.10 0.17
AA964296 2.42 0.27
TC483914 LOC310395 2.15 0.19
NM_021693 Snf1lk 3.67 0.59
M12199 -2.27 0.27
XM_343169 Adn -4.50 0.92
NM_013086 Crem 2.41 0.32
BF544403 4.92 1.29
AA858639 Comt -2.21 0.29
AI013671 2.84 0.46
TC487987 2.86 0.40
NM_144744 Acdc -2.72 0.42
NM_017151 Rps15 -2.10 0.25
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BF549650 2.65 0.41
NM_017240 Myh7 -2.35 0.35
NM_001002850 Prm1 -2.21 0.32
NM_017259 Btg2 2.53 0.47
NM_181368 Mustn1 4.05 1.16
XM_216062 Smarcd3_predicted -2.08 0.34
NM_017239 Myh6 -2.08 0.35
AW918430 Lpin1_predicted 3.13 0.71
AI008316 2.64 0.62
NM_212505 RGD:1303321 -2.31 0.48
NM_012604 Myh3 -2.43 0.49
XM_341642 Dok4_predicted -2.32 0.46
NM_175844 Stars 3.24 1.01
NM_017184 Tnni1 -2.73 0.62
NM_024349 Ak1 2.16 0.48
XM_340817 Myh4 3.29 0.93
XM_342599 Col9a3_predicted -1.95 0.33
NM_030826 Gpx1 -1.76 0.13
NM_019143 Fn1 -2.14 0.54
XM_228900 LOC317454 -4.22 1.49
XM_341671 Tradd -2.34 0.63
NM_012935 Cryab -2.10 0.48
NM_013172 Myf6 2.46 0.62
NM_134349 Mgst1 -1.91 0.29
Gene changes in regards to family are listed in Table 10.  Genes known to be in 
multiple families may be listed more than once.  The same coding sequence as Table 9 is 
used in Table 10.
Table 10: DNA Microarray Results Sorted by Gene Family
Family
Genebank 
Number Symbol
Mean 
Change SEM
dopamine catabolism
AA858639 Comt -2.21 0.29
metabolism
NM_019143 Fn1 -2.58 0.58
NM_012912 Atf3 4.87 0.73
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NM_144744 Acdc -2.72 0.42
NM_024349 Ak1 2.16 0.48
NM_138828 Apoe -2.12 0.15
response to wounding
NM_181368 Mustn1 4.05 1.16
NM_019143 Fn1 -2.58 0.58
Protein amino acid phosphorylation
NM_021693 Snf1lk 3.67 0.59
regulation of transcription from RNA polymerase II promoter
NM_021693 Snf1lk 3.67 0.59
NM_012543 Dbp -1.66 0.02
NM_013172 Myf6 2.36 0.67
circulation
NM_138828 Apoe -2.12 0.15
response to oxidative stress
NM_138828 Apoe -2.12 0.15
NM_030826 Gpx1 -1.76 0.13
NM_134349 Mgst1 -1.91 0.29
apoptosis
NM_030826 Gpx1 -1.76 0.13
XM_341671 Tradd -2.29 0.65
NM_024388 Nr4a1 5.26 0.90
NM_138828 Apoe -2.12 0.15
response to stress
NM_019143 Fn1 -2.58 0.58
NM_012935 Cryab -2.10 0.48
circadian rhythm
NM_012543 Dbp -1.66 0.02
visceral muscle development
NM_017239 Myh6 -2.08 0.35
Muscle contraction
NM_012935 Cryab -2.10 0.48
NM_012604 Myh3 -2.43 0.49
NM_017240 Myh7 -2.35 0.35
NM_017184 Tnni1 -2.73 0.62
NM_017239 Myh6 -2.08 0.35
skeletal development
XM_213440 Col1a1 -2.59 0.23
NM_053356 Col1a2 -2.35 0.18
ossification
NM_012656 Sparc -1.78 0.05
perception of sound
XM_213440 Col1a1 -2.59 0.23
NM_053356 Col1a2 -2.35 0.18
cell cycle regulation
NM_012543 Dbp -1.66 0.02
NM_013172 Myf6 2.36 0.67
NM_021693 Snf1lk 3.67 0.59
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NM_024349 Ak1 2.16 0.48
neurotransmitter catabolism
AA858639 Comt -2.21 0.29
myogenesis
NM_013172 Myf6 2.46 0.62
cytoskeleton organization and biogenesis
NM_012604 Myh3 -2.43 0.49
NM_138828 Apoe -2.12 0.15
NM_017239 Myh6 -2.08 0.35
transcription
NM_013086 Crem 2.41 0.32
NM_024388 Nr4a1 5.26 0.90
NM_031628 Nr4a3 17.47 2.70
NM_012543 Dbp -1.66 0.02
NM_012912 Atf3 4.87 0.73
NM_013172 Myf6 2.46 0.62
NM_031347 Ppargc1a 2.11 0.14
adenine metabolism
NM_024349 Ak1 2.16 0.48
sensory organ development
NM_012935 Cryab -2.10 0.48
development
NM_013172 Myf6 2.46 0.62
spermatogenesis
NM_013086 Crem 2.41 0.32
NM_021989 Timp2 -1.54 0.02
AW918612 Timp2 -1.82 0.05
eye morphogenesis
NM_012935 Cryab -2.10 0.48
Protein biosynthesis
NM_017151 Rps15 -2.10 0.25
cell-substrate junction 
assembly
NM_019143 Fn1 -2.58 0.58
cholesterol homeostasis
NM_138828 Apoe -2.12 0.15
electron transport
NM_031347 Ppargc1a 2.11 0.14
regulation of  synaptic activity
XM_341642 Dok4_predicted -2.32 0.46
NM_138828 Apoe -2.12 0.15
proteolysis and peptidolysis
XM_343169 Adn -4.50 0.92
caspase activity
NM_024388 Nr4a1 5.26 0.90
catecholamine metabolism
AA858639 Comt -2.21 0.29
tissue generation
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XM_223124 Col9a1_predicted -2.20 0.13
NM_017184 Tnni1 -2.73 0.62
NM_012935 Cryab -2.10 0.48
NM_012604 Myh3 -2.43 0.49
NM_017240 Myh7 -2.35 0.35
NM_017239 Myh6 -2.08 0.35
NM_013172 Myf6 2.46 0.62
NM_181368 Mustn1 4.05 1.16
cell adhesion
XM_342599 Col9a3_predicted -1.95 0.33
XM_213440 Col1a1 -2.59 0.23
XM_223124 Col9a1_predicted -2.20 0.13
NM_053356 Col1a2 -2.35 0.18
NM_019143 Fn1 -2.58 0.58
embryonic limb morphogenesis
NM_181368 Mustn1 4.05 1.16
epidermis development
XM_213440 Col1a1 -2.59 0.23
cell migration
NM_019143 Fn1 -2.58 0.58
learning and/or memory
NM_138828 Apoe -2.12 0.15
intracellular transport
NM_138828 Apoe -2.12 0.15
Protein homooligomerization
NM_144744 Acdc -2.72 0.42
signal transduction
NM_144744 Acdc -2.72 0.42
NM_013086 Crem 2.41 0.32
XM_341642 Dok4_predicted -2.32 0.46
NM_024388 Nr4a1 5.26 0.90
Protein folding
NM_012935 Cryab -2.10 0.48
complement activation, alternative pathway
XM_343169 Adn -4.50 0.92
regulation of T cell proliferation
NM_212505 RGD:1303321 -2.31 0.48
intracellular phosphate 
transport
NM_021693 Snf1lk 3.67 0.59
NM_144744 Acdc -2.72 0.42
XM_342599 Col9a3_predicted -1.95 0.33
XM_213440 Col1a1 -2.59 0.23
XM_223124 Col9a1_predicted -2.20 0.13
NM_053356 Col1a2 -2.35 0.18
mesoderm formation
NM_031628 Nr4a3 17.47 2.70
ribosome biogenesis
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NM_017151 Rps15 -2.10 0.25
unknown
XM_215375 LOC294337 -1.95 0.05
NM_017259 Btg2 2.53 0.47
NM_175844 RGD:708493 3.24 1.01
XM_346881 LOC360478 -2.10 0.17
XM_227446 LOC310670 -1.60 0.05
XM_225173 -2.01 0.15
AA964296 2.42 0.27
TC483914 2.15 0.19
M12199 -2.27 0.27
BF544403 4.92 1.29
AI013671 2.84 0.46
TC487987 2.86 0.40
BF549650 2.65 0.41
NM_001002850 -2.21 0.32
XM_216062 -2.08 0.34
AW918430 3.13 0.71
AI008316 2.64 0.62
XM_340817 3.29 0.94
XM_228900 -4.22 1.49
Table 11 contains fluorescence data for all genes which were reported as 
significantly altered.  While it is not possible to accurately measure exact gene transcript 
number using microarray analysis, this type of analysis can measure the signal intensity 
from the dye incorporated within the cDNA of each gene.  Therefore, it appears as 
though signal intensity (or fluorescence) is a good method with which to extrapolate this 
information.  The same coding sequence is used in Table 11.
Table 11: Fluorescence Data for all Significantly Altered Genes
Genbank 
Number Gene Symbol E Fluor SEM C Fluor SEM
NM_012543 Dbp 726.0 173.9 1226.8 249.5
XM_215375 LOC294337 290.3 62.5 538.8 100.8
NM_021989 Timp2 461.3 101.1 654.5 106.5
AW918612 181.3 35.7 325.0 62.5
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NM_012656 Sparc 3209.8 618.2 5210.8 1057.0
NM_031628 Nr4a3 1363.5 366.6 81.5 20.8
XM_227446 LOC310670 136.8 24.2 216.3 31.4
XM_223124 Col9a1_predicted 224.0 59.8 508.0 156.7
NM_031347 Ppargc1a 247.0 53.7 114.5 20.4
NM_053356 Col1a2 2265.5 460.8 4854.5 1386.9
NM_024388 Nr4a1 979.0 214.6 185.0 43.5
XM_213440 Col1a1 11741.3 2488.2 24496.8 5112.2
NM_138828 Apoe 448.8 105.6 900.3 170.4
XM_225173 Pfn3_predicted 658.5 180.4 1158.5 345.1
NM_012912 Atf3 555.3 169.2 115.5 27.6
XM_346881 LOC360478 406.8 120.6 859.3 307.2
AA964296 512.0 117.4 186.3 25.1
TC483914 LOC310395 324.0 95.0 148.0 35.0
NM_021693 Snf1lk 860.8 197.2 251.8 74.4
M12199 15758.0 2955.9 34760.0 8493.0
XM_343169 Adn 201.0 67.7 832.5 245.7
NM_013086 Crem 150.8 32.1 64.0 17.2
BF544403 295.3 75.6 83.3 24.5
AA858639 Comt 1139.8 358.4 2380.8 755.7
AI013671 183.8 32.9 71.5 20.5
TC487987 742.8 124.1 386.3 100.6
NM_144744 Acdc 119.8 40.6 293.8 67.1
NM_017151 Rps15 6976.5 2417.5 13158.8 3989.2
BF549650 151.5 33.1 63.5 18.6
NM_017240 Myh7 19131.3 4507.4 35173.8 5483.4
NM_001002850 Prm1 9204.3 3358.4 17291.5 5219.6
NM_017259 Btg2 357.5 71.9 154.0 39.5
NM_181368 Mustn1 1753.3 462.5 444.0 113.3
XM_216062 Smarcd3_predicted 6236.3 2654.4 12113.0 4479.6
NM_017239 Myh6 19753.3 4364.5 32931.3 6467.9
AW918430 Lpin1_predicted 235.0 43.6 71.8 18.1
AI008316 208.5 49.9 82.3 21.8
NM_212505 RGD:1303321 122.3 37.0 244.8 37.3
NM_012604 Myh3 7001.0 4181.9 9163.0 4895.8
XM_341642 Dok4_predicted 49.0 9.8 62.8 13.2
NM_175844 Stars 3418.5 987.5 1046.3 308.7
NM_017184 Tnni1 7748.5 2865.5 15443.0 2814.7
NM_024349 Ak1 139.5 44.8 61.8 17.8
XM_340817 Myh4 9670.3 3335.8 2388.3 581.8
XM_342599 Col9a3_predicted 276.5 196.3 382.5 243.9
NM_030826 Gpx1 1552.3 479.9 2209.3 473.5
NM_019143 Fn1 285.0 74.6 704.0 225.8
XM_228900 LOC317454 958.0 454.1 2413.8 357.0
XM_341671 Tradd 191.3 57.2 262.8 80.7
NM_012935 Cryab 20608.0 5314.8 32182.5 5347.3
NM_013172 Myf6 854.5 205.9 388.5 101.2
NM_134349 Mgst1 79.3 18.9 146.5 32.7
73
Real Time PCR
In order to validate the genes of interest analyzed on the microarray, real time 
PCR was performed on 4 selected genes known to be involved in either the pro- or 
antioxidant response of the muscle.  The results of the microarray were consistent with 
what was found using real time PCR.  Table 12 compares the differences reported in 
Atf3, Mgst1, NFκB and TNFα between the microarray and PCR analysis.
Table 12: Gene Fold Differences as Reported by Microarray and PCR Analysis
Gene Array Q-PCR
Atf3 4.87 ± 0.73 * 4.97 ± 1.01 *
Mgst1 -1.91 ± 0.29 * -2.25 ± 0.06 *
NFκB -1.05 ± 0.34 -1.2 ± 0.14
TNFα 1.12 ± 0.83 1.30 ± 0.34
All values are mean ± SEM. The * denotes significance at a 1.5 fold difference on the 
array, or p< 0.05 using an independent T-test for PCR results.  Negative numbers indicate 
higher transcript levels in the control animals.
For Mgst1, the array reported an average fold difference of -1.91 (or 0.52) when 
comparing the E group to C group whereas the real time PCR revealed a -2.25 (or 0.20) 
fold difference.  This gene was significantly lowered in response to the exercise bout.  
For Atf-3, the array reported an average fold difference of 4.87 when comparing the E 
group to C group whereas the real time PCR revealed a 4.97 fold difference.  This gene 
was significantly up-regulated in response to the exercise bout.  For NFκB, the array 
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reported no difference when comparing the E group to C group whereas the real time 
PCR revealed a -0.15 fold difference.  This gene was not significantly altered in response 
to the exercise bout.  For TNFα, the array reported no difference when comparing the E 
group to C group whereas the real time PCR revealed a 0.3 the fold difference.  This gene 
was not significantly altered in response to the exercise bout.  
Protein Isolation
There was no difference in the total protein content of the soleus muscle between 
the 2 groups.  The E group had a content of 10.2 ± 6.1 µg/µl, while the C group had a 
protein content of 11.6 ± .40 µg/µl.
Western Blot Analysis
Western Blot analysis was performed on the p65 sub-unit of NFκB, and Atf-3 in 
order to determine if the gene levels would match the protein levels.  Consistent with the 
gene levels, there was no difference in protein levels of NFκB between the E and C 
groups, and there was a significant increase in Atf-3 protein levels between the E and C 
groups.  For this analysis, all values were normalized to the C group optical density (OD).  
Please refer to Figures 5, 6, 7, and 8 for results.
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Figure 5: Sample Western Blot of NFκB
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Figure 6: NFκB Protein Expression Levels
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All values are mean ± SEM and are normalized to the C group.
Figure 7: Sample Western Blot of Atf-3 
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Figure 8: Atf-3 Protein Expression Levels
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All values are mean ± SEM and are normalized to the C group. The * denotes 
significance at p< 0.05 using an independent T-test comparing group means.
*
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CHAPTER V
DISCUSSION AND CONCLUSIONS
This study was completed in order to compare mRNA alterations in the working 
skeletal muscle (the soleus in this case) following a single bout of aerobic exercise.  
Another aim of this particular study was to validate some of the mRNA changes, as well 
as seeing if these gene changes match protein changes.  To our knowledge, this is the first 
study to use microarray analysis one hour following a single bout of aerobic exercise that 
specifically looked at the working limb muscle and also compared gene changes with 
protein changes.  Several previous investigators have looked at the response of cardiac 
muscle following exercise (e.g. 42, 76, 201), but not skeletal muscle.  It was hypothesized 
that at the one hour post-exercise time point genes involved in RONS production would 
be down-regulated in the E group, and that genes involved in RONS protection would be 
up-regulated in the E group.  It was also hypothesized that gene and protein levels would 
not match since the process from gene transcription to protein translation is a complex 
process.  These hypotheses were not accepted as since the current study found the
opposite effect occurring in the soleus muscle.  The major families of genes reported as 
changed on the microarray were metabolism, apoptosis, muscle contraction, 
transcription/cell signaling, tissue generation, and inflammatory genes (a known 
secondary source of RONS production), and gene and protein levels that were measured 
matched.
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Thus, the main findings of this experiment reveal that: 1) According to the 
microarray, genes involved in the stress response were up-regulated in the E group, while 
genes involved in stress protection were mainly down-regulated in the E group, 2) the 4 
genes tested with real time PCR (TNFα, NFκB, Mgst1, and Atf3) matched the results
seen in the microarray and 3) the protein levels of NFκB and Atf-3 match the gene levels
seen under these particular conditions.
These data suggest that in the soleus muscle 1 hour after a 2 hour run at 22 m/min, 
down-regulation of genes involved in the protection from oxidative stress one hour post-
exercise occurred.  Conversely, genes involved in stress production are up-regulated as 
several genes involved in the inflammatory process (a known secondary source of RONS 
production) are up-regulated 10, 62, 63, 80, 81, 119, 125, 128, 174.  This experiment also provides 
evidence that future investigators concerned with RONS protection should investigate 
some time point after this one hour time point used.  This is also the first known 
investigation to measure gene changes of Atf3 and Mgst1 following exercise.
This chapter discusses the results from the present study in comparison to 
previous published research.  Based on the results of this study, the rejection of the 
hypotheses is discussed.  Finally, recommendations for future research within this area 
are proposed.
Exercise Session
The rats utilized in this study were all approximately 10 weeks old at the time of 
the exercise session and sample collection.  Since all rats walked slowly on the treadmill
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prior to the exercise session for short periods of time, and were handled daily, the 
influence of stress due to animal handling and treadmill apprehension were minimized .  
Since all animals were fasted for at least 12 hours at the time of decapitation, dietary 
influences were likely equal between the 2 groups.  Finally, body weights and muscle 
weights were not different between the 2 groups.  It therefore appears that no training 
effect took place in regards to the aforementioned measures.
DNA Microarray
As previously indicated, 52 genes were reported as significantly altered due to a 
single session of exercise on all 4 arrays.  According to the array, of the families of genes 
from which the 52 genes which were reported as significantly altered were metabolism
(~10% of all genes altered), apoptosis (~8% of all genes altered), muscle contraction
(~10% of all genes altered), transcription/cell signaling (~17%of all genes altered), tissue 
generation (~15.5% of all genes altered), and inflammatory genes (~10% of all genes 
altered).  This suggests that at this time point, genes involved in the inflammatory and 
pro-stress processes are up-regulated, while stress protection genes are either unaltered or 
down-regulated.  Clearly, in order to confirm whether or not these gene changes actually 
occurred, PCR analysis would need to be performed on each of the genes in question.  
Therefore, the results of this array will be compared to families of genes as grouped by 
other investigators in other array experiments, and not necessarily on a gene by gene 
basis.
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The results from the current microarray are consistent with a recent study 
published by Mahoney et al. 118.  In this particular study, 14 untrained males cycled to 
exhaustion for ~75 minutes.  Muscle biopsies were taken 3 hours post-exercise and RNA 
was isolated and 3 DNA microarrays were performed on the muscle samples.  It should 
be noted that in their study, muscle samples were taken from the vastus lateralis (VL, a 
mixed quadriceps muscle).  Previous EMG analysis has shown that the VL is recruited 
during cycling exercise 184.  However, since muscle biopsies take only a small sample of 
the entire muscle, these biopsies may not reflex the entire muscle’s response, and 
biopsies may initiate the inflammatory response. In their study, 173 genes were altered 
due to the exercise bout.  In agreement with the present study, the families of genes most
altered were metabolism genes, stress response genes, apoptosis genes, tissue 
regeneration genes, and transcriptional genes.  In the Mahoney study, 8% of the altered 
genes were metabolism genes, 10% of the genes altered were stress response genes, 2.5% 
were apoptosis related, 6% were tissue regeneration genes, and 3.5% were transcription
related genes.  While not exact, these percentages are similar to the current study despite 
differences in species (humans vs. rats), muscle (VL vs. soleus), and time point measured
(3 hours post vs. 1 hour post).
Timmons et al. also examined the gene response in human VL muscles following
6 weeks of cycle training at 65% of max 210.  In this particular study, the microarray was 
performed on tissues taken 24 hours after the last exercise session.  Subjects were also 
classified post-exercise as high or low exercise responders, and the microarray was only 
run on tissue from the high responders.  There were 387 genes were significantly altered 
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due to exercise training. In this study, ~6% of the genes altered were related to 
metabolism, ~13% were stress response genes, and 14% were related to cell signaling.  
The authors did not report any information on apoptosis or tissue regeneration genes.  
There were also several differences between this study and the present study.  As with the 
Mahoney article, their study used a different species, a different muscle, and a different 
time point to test gene expression.  The biggest difference however is that Timmons et al. 
used trained subjects, and only high exercise responders were included for array analysis.  
It is unknown if the changes reported in this study were due to the cumulative effect of 6 
weeks of training, or the last single exercise session.  This is one possibility as to why no 
genes of tissue regeneration or apoptosis were reported as the trained subjects muscles 
may have already adapted to the repeated stress of the exercise session.  This study did 
not report which exact genes were altered, thus, comparing the exact gene responses to 
another study is impossible. Although several gene “families” did change in similar 
fashion to our study it is unknown if this is a chronic training adaptation, or an acute 
exercise bout response, as this was not measured.  Trained muscle was reported to 
respond differently than untrained muscle to exercise stress 87, 157, 158, 160 so comparisons 
may not be consistent.
Another study examined the influence of aerobic exercise training using elderly 
men that were aerobically trained on a cycle ergometer for 12 weeks . The VL muscle was 
biopsied for subsequent microarray analysis 72 hours after completion of the last exercise 
bout 168.  They reported 397 genes as different following the 12 week training program.  
In this study, ~44% of the genes altered were related to metabolism.  Another ~5% were 
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tissue regeneration genes, and the authors grouped 103 genes or ~26% as physiological 
processes, which may include some of the other functions previously listed from the 
present study. This study used trained subjects, a different species, a different muscle, 
and used elderly subjects compared to the present study, which could account for the 
differences.
While a few other studies involving aerobic exercise and microarray analysis 
exist, many continue to use long term training in conjunction with certain disease 
processes like insulin sensitivity 208, and cardiovascular disease 213.  It is clear that the 
muscle responds differently to aerobic training than it does to resistance training, but both 
appear to alter the oxidative stress response of the muscle 21, 51, 53, 54, 84, 85, 87, Therefore, 
some published articles using microarrays and resistance training warrants mentioning.
A study by Zambon et al. recently examined the gene response to a single session 
of exhaustive resistance exercise in the VL of middle aged male adult humans 229.  In this 
study, 6 hours and 18 hours after training, 608 genes were altered.  ~10% of the genes 
altered were metabolic genes, ~10% were related to tissue regeneration, ~9% were 
apoptosis related, ~4% were stress response genes, and ~6% were transcriptional related 
genes.  The groupings of genes altered are similar to the results from current study.  
Again, differences in expression of specific genes maybe due to species (humans vs. 
rats), the type of exercise (resistance vs. aerobic), and the muscle (VL vs. soleus) used as 
well as the time (6-18 hours vs. 1 hour) for analysis.  
Roth et al. published a study that examined the effects of resistance training on 
the VL muscle of both young and old, men and women.  In their study, subjects  trained at 
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least 3 days a week for 9 weeks and muscle biopsies arrays were performed  48-72 hours 
after the last training session for array analysis.  Comparisons with this study prove 
difficult, as the authors break down comparisons, by age, gender, and training.  In order 
for a gene to count as altered due to training, it had to be altered in all 4 groups: young 
men, older men, young women, older women.  Since aged muscle likely responds 
differently than young muscle 67, 220, 234, this clearly would limit the number of genes 
altered in all 4 groups.  Taking this under consideration, 54 genes were altered in all 4 
groups after training with most genes being altered grouped as either metabolism genes 
or tissue regeneration genes.  Along with several other factors which have been 
previously mentioned, the fact that aged skeletal muscle was used clearly accounts for 
some differences.
In 2003, Chen et al. 34 reported the effects of a single session of exhaustive 
exercise; one leg underwent concentric contractions only, while the opposite leg 
underwent eccentric and concentric exercise.  It is well established that eccentric exercise 
causes much more damage and soreness than concentric exercise 20, 51, 53.  Three adult, 
young men had biopsies taken from their VL ~4 hours post-exercise.  The authors in this 
study were concerned with the difference in the gene response between the two types of 
exercise.  The authors concluded that the 28 genes which were differentially expressed 
were of the family of genes responsible for tissue regeneration, the stress response, 
metabolism, and cell signaling.  Despite differences in their study to the present 
investigation (such as concentric contractions only), the genes that were expressed are 
consistent in group function to the present study.
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Resistance training, although resulting in adaptation differences within the 
working muscle, can show similar alterations in the family of genes.  Therefore, future 
work needs to identify the specific genes that are altered, and determine the time course 
of these changes with the protein changes observed within the working muscle.
Clearly, not all genes which the array identified as altered could be confirmed 
using PCR analysis.  However, some select other gene alterations warrants mentioning.  
The transcript levels of the genes Nr4a3 and Nr4a1 were reported as significantly 
elevated due to exercise.  These genes are from a family of nuclear receptors and are 
classified as early response genes.  It has been repeatedly hypothesized that this family of 
genes is critical in early apoptosis signaling 93, 106, 118, 123.  This suggests that one-hour 
post exercise the apoptosis process is clearly activated.  This is supported by Atf3 
findings in the present study.  Another gene which warrants mentioning is ApoE which is 
related to apoptosis 12, oxidative stress 215 and is critical for proper cholesterol 
metabolism 16, 185.  In the present investigation, this gene was significantly decreased one 
hour following exercise. Recently, ApoE has gained notoriety for its role in Alzheimer’s 
disease 129, as a variation in this gene seems to increase the occurrence of this disease.  
The role of AopE in regards to Alzheimer’s disease and exercise warrants further 
investigation.  One final gene which warrants discussion is Snf Ik (splicing necessary 
factor).  This gene which has been identified for protein splicing was significantly 
elevated in the present investigation following exercise.  In addition, it is believed that 
this gene is critical for apoptotic signaling to occur 95, 175, suggesting that condition are 
favorable for apoptosis one hour post-exercise.
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 In conclusion, it appears that any type of exercise is a major modulator of genes 
related to metabolism, apoptosis, muscle contraction, transcription/cell signaling, tissue 
generation, and inflammatory genes.  It does seem that there is some consistency with 
exercise across subjects, exercise type, and training status but these needs to be 
substantiated with the specific genes within these categories.
Real Time PCR
To confirm that a gene that truly altered on the microarray, PCR analysis was 
used to substantiate that changes actually occurred.   In the present investigation, real
time PCR was performed on 4 genes, 2 genes which our array identified as altered and 
known to play a role in the oxidative stress response, and 2 genes which were unchanged, 
yet have been reported in some conditions to play a role in the stress response. In this
experiment, the results of the 4 genes tested using real time PCR matched the results from 
the microarray.  The microarray reported a significant down-regulation of the gene Mgst1 
(microsomal glutathione S-transferase 1), an up-regulation of the gene Atf3 (activating 
transcription factor 3), and no significant differences in NFκB (nuclear factor kappa beta) 
and TNFα (tumor necrosis factor alpha).
Mgst1
In the present study, Mgst1 was reported as significantly down-regulated one hour 
after exercise by both the microarray and PCR analysis.  The gene Mgst1 is known to 
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play a role in the glutathione system of the muscle. This gene is important in defense 
from RONS 90, 91, 135.  Mgst1is responsible for the production of the membrane bound 
enzyme which functions as both a glutathione transferase (GST) and a glutathione 
peroxidase (GPx) 104.  GST acts to catalyze the reaction between the SH group of GSH 
and the alkylating agent.  This neutralizes their electrophilic site leaving them more water 
soluble which allows GSH to carry out its detoxifying effects.  GPx (in the presence of 
GSH) acts to convert hydrogen peroxide into water and GSSG 194.  Clearly, this is an 
important gene for the body’s endogenous antioxidant defense system.  However, in our 
study, this gene was down-regulated, implying that the glutathione defense system was 
expressed less than in controls.
Several previous studies have reported altered Mgst1 levels, however none of 
them have used exercise as their model.  Mgst1 levels were shown to be up-regulated in 
cells which were exposed to various types of tumor cells 45.  The authors speculated that 
Mgst1 is important in the body’s ability to fight off conditions like cancer which increase 
RONS through the glutathione defense system. In a different study, rats were exposed to 
high levels of toxic gases known to increase RONS levels for 2 weeks for 2 hours per 
day.  Mgst1 was up-regulated 24 hours after the last exposure 111.  This was also reported 
by Maeda et al. in which two types of cell cultures were exposed to RONS, one type of 
cells contained Mgst1 siRNA (this essentially knocks down the gene levels), while the 
other group was wild type.  Glutathione activity and subsequent cell survival was over 
40% lower in the cells with Mgst1 siRNA, again, suggesting that RONS will activate this 
gene 116 and that it is likely important for cell survival.
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Clearly, the above results differ from what was seen in the current experiment.  
Three possibilities therefore exist as to why Mgst1 levels were down-regulated: 1) 
exercise causes a different response than other RONS producing mediums, 2) at the one 
hour time point chosen, the antioxidant defense system was not yet up-regulated, or 3) 
this is not the rate limiting factor for glutathione pathways.  Since exercise has repeatedly 
been shown to increase the body’s ability to defend against RONS using glutathione 
pathways 52-54, 86, 87, 89, 116, option one seems unlikely.  It therefore appears that had a later 
time point been chosen, Mgst1 levels may have been elevated in the exercise group.  This 
is the first known study measuring Mgst1 levels using exercise as the stressor.  Since 
Mgst1 is a known RONS protector and the levels were down-regulated, this suggests that 
the muscles from the current study are susceptible to attack and apoptosis.  This clearly 
contributes to the rejection of the hypothesis that genes involved in antioxidant protection 
would be up-regulated, as this very important protector is actually significantly down-
regulated.
Atf3
In the present study, Atf3 levels were significantly higher one hour following 
exercise compared to the controls according to both microarray and PCR analysis.  Atf3 
is an activating factor with several proposed functions.  However, its main functions 
appear to be in regard to cell cycle.  It appears as though this gene acts as both an 
apoptotic factor 137 and as a cell proliferation factor 206.  It has been hypothesized that this 
gene is a stress response gene 206.  Atf3 is induced upon a variety of different 
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physiological stimuli including ischemia, reperfusion, wounding, and other stress signals 
61.  In the present experiment, many genes involved in cell cycle controls were altered, 
and Atf3 certainly fits in this category.  
Yan et al. reported that Atf3 is essential for proper function of the tumor 
suppressor p53, which plays a major role in cell cycle arrest and apoptosis 225.  This 
group reported that in most types of cancer, Atf3 levels were down-regulated, suggesting 
the critical role Atf3 plays in cell proliferation and apoptosis.
Consistent with the previous study, Hua et al. reported that rat cells which over 
expressed Atf3 directly inhibited NFκB dependent apoptosis.  The authors believed that 
this regulation is through a TNFα response, as it has been suggested that Atf3 levels 
allow TNFα induced apoptosis to occur 75, 78.
Atf3 also appears to be critical for proper cell growth.  It has been reported that 
even in cells lacking other cell proliferation factors (such as c-Myc), that if Atf3 levels 
are stimulated, close to normal cell proliferation can occur.  However, in Atf3 knockout 
cells, cell proliferation was only about 50% of controls.  This suggests that in order for 
optimal proliferation to occur, Atf3 and c-Myc must both be present, but Atf3 appears 
much more critical 206.
Abe et al. stimulated an inflammatory response in rat hind limb muscle by 
applying a tourniquet.  One hour after the tourniquet was removed, Atf3 levels were 
significantly higher than controls.  The authors also reported several other 
inflammatory/tissue regeneration genes altered in response to this stress as well and 
concluded that Atf3 was important in the muscles stress response 1.
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It does appear Atf3 may play a role in protecting proteins from degradation as 
well.  It is believed that Atf3 can work with JNK and c-Jun as previously described and 
lead to increased HSP 27 levels 109.  HSPs function to help proteins properly fold so that 
they do not undergo degradation.  It therefore appears Atf3 does indeed provide some 
direct protection to cells as is related to oxidative stress.
In conclusion, Atf3 has been shown to be active in a variety of pathways whether 
it is apoptotic, or antiapoptotic.  The one constant factor that appears to be present in all 
cases is that Atf3 is up-regulated in response to stress, and this coincides with results 
from the present experiment with both the microarray and PCR results.  Since the 
apoptotic role of Atf3 is well established, and the fact that several other inflammatory and 
apoptotic genes were up-regulated, it appears as though conditions in the soleus muscle 
of the current study favor apoptosis.  Future studies may measure various apoptotic 
measures and compare these measures to gene levels.
NFκB
In the present study, no difference was noted in NFκB levels between exercised 
rats or control rats one hour after exercise using either microarray or PCR analysis.  
NFκB (nuclear factor kappa beta) is also known as the Rela gene.  NFκB is known to be 
present in a variety of circumstances including ischemia/reperfusion injury 224, the 
inflammatory process 217, apoptosis 88 and in response to oxidative stress 28.  Almost all 
published studies address NFκB protein activity, and not necessarily changes in the gene 
or protein levels.  It is known that NFκB is partly responsible for NFAT activation 72, 195, 
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which is a cytolsolic protein which when dephosphorylated crosses the nuclear 
membrane and is responsible for gene transcription.  The NFκB pathway is very 
complex.  Although gene levels of NFκB were not altered, NFκB activation may have 
taken place as one of several inhibitors could have been altered (IKBalpha 
phosphorylation, IKK levels down-regulated). Clearly this is a complicated process as 
indicated in Figure 9.  In hindsight, it appears to be NFκB activity that may be altered and 
that NFκB levels may not be the most important aspect. This needs to be substantiated 
with further studies.
Figure 9: NFκB Activation Pathway
Adapted from Biocarta 18
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In Figure 9 the legend is as follows: the dark blue circle represents TNFα, the
green circle represents the IKK complex, the yellow circle represents IKβ, the purple 
circle represents NFκB, the small red circles represent phosphorylation groups, the thin 
black lines represent ubiquitin, the light blue circle is the nucleus, and the gray inside the 
nucleus is DNA.  Briefly, the IKK complex has the ability to phosphorylate the IKβ
complex which is joined with NFκB, thus further deactivating it.  Ubiquitin has the 
ability to bind to IKβ and remove the phosphorylation, as well as the IKβ complex, 
activating NFκB.  Once NFκB is active, it can cross the nuclear membrane where it binds 
to DNA and acts as a transcription factor.
TNFα
In the present study, no differences were noted in TNFα (tumor necrosis factor 
alpha) levels between the exercised animals or the control animals using either 
microarray or PCR analysis.  TNFα is well defined as an integral part of the 
inflammatory process as it has been specifically linked to being an activator of apoptosis 
48 and as being activated as part of the inflammatory process 7.  TNFα is also thought to 
play a role in altering insulin sensitivity 178. TNFα has been shown to directly altering 
NFκB activity by altering IKK levels 181, 211.
Paton et al. examined TNFα gene levels in elderly subjects trained aerobically for 
6 months at 50-70% and blood TNFα expression levels were tested.  After a single 
aerobic exercise bout, there was a slight increase in TNFα levels 2 hours post-exercise.  
The levels were even higher 4 hours post-exercise.  Following the 6 months of aerobic 
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training, TNFα levels were again significantly higher again at both the 2 and 4 hour time 
points, however, the trained subjects had significantly lower TNFα than the untrained 
controls at rest as well as post-exercise 150.  The authors suggested that the original 
exercise bout caused increases in TNFα levels due to the induction of the inflammatory 
process.  They also concluded that since TNFα levels decrease with training, one major 
training response is an attenuation of the inflammation process.
However, a study by Colbert et al. refutes the above study’s findings.  In this 
particular study, mice ran for either 60 minutes or to exhaustion and tissue was collected 
immediately post-exercise, 1.5 hours post-exercise, or 3 hours post-exercise.  There were 
no significant differences in TNFα levels at any time point, however, other known 
inflammatory markers were elevated at various time points measured 37.  Perhaps TNFα
is not essential for the inflammatory process as there are several factors that activate this 
process. Perhaps there are post-translational modifications that may be activated by the 
inflammation response.  Finally, both the present investigation and the Colbert study did 
not report changes in TNFα in rodent tissues after exercise.  It is possible that the rodent 
model may not reflect a similar change in TNFα compared to humans.
Thomas et al. used a cell culture model to examine the effects of short term and 
long term oxidative stress exposure 209.  Cells were exposed to a low level of stress and 
then several inflammatory markers were measured 24 hours after exposure.  The authors 
reported increased TNFα after both acute and chronic exposure to stress.  The cells with 
increased TNFα levels also had higher levels of other inflammatory markers.  The 
authors concluded that cells exposed to oxidative stress, whether acutely, or chronically 
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are at greater risk for alterations or damage than other cells, likely through a TNFα
mediated pathway 209.
Li et al. reported the importance of TNFα in the stress response, as cells were 
exposed to several apoptotic activators and inhibitors. One of the major pathways of 
apoptosis activation is through the ASK1-JNK-p38 pathway (apoptosis signal regulating 
kinase, c-Jun-terminal-kinase).  When the cells were exposed to TNFα inhibitors, they 
had significantly less apoptosis.  This led the authors to conclude that in order for optimal 
apoptosis to occur through the ASK1-JNK-p38 pathway, TNFα must be present to induce 
these factors 108.
An I/R (ischemia/reperfusion) injury study examined both TNFα and NFκB 
levels. Rat cardiac tissue was exposed to 5 minutes of ischemia followed by 30 minutes 
of reperfusion.  The authors reported force decrements of nearly 50% following the I/R 
bout.  TNFα expression was greater after I/R than in control hearts, as was, NFκB 
activity.  This led the authors to conclude that both TNFα and NFκB likely play an 
important role in I/R associated injury in the heart 232. It is not known if this same 
response would occur within skeletal muscle.
In conclusion, the present study reports no difference in TNFα expression levels 
between the exercise and control groups in soleus muscle.  This is consistent with the 
mice data from Colbert et al. 37 but somewhat inconsistent with some of the published 
literature with cell culture 108, 209, 232and human research 150.  These inconsistencies may 
be related to the model used to examine the response, or the time point examined and the 
extent of stress.  It is possible that: 1) the one hour time point was not the optimal time to 
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see changes in TNFα expression, 2) even though several apoptotic genes were up-
regulated, it is possible that apoptotic genes were activated by factors other than TNFα, 
and 3) the levels of TNFα in the working soleus skeletal limb mus cle may respond 
differently than what is seen in other tissues like the heart, and 4) the rodent model may 
demonstrate differences to humans. Studies need to be performed to address these issues.
Again, in looking at the published literature, it is likely that a later time point would have 
been better for optimal analysis of changes in TNFα levels.
Western Blot Analysis
To confirm that protein changes occurred, Western Blot analysis was used.   In 
the present investigation, Western Blot analysis was performed on 2 proteins (NFκB and 
Atf-3) which previously had their gene levels measured using PCR analysis. In this 
experiment, the results of the 2 proteins tested Western Blot analysis matched the results 
from gene PCR analysis.  The Western Blots reported no significant differences in NFκB 
protein levels and whereas Atf-3 protein levels were significantly elevated in the E group.
NFκB
NFκB (p- 65 subunit) protein content was determined using western blot analysis.
There was no difference detected between the E and C groups one hour after exercise 
with this particular protein from the soleus muscle homogenates.  This is consistent with 
the results from NFκB gene level, as this gene was not significantly activated at this time 
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point comparing the two groups.  It is currently known that in most instances, a gene that 
is activated will result in gene transcription.  This process is normally followed by protein 
translation.  These processes are usually coupled, although there may be instances when 
these processes are not always coupled.  It is possible for a gene to be up-regulated or 
down-regulated, without any change in protein concentration.  It is also possible to see 
protein concentration changes without gene alterations occurring.  This may occur as a 
result in changes often referred to as post-translational modifications. For example, a 
gene may be activated to form a protein but another factor may modify its actual 
production within the cell.  In addition, other factors beside protein synthesis can modify 
protein concentration.  Protein concentration can be modified by altering degradation 
rates. For example, a slowing of the degradation rate for a protein without altering the 
synthesis rate will lead to increased protein concentration. Furthermore, enhancing 
degradation rates without changes in protein synthesis would lead to lower protein 
concentration. Therefore, not only gene expression but alteration of degradative processes 
and post-translational modification factors need to be considered when determining the 
factors to alter protein concentration.  This is especially true when only determining the 
concentration of a protein at a single time point.  Finally, the time to activate the 
processes noted above may not always match.  
NFκB protein concentration following exercise was examined by Sriwijitkamol et 
al.  It should be noted that this particular study used diabetic patients, so they may 
respond to exercise differently than normal healthy subjects.  Subjects trained 4 times a 
week at 75% of VO2 max for 45 minutes for 8 weeks and had a biopsy taken from their 
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VL muscle both before and after the 8 weeks of exercise training.  NFκB levels were 
unchanged following exercise training at the 24 hour time point.  However, IκBα and 
IκBβ protein levels were both shown to be about double pre exercise values 199.  Figure 9, 
which was previously shown, illustrates how IκB is an inhibitor of NFκB translocation to 
the nucleus.  This suggests that an adaptation seen with training is an inhibition of NFκB 
levels through IκB.  It could be hypothesized that NFκB protein levels following a single 
exercise session should be elevated to stimulate this inhibitory response seen later after 
repeated bouts.  However, their study did not measure changes following one bout so the 
acute change is still an unanswered question.  Clearly, there are several differences 
between this study and the current study.  The subjects in the Sriwijitkamol study were 
diabetic, the VL muscle was used, and their study examined the training response of 
NFκB, not the single session response.  Additionally, samples were taken 24 hours after 
exercise whereas the current study collected samples 1 hour post-exercise.  This is 
consistent with the hypothesis of Sen et al. which stated that intense acute aerobic 
exercise caused oxidation of glutathione and therefore increased NFκB levels.  However, 
regular, repeated exercise can increase glutathione levels and will therefore decrease 
NFκB levels 189.  In addition, other antioxidant protective enzymes are activated with 
training.
Vider et al. examined NFκB levels following exercise as human subjects 
exercised at 80% of VO2 for 60 minutes and blood was taken from the antecubital vein 
both prior to and immediately following exercise.  NFκB protein levels were ~50% 
higher following a single session of exercise in blood lymphocytes.  The authors further 
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measured  an increase in lipid peroxidation following exercise and suggested that NFκB  
levels are likely at least in part regulated by RONS 216.  The authors also acknowledged
that NFκB levels are often transiently increased and variable, as 3 of their 12 subjects had 
no change in NFκB in the blood lymphocytes.  There are several major differences 
between their study and the current study.  Obviously, it is possible that the rats used in 
the current study may respond differently than humans reported in Vider et al.  Also, 
Vider et al. reported changes in blood lymphocytes. Blood lymphocyte levels will 
increase with exercise 216.  Others have reported differences in NFκB levels between 
different working limb muscles 13, so it would seem possible that blood lymphocytes and 
muscle NFκB levels could be different. It is also possible that in order to elevate NFκB 
concentration inside a muscle cell that many different processes and signals are involved.  
Cleary, this would have to be investigated further to confirm this.  Finally, the time factor 
for the present study was one hour after exercise and the blood was collected immediately 
after exercise in the Vider et al. study.
Additionally, Ho et al. examined NFκB protein activity following exercise in 
male Wistar rats.  Rats aerobically exercised on a treadmill for 15, 30, or 60 minutes at a 
moderate intensity and had their gastrocnemius muscle removed 1 hour, 3.5 hours, or 5 
hours post-exercise.  NFκB nuclear binding activity was 50% higher post- exercise at both 
the 1 hour and 3.5 hour times 70.  It should be noted that this study did not measure NFκB 
protein, but NFκB protein expression, which are separate measures.
Ji et al. ran rats on a treadmill at 75% of max for 2 hours and killed immediately 
following the exercise bout and the VL was removed.  NFκB activity was 66% higher 
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following exercise compared to controls.  These authors concluded that NFκB activity is 
redox regulated, and that NFκB activity is a very complex pathway with many factors 
having input 88. Again, it should be noted that NFκB protein levels were not measured.  
However, this group examined the time course of soleus NFκB activation in rats and 
reported that despite an activation at 1, 2 and 4 hours after exercise the increase in NFκB 
activity did not translate into an increase in protein until 24 hours after the exercise 88. 
This suggests that the process of gene transcription and protein translation is not 
necessarily matched and that in order to determine whether these processes are linked, 
investigators may need to measure protein changes at a later time point.  It should be 
noted that the nuclear fraction concentration of NFκB was increased and not the total 
muscle homogenate in their study.
Recently, Bar-Shai et al. examined NFκB protein levels, except immobilization 
was used as their model and not exercise.  It was previously reported that both exercise 
and immobilization do increase RONS levels.  In their study, 6 month or 24 month old 
rats underwent hind limb immobilization for up to 4 weeks.  NFκB levels were elevated 
in the quadriceps of both young and old rats, but it took 3 weeks of immobilization in 
young rats and 4 weeks in old rats.  This suggests that it is possible that the age of the 
subjects can influence their NFκB response as young and old subjects may not respond 
the same 15.  Clearly, this study is different from the current study in that it used an 
immobilization model and not exercise, but, as previously noted, both of these models are 
known to alter RONS and therefore the NFκB response is similar.  It is also worth noting
that the quadriceps muscles (a mixed group of muscles) were used in their study.
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One additional study examined NFκB both in vivo and in vitro.  Aoi et al. 
exposed L6 myoblasts to hydrogen peroxide for up to 3 hours and examined NFκB 
levels.  They reported that by one hour NFκB levels had doubled compared to baseline 
levels and that by 3 hours the NFκB levels had increased by 400% by 3 hours.  The 
authors concluded that RONS can activate NFκB protein levels in isolated myoblasts 8.
In order to see if the results from a cell culture experiment would hold true to a real world 
example, NFκB protein levels were measured following a single 60 minute run at 80% of 
max in male Sprague Dawley rats.  The gastrocnemius muscle showed a 50% increase in 
NFκB protein levels one hour post-exercise and a 125% increase at 24 hours post-
exercise.  The authors also reported increased lipid peroxidation suggesting a role for 
RONS in this process.  This suggests that NFκB protein levels likely increase for at least 
24 hours following a single bout of aerobic exercise in the gastrocnemius muscle 8.  The 
major difference between this experiment and the present experiment is the muscle group 
analyzed and the intensity and duration of exercise.  Since it is well established that the 
gastrocnemius is primarily a fast twitch muscle and the soleus is primarily composed of 
slow twitch muscles, some differences may be expected.  The fact that they used a higher 
intensity of exercise may have helped recruit more of the gastrocnemius in their study 
and perhaps observed the increase at one hour after exercise. Also, several of the above 
studies have mentioned a possible role for RONS in NFκB protein levels.  It has been 
repeatedly shown that slow twitch fibers contain more antioxidant enzymes and are better 
able to deal with RONS related injuries than fast twitch fibers 87, 157, 160.
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NFκB protein concentration results have varied depending on the model used
(human vs. rat vs. cell culture), the time of measurement and the type of tissue examined. 
The current study reports that one-hour after moderate exercise for two hours that NFκB 
concentration in the soleus is not significantly modified in muscle homogenates.   The 
present study is consistent with some investigations that suggest that one-hour after 
exercise NFκB content is not significantly altered in soleus muscle 74.  It appears it takes 
some time to increase the content of this molecule but the activation of this molecule can 
be rather rapid. This response is most likely due to 3 main factors as: 1) it appears that 
NFκB protein concentration can increase in response to stress, but it may not occur for 
some time (at least 24 to 48 hours).  It is possible that had the animals in the current study 
been sacrificed at a later time point that NFκB levels might have increased; 2) several 
studies measured NFκB activity and not NFκB protein levels, which might be a better 
measure because it takes into account all factors which may play a role in altering NFκB 
(such as IκB, Iκκ, and phosphorylation status among others) and takes into account 
whether a biological response is likely to occur; and 3) the soleus muscle is known to be 
a slow twitch muscle which has higher concentrations of antioxidant enzymes than fast 
twitch muscles. It is possible that the soleus muscle has a different time course of 
increasing the NFκB concentration compared to the gastrocnemius but this factor needs 
to be confirmed.  However, the present study did not show activation of the NFκB gene 
and the NFκB protein concentration one-hour after the exercise.  The process of gene 
transcription to protein translation to active protein with post translational modification 
does not always match.  
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Atf-3 
 Atf-3 gene levels were previously reported as significantly altered between the E
and C groups by both microarray and PCR analysis.  This group difference was also 
present using western blot analysis for protein concentration.  As previously mentioned, 
the process of gene transcription to protein translation is an intricate pathway and
transcription does not always lead to translation. Therefore, it can not be assumed that up-
regulated gene transcript levels will always match protein levels.  Ji et al. reported a 24-
hour time lag from significant gene up-regulation to significant changes in protein 
concentration of NFκB 88.   This suggests that the time from transcription to translation 
may take some time and it may be different for each protein. This study only measured 
Atf-3 at the one-hour post-exercise time point.   Further research is needed to determine 
the exact time course of protein translation, as well as the length of the response of Atf-3 
protein levels.  The current investigation is the first known study to examine Atf-3 levels 
in rats following an exercise bout.  In the following paragraphs, the results from the 
current study will be compared to other studies which have used various stresses (as 
exercise is a known stress).  Therefore, it should be taken into consideration that the 
stress response to exercise may differ from these other stress responses.
Okamoto et al. recently examined Atf-3 in diabetic endothethial cells in which 
hyperglycemia was used to induce RONS.  Atf-3 levels were significantly elevated post 
exposure 144.  No marker of specific RONS damage was determined.  This study 
suggested that in situations in which RONS may become elevated, Atf-3 will likely 
become elevated as well after RONS exposure.  Clearly, since this study used diabetic 
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cells for their model, there are several striking differences.  It appears as though cells and 
whole rat muscle respond the same to stress in regards to Atf-3 gene activation.  
However, it warrants mentioning that the whole muscle measurement used muscle that 
was part of a working physiological system, whereas isolated cells are not from such a 
system.  In addition, whole muscle cells undergo physiological levels of various stimuli, 
whereas cell culture studies typically use RONS levels above what would be considered 
physiological from the working system.  Also, diabetic cells are not normal, healthy cells 
and may therefore respond differently.
Human foreskin fibroblasts were examined by Kool et al.  In this study cells were 
exposed to ionizing radiation.  By 2 hours post radiation exposure, cells had significant 
increases in Atf-3 protein levels 97.  Increases in Atf-3 were present at all time points 
measured up to the final measurement at 8 hours.  Again, this study examined isolated 
fibroblast cells instead of a muscle cells.  Additionally, protein levels were measured 2 
hours through 8 hours post exposure, so there were no 1 hour post-stress measures 
determined at this time.  Since the present study only examined through one-hour post 
exercise, whether or not these time points match remains to be elucidated.
Hashimoto et al. examined Atf-3 protein levels in human umbilical vein 
endothelial cells (HUVECs).  These cells were exposed to various RONS producers and 
Atf-3 protein levels were significantly elevated immediately following RONS exposure 
65.  The results from Hashimoto et al. agree with the present study.  As previously 
mentioned, differences between cell cultures and whole muscles can not be ignored.  
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Future studies are needed to determine if the time course following exercise would match 
this study since the present study did not measure Atf-3 immediately following exercise.
Tamura et al. examined the Atf-3 protein response in rat embryonic cells which 
were exposed to radiation or RONS producing medium for 48 hours.  Both conditions 
resulted in significant increases in Atf-3 protein levels immediately following exposure 
206.  This study demonstrated increases in rat embryonic cells; this may not match skeletal 
muscle changes.
Additionally, Yan et al. examined the effects of exposing mouse embryonic 
fibroblast cells to various genotoxic stresses.  Atf-3 protein levels were measured at the 
following time points post-stress: 0h, 0.5h, 1h, 2h, and 4h and found significantly 
increased protein levels at all time points 226.  This again suggests the role of Atf-3 in the 
early stress response of cells.  Yan et al. measured protein levels at a variety of time 
points and saw significant increases at all time points, suggesting that this is not a 
transient increase.  The present study only measured Atf-3 at the one hour post-exercise 
time point.  Clearly, further measurements would need to be made post exercise in the 
soleus muscle in order to determine if the whole skeletal muscle will match the time 
course reported here by Yan et al.  It also remains to be elucidated whether or not this 
increase is transient.
In conclusion, it appears as though Atf-3 protein levels are elevated in response to 
a variety of stress induced RONS situations.  It was previously mentioned that Atf-3 is 
known to play a role in both apoptosis 137 and cell proliferation 206.  The exact role of Atf-
3 in response to exercise remains unknown as it appears to act in a different role in 
104
response to various stressors.  It does however appear that Atf-3 will become 
significantly elevated in response to stress.  Since Atf-3 protein levels were elevated in 
response to the aerobic exercise bout 2 possible explanations seem likely: 1) Atf-3 
responds to exercise in a similar manner to other stresses, and 2) the time course from 
gene transcription to protein translation is different for every protein and this process 
occurs very quickly in regards to Atf-3.  Since Atf-3 has repeatedly been reported to be 
elevated due to a variety of stresses rapidly, it has been called an early stress responder 29, 
33, 138.  This is consistent with the findings of the present study which reported increase in 
both Atf-3 at the gene and protein level following a significant stress to the muscle.  The 
present study is the first known investigation to examine Atf-3 following aerobic 
exercise, and can serve as the beginning of a time course investigation as to the levels of 
this protein.
Summary
The microarray results indicate that 52 genes were significantly altered at the one 
hour post-exercise time point by the single session of aerobic exercise.  The genes 
affected were mainly in the families of metabolism, apoptosis, muscle contraction, 
transcription/cell signaling, tissue generation, and inflammation.  The PCR analysis 
confirmed the findings of the micro arrays for 4 genes: Atf3, Mgst1, NFκB and TNFα.
Atf3 is known to be activated in response to stress and was up-regulated in the present 
experiment.  Mgst1 is part of the glutathione defense system and helps protect the body 
from RONS damage.  In the current experiment it was found to be down- regulated one 
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hour post-exercise.  Additionally, both NFκB and TNFα were found to be unchanged one 
hour after exercise.  Finally, NFκB protein concentration was also unchanged and 
matched the result observed with the transcript level.  Based on these findings, it appears 
that at the one hour time point after the exercise, the stress response was still active in the 
soleus muscle and that the antioxidant defense system had not been altered at the gene or 
protein level.
Recommendations
Further research is required to fully understand the gene response to exercise.  
This is an important topic to study as more and more people begin to realize the benefits 
of exercise and start regular exercise programs.  A better understanding of the oxidative 
response to exercise will allow for more optimal exercise programs to be designed.  
Additionally, the knowledge gained from the antioxidant defense system could perhaps 
be used to treat other conditions in which RONS are known to play a role.
Recommendations for future research are as follows:
1. The present experiment should be repeated over a longer period of time for 
observing changes in gene and protein levels.  As previously mentioned, this 
experiment only measured gene changes one hour post-exercise.  It would be 
beneficial to ascertain if changes at this intensity of exercise would alter the gene 
expression and protein concentration at some later time as suggested by the 
Hollander study 74.
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2. It would also be of interest to carry out a time course experiment following 
several different training periods to compare the differences at various times of a 
single session against weeks, or months of repeated bouts to get a better 
understanding of the genetic changes that lead to adaptations from exercise.
3. Aerobic exercise is only 1 type of exercise training.  All of the current 
experiments, as well as future experiments could be carried out using resistance 
training to better understand differences in the muscular response to different 
types of exercise.
4. This experiment only utilized the soleus muscle, which is known to be a type I or 
slow twitch fiber.  Understanding the differences in the exercise response in 
different types of muscles (using mixed or fast twitch muscles) could aid in the 
prescription of various exercise programs.
5. It is well established that various antioxidants protect the body from RONS 
damage.  Repeating the current experiments with an antioxidant group could help 
clarify the mechanism behind this protection.
6. It is well known that exercise, while causing RONS damage, increases RONS
defense as well.  It would be of interest to determine how various treatments 
(exercise) or pharmaceutical interventions can alter other disease processes 
(cancer, HIV) in which elevated RONS have been implicated.
7. Finally, understanding which genes are altered could lead to pharmaceutical or 
nutritional interventions being developed that might help up-regulate specific 
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genes that increase RONS defenses while other treatments could be developed 
that decrease RONS producers.  This is what some have called the “exercise pill.”
108
REFERENCES
1. Abe, S., I. Mizusawa, K. Kanno, A. Yabashi, T. Honda, M. Suto, M. Kuraya, and 
K. Hiraiwa. Changes in mRNA expression patterns for cytokines in blood 
leukocytes of a rat tourniquet model. Leg Med (Tokyo). 5 Suppl 1:S275-277, 
2003.
2. Alessio, H. M. and A. H. Goldfarb. Lipid peroxidation and scavenger enzymes 
during exercise: adaptive response to training. J Appl Physiol. 64:1333-1336, 
1988.
3. Alessio, H. M., A. H. Goldfarb, and G. Cao. Exercise-induced oxidative stress 
before and after vitamin C supplementation. Int J Sport Nutr. 7:1-9, 1997.
4. Alessio, H. M., A. H. Goldfarb, and R. G. Cutler. MDA content increases in fast-
and slow-twitch skeletal muscle with intensity of exercise in a rat. Am J Physiol. 
255:C874-877, 1988.
5. Alessio, H. M., A. E. Hagerman, B. K. Fulkerson, J. Ambrose, R. E. Rice, and R. 
L. Wiley. Generation of reactive oxygen species after exhaustive aerobic and 
isometric exercise. Med Sci Sports Exerc. 32:1576-1581, 2000.
6. American College of Sports Medicine., B. A. Franklin, M. H. Whaley, E. T. 
Howley, and G. J. Balady. ACSM's guidelines for exercise testing and 
prescription. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2000, xix, 368.
7. Andreakos, E. T., B. M. Foxwell, F. M. Brennan, R. N. Maini, and M. Feldmann. 
Cytokines and anti-cytokine biologicals in autoimmunity: present and future. 
Cytokine Growth Factor Rev. 13:299-313, 2002.
8. Aoi, W., Y. Naito, Y. Takanami, Y. Kawai, K. Sakuma, H. Ichikawa, N. Yoshida, 
and T. Yoshikawa. Oxidative stress and delayed-onset muscle damage after 
exercise. Free Radic Biol Med. 37:480-487, 2004.
9. Armstrong, J. S., M. Whiteman, H. Yang, D. P. Jones, and P. Sternberg, Jr. 
Cysteine starvation activates the redox-dependent mitochondrial permeability 
transition in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 45:4183-
4189, 2004.
10. Armstrong, R. B. Initial events in exercise-induced muscular injury. Med Sci 
Sports Exerc. 22:429-435, 1990
109
11. Aronson, D., M. D. Boppart, S. D. Dufresne, R. A. Fielding, and L. J. Goodyear. 
Exercise stimulates c-Jun NH2 kinase activity and c-Jun transcriptional activity in 
human skeletal muscle. Biochem Biophys Res Commun. 251:106-110, 1998.
12. Ashe, P. C. and M. D. Berry. Apoptotic signaling cascades. Prog 
Neuropsychopharmacol Biol Psychiatry. 27:199-214, 2003.
13. Atherton, P. J., J. M. Higginson, J. Singh, and H. Wackerhage. Concentrations of 
signal transduction proteins exercise and insulin responses in rat extensor 
digitorum longus and soleus muscles. Mol Cell Biochem. 261:111-116, 2004.
14. Baldi, P. and G. W. Hatfield. DNA microarrays and gene expression : from 
experiments to data analysis and modeling. Cambridge, U.K. ; New York: 
Cambridge University Press, 2003, xvi, 213.
15. Bar-Shai, M., E. Carmeli, and A. Z. Reznick. The Role of NF-{kappa}B in 
Protein Breakdown in Immobilization, Aging, and Exercise: From Basic 
Processes to Promotion of Health. Ann N Y Acad Sci. 1057:431-447, 2005.
16. Bernstein, M. S., M. C. Costanza, R. W. James, M. A. Morris, F. Cambien, S. 
Raoux, and A. Morabia. Physical activity may modulate effects of ApoE genotype 
on lipid profile. Arterioscler Thromb Vasc Biol. 22:133-140, 2002.
17. Bette, M., S. Schlimme, R. Mutters, S. Menendez, S. Hoffmann, and S. Schulz. 
Influence of different anaesthetics on pro-inflammatory cytokine expression in rat 
spleen. Lab Anim. 38:272-279, 2004.
18. Biocarta- Charting Pathways of Life. 8 June 2006. Biocarta 
<http://www.biocarta.com/genes/index.asp>.
19. Bloomer, R. J., A. H. Goldfarb, and M. J. McKenzie. Oxidative stress response to 
aerobic exercise: Comparison of antioxidant supplements. Med Sci Sport and 
Exer. 38:1098-1105, 2006.
20. Bloomer, R. J., A. H. Goldfarb, M. J. McKenzie, T. You, and L. Nguyen. Effects 
of antioxidant therapy in women exposed to eccentric exercise. Int J Sport Nutr 
Exerc Metab. 14:377-388, 2004.
21. Bloomer, R. J., A. H. Goldfarb, L. Wideman, M. J. McKenzie, and L. A. Consitt. 
Effects of acute aerobic and anaerobic exercise on blood markers of oxidative 
stress. J of Str and Cond Res. 19:1-10, 2005.
22. Boluyt, M. O., A. M. Loyd, M. H. Roth, M. J. Randall, and E. Y. Song. 
Activation of JNK in rat heart by exercise: effect of training. Am J Physiol Heart 
Circ Physiol. 285:H2639-2647, 2003.
110
23. Booth, F. W. and P. D. Neufer. Exercise controls gene expression. Am Scientist. 
93:28-35, 2005.
24. Boppart, M. D., S. Asp, J. F. Wojtaszewski, R. A. Fielding, T. Mohr, and L. J. 
Goodyear. Marathon running transiently increases c-Jun NH2-terminal kinase and 
p38 activities in human skeletal muscle. J Physiol. 526 Pt 3:663-669, 2000.
25. Bustin, S. A. A-Z of quantitative PCR. La Jolla, CA: International University 
Line, 2004, xxix, 882.
26. Caiozzo, V. J. and S. Green. Breakout session 2: muscle injury. Clin 
Orthop:S120-125, 2002.
27. Camus, G., A. Felekidis, J. Pincemail, G. Deby-Dupont, C. Deby, A. Juchmes-
Ferir, R. Lejeune, and M. Lamy. Blood levels of reduced/oxidized glutathione and 
plasma concentration of ascorbic acid during eccentric and concentric exercises of 
similar energy cost. Arch Int Physiol Biochim Biophys. 102:67-70, 1994.
28. Catani, M. V., I. Savini, G. Duranti, D. Caporossi, R. Ceci, S. Sabatini, and L. 
Avigliano. Nuclear factor kappaB and activating protein 1 are involved in 
differentiation-related resistance to oxidative stress in skeletal muscle cells. Free 
Radic Biol Med. 37:1024-1036, 2004.
29. Chen, B. P., C. D. Wolfgang, and T. Hai. Analysis of ATF3, a transcription factor 
induced by physiological stresses and modulated by gadd153/Chop10. Mol Cell 
Biol. 16:1157-1168, 1996.
30. Chen, F., V. Castranova, Z. Li, M. Karin, and X. Shi. Inhibitor of nuclear factor 
kappaB kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-
terminal kinase activation induced by arsenic. Cancer Res. 63:7689-7693, 2003.
31. Chen, F., Y. Lu, Z. Zhang, V. Vallyathan, M. Ding, V. Castranova, and X. Shi. 
Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent 
GADD45 induction by arsenite. J Biol Chem. 276:11414-11419, 2001.
32. Chen, J. and J. L. Mehta. Role of oxidative stress in coronary heart disease. Indian 
Heart J. 56:163-173, 2004.
33. Chen, S., Z. A. Khan, M. Cukiernik, and S. Chakrabarti. Differential activation of 
NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of 
diabetic complications. Am J Physiol Endocrinol Metab. 284:E1089-1097, 2003.
34. Chen, Y. W., M. J. Hubal, E. P. Hoffman, P. D. Thompson, and P. M. Clarkson. 
Molecular responses of human muscle to eccentric exercise. J Appl Physiol. 
95:2485-2494, 2003.
111
35. Chevion, M., E. Berenshtein, and E. R. Stadtman. Human studies related to 
protein oxidation: protein carbonyl content as a marker of damage. Free Radic 
Res. 33 Suppl:S99-108, 2000.
36. Chomczynski, P. and N. Sacchi. Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-
159, 1987.
37. Colbert, L. H., J. M. Davis, D. A. Essig, A. Ghaffar, and E. P. Mayer. Tissue 
expression and plasma concentrations of TNFalpha, IL-1beta, and IL-6 following 
treadmill exercise in mice. Int J Sports Med. 22:261-267, 2001.
38. Criswell, D., S. Powers, S. Dodd, J. Lawler, W. Edwards, K. Renshler, and S. 
Grinton. High intensity training-induced changes in skeletal muscle antioxidant 
enzyme activity. Med Sci Sports Exerc. 25:1135-1140, 1993.
39. Criswell, D. S., R. A. Shanely, J. J. Betters, M. J. McKenzie, J. E. Sellman, D. L. 
Van Gammeren, and S. K. Powers. Cumulative effects of aging and mechanical 
ventilation on in vitro diaphragm function. Chest. 124:2302-2308, 2003.
40. de Moffarts, B., N. Kirschvink, T. Art, J. Pincemail, and P. Lekeux. Effect of oral 
antioxidant supplementation on blood antioxidant status in trained thoroughbred 
horses. Vet J. 169:65-74, 2005.
41. DeRuisseau, K. C., R. A. Shanely, N. Akunuri, M. T. Hamilton, D. Van 
Gammeren, A. M. Zergeroglu, M. McKenzie, and S. K. Powers. Unloading the 
diaphragm via controlled mechanical ventilation promotes transcriptional 
alterations. Am J Respir Crit Care Med. In Press, 2005.
42. Diffee, G. M., E. A. Seversen, T. D. Stein, and J. A. Johnson. Microarray 
expression analysis of effects of exercise training: increase in atrial MLC-1 in rat 
ventricles. Am J Physiol Heart Circ Physiol. 284:H830-837, 2003.
43. Dotan, Y., D. Lichtenberg, and I. Pinchuk. Lipid peroxidation cannot be used as a 
universal criterion of oxidative stress. Prog Lipid Res. 43:200-227, 2004.
44. Duthie, G. G., J. D. Robertson, R. J. Maughan, and P. C. Morrice. Blood 
antioxidant status and erythrocyte lipid peroxidation following distance running. 
Arch Biochem Biophys. 282:78-83, 1990.
45. Efferth, T. and M. Volm. Glutathione-related enzymes contribute to resistance of 
tumor cells and low toxicity in normal organs to artesunate. In Vivo. 19:225-232, 
2005.
112
46. Faist, V., J. Koenig, H. Hoeger, and I. Elmadfa. Mitochondrial oxygen 
consumption, lipid peroxidation and antioxidant enzyme systems in skeletal 
muscle of senile dystrophic mice. Pflugers Arch. 437:168-171, 1998.
47. Fatouros, I. G., A. Z. Jamurtas, V. Villiotou, S. Pouliopoulou, P. Fotinakis, K. 
Taxildaris, and G. Deliconstantinos. Oxidative stress responses in older men 
during endurance training and detraining. Med Sci Sports Exerc. 36:2065-2072, 
2004.
48. Goetz, F. W., J. V. Planas, and S. MacKenzie. Tumor necrosis factors. Dev Comp 
Immunol. 28:487-497, 2004.
49. Goldfarb, A. H. Antioxidants: role of supplementation to prevent exercise-
induced oxidative stress. Med Sci Sports Exerc. 25:232-236, 1993.
50. Goldfarb, A. H. Nutritional antioxidants as therapeutic and preventive modalities 
in exercise-induced muscle damage. Can J Appl Physiol. 24:249-266, 1999.
51. Goldfarb, A. H., R. J. Bloomer, and M. J. McKenzie. Combined antioxidant 
treatment effects on blood oxidative stress to eccentric exercise. Med Sci Sport 
and Exer. 37:234-239, 2005.
52. Goldfarb, A. H., R. J. Bloomer, and M. J. McKenzie. Effect of Microhydrin on 
blood lactate, Protein Carbonyls, and Glutathione status in Rats Before and After 
Aerobic Exercise. Int J Sport Nutr Exerc Metab. 14:550-559, 2004.
53. Goldfarb, A. H., Bloomer, R. J., and McKenzie, M.J. Effect of combination 
antioxidant treatment on biomarkers of oxidative stress following eccentric 
exercise. MSSE. in review, 2004.
54. Goldfarb, A. H., T. You, R. J. Bloomer, S. Landes, and C. Murphy. Blood 
oxidative stress markers in response to aerobic exercise. Med Sci Sport and Exer. 
34:S249, 2002.
55. Gore, M., R. Fiebig, J. Hollander, C. Leeuwenburgh, H. Ohno, and L. L. Ji. 
Endurance training alters antioxidant enzyme gene expression in rat skeletal 
muscle. Can J Physiol Pharmacol. 76:1139-1145, 1998.
56. Gosker, H. R., A. Bast, G. R. Haenen, M. A. Fischer, G. J. van der Vusse, E. F. 
Wouters, and A. M. Schols. Altered antioxidant status in peripheral skeletal 
muscle of patients with COPD. Respir Med. 99:118-125, 2005.
57. Greene, V., H. Cao, F. A. Schanne, and D. C. Bartelt. Oxidative stress-induced 
calcium signalling in Aspergillus nidulans. Cell Signal. 14:437-443, 2002.
113
58. Griffiths, H. R., P. Mistry, K. E. Herbert, and J. Lunec. Molecular and cellular 
effects of ultraviolet light-induced genotoxicity. Crit Rev Clin Lab Sci. 35:189-
237, 1998.
59. Grissom, S. F., E. K. Lobenhofer, and C. J. Tucker. A qualitative assessment of 
direct-labeled cDNA products prior to microarray analysis. BMC Genomics. 6:36, 
2005.
60. Gunduz, F. and U. K. Senturk. The effect of reactive oxidant generation in acute 
exercise-induced proteinuria in trained and untrained rats. Eur J Appl Physiol. 
90:526-532, 2003.
61. Hai, T., C. D. Wolfgang, D. K. Marsee, A. E. Allen, and U. Sivaprasad. ATF3 
and stress responses. Gene Expr. 7:321-335, 1999.
62. Halliwell, B. Oxygen radicals: a commonsense look at their nature and medical 
importance. Med Biol. 62:71-77, 1984.
63. Halliwell, B. Reactive oxygen species in living systems: source, biochemistry, 
and role in human disease. Am J Med. 91:14S-22S, 1991.
64. Halliwell, B. and J. M. C. Gutteridge. Free radicals in biology and medicine. 3rd 
ed. Oxford, New York: Clarendon Press; Oxford University Press, 1999, xxxi, 
936 p.
65. Hashimoto, Y., C. Zhang, J. Kawauchi, I. Imoto, M. T. Adachi, J. Inazawa, T. 
Amagasa, T. Hai, and S. Kitajima. An alternatively spliced isoform of 
transcriptional repressor ATF3 and its induction by stress stimuli. Nucleic Acids 
Res. 30:2398-2406, 2002.
66. Heller, R. A., M. Schena, A. Chai, D. Shalon, T. Bedilion, J. Gilmore, D. E. 
Woolley, and R. W. Davis. Discovery and analysis of inflammatory disease-
related genes using cDNA microarrays. Proc Natl Acad Sci U S A. 94:2150-2155, 
1997.
67. Hepple, R. T., J. L. Hagen, D. J. Krause, and C. C. Jackson. Aerobic power 
declines with aging in rat skeletal muscles perfused at matched convective O2 
delivery. J Appl Physiol. 94:744-751, 2003.
68. Hildebrandt, A. L., H. Pilegaard, and P. D. Neufer. Differential transcriptional 
activation of select metabolic genes in response to variations in exercise intensity 
and duration. Am J Physiol Endocrinol Metab. 285:E1021-1027, 2003.
69. Hitchon, C. A. and H. S. El-Gabalawy. Oxidation in rheumatoid arthritis. Arthritis 
Res Ther. 6:265-278, 2004.
114
70. Ho, R. C., M. F. Hirshman, Y. Li, D. Cai, J. R. Farmer, W. G. Aschenbach, C. A. 
Witczak, S. E. Shoelson, and L. J. Goodyear. Regulation of IkappaB kinase and 
NF-kappaB in contracting adult rat skeletal muscle. Am J Physiol Cell Physiol. 
289:C794-801, 2005.
71. Hoberg, J. E., F. Yeung, and M. W. Mayo. SMRT derepression by the IkappaB 
kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol Cell. 
16:245-255, 2004.
72. Hogan, P. G., L. Chen, J. Nardone, and A. Rao. Transcriptional regulation by 
calcium, calcineurin, and NFAT. Genes Dev. 17:2205-2232, 2003.
73. Hollander, J., R. Fiebig, M. Gore, J. Bejma, T. Ookawara, H. Ohno, and L. L. Ji. 
Superoxide dismutase gene expression in skeletal muscle: fiber-specific 
adaptation to endurance training. Am J Physiol. 277:R856-862, 1999.
74. Hollander, J., R. Fiebig, M. Gore, T. Ookawara, H. Ohno, and L. L. Ji. 
Superoxide dismutase gene expression is activated by a single bout of exercise in 
rat skeletal muscle. Pflugers Arch. 442:426-434, 2001.
75. Hua, B., M. Tamamori-Adachi, Y. Luo, K. Tamura, M. Morioka, M. Fukuda, Y. 
Tanaka, and S. Kitajima. A splice variant of stress response gene ATF3 
counteracts NF-kappaB-dependent anti-apoptosis through inhibiting recruitment 
of CREB-binding protein/p300 coactivator. J Biol Chem. 281:1620-1629, 2006.
76. Iemitsu, M., S. Maeda, T. Miyauchi, M. Matsuda, and H. Tanaka. Gene 
expression profiling of exercise-induced cardiac hypertrophy in rats. Acta Physiol 
Scand. 185:259-270, 2005.
77. Imbeaud, S., E. Graudens, V. Boulanger, X. Barlet, P. Zaborski, E. Eveno, O. 
Mueller, A. Schroeder, and C. Auffray. Towards standardization of RNA quality 
assessment using user-independent classifiers of microcapillary electrophoresis 
traces. Nucleic Acids Res. 33:e56, 2005.
78. Inoue, K., T. Zama, T. Kamimoto, R. Aoki, Y. Ikeda, H. Kimura, and M. 
Hagiwara. TNFalpha-induced ATF3 expression is bidirectionally regulated by the 
JNK and ERK pathways in vascular endothelial cells. Genes Cells. 9:59-70, 2004.
79. Jackson, M. Exercise and oxygen radical production by muscle. In: Handbook of 
oxidants and antioxidants in exercise. C. K. Sen, Packer, L., Hanninen, O., (Ed.) 
Amsterdam: Elsevier Science, 2000, pp. 57-68.
80. Jenkins, R. R. Exercise and oxidative stress methodology: a critique. Am J Clin 
Nutr. 72:670S-674S, 2000.
115
81. Jenkins, R. R. Free radical chemistry. Relationship to exercise. Sports Med. 
5:156-170, 1988.
82. Jenkins, R. R., R. Friedland, and H. Howald. The relationship of oxygen uptake to 
superoxide dismutase and catalase activity in human skeletal muscle. Int J Sports 
Med. 5:11-14, 1984.
83. Jewett, S. L., L. J. Eddy, and P. Hochstein. Is the autoxidation of catecholamines 
involved in ischemia-reperfusion injury? Free Radic Biol Med. 6:185-188, 1989.
84. Ji, L. L. Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med. 
222:283-292, 1999.
85. Ji, L. L. Exercise-induced modulation of antioxidant defense. Ann N Y Acad Sci. 
959:82-92, 2002.
86. Ji, L. L. and R. Fu. Responses of glutathione system and antioxidant enzymes to 
exhaustive exercise and hydroperoxide. J Appl Physiol. 72:549-554, 1992.
87. Ji, L. L., R. Fu, and E. W. Mitchell. Glutathione and antioxidant enzymes in 
skeletal muscle: effects of fiber type and exercise intensity. J Appl Physiol. 
73:1854-1859, 1992.
88. Ji, L. L., M. C. Gomez-Cabrera, N. Steinhafel, and J. Vina. Acute exercise 
activates nuclear factor (NF)-kappaB signaling pathway in rat skeletal muscle. 
Faseb J. 18:1499-1506, 2004.
89. Ji, L. L., F. W. Stratman, and H. A. Lardy. Antioxidant enzyme systems in rat 
liver and skeletal muscle. Influences of selenium deficiency, chronic training, and 
acute exercise. Arch Biochem Biophys. 263:150-160, 1988.
90. Ji, Y. and B. M. Bennett. Activation of microsomal glutathione s-transferase by 
peroxynitrite. Mol Pharmacol. 63:136-146, 2003.
91. Ji, Y., I. Neverova, J. E. Van Eyk, and B. M. Bennett. Nitration of tyrosine 92 
mediates the activation of rat microsomal glutathione s-transferase by 
peroxynitrite. J Biol Chem. 281:1986-1991, 2006.
92. Kanter, M. M., L. A. Nolte, and J. O. Holloszy. Effects of an antioxidant vitamin 
mixture on lipid peroxidation at rest and postexercise. J Appl Physiol. 74:965-969, 
1993.
116
93. Ke, N., G. Claassen, D. H. Yu, A. Albers, W. Fan, P. Tan, M. Grifman, X. Hu, K. 
Defife, V. Nguy, B. Meyhack, A. Brachat, F. Wong-Staal, and Q. X. Li. Nuclear 
hormone receptor NR4A2 is involved in cell transformation and apoptosis. 
Cancer Res. 64:8208-8212, 2004.
94. Kennedy, J. Personal Interview to A.H. Goldfarb, Indianapolis, 1 June 2004.
95. Klochendler-Yeivin, A., E. Picarsky, and M. Yaniv. Increased DNA damage 
sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF 
chromatin remodeling complex. Mol Cell Biol. 26:2661-2674, 2006.
96. Knight, J. A. Free radicals, antioxidants, aging, and disease. Washington, DC: 
American Association for Clinical Chemistry Press, 1999
97. Kool, J., M. Hamdi, P. Cornelissen-Steijger, A. J. van der Eb, C. Terleth, and H. 
van Dam. Induction of ATF3 by ionizing radiation is mediated via a signaling 
pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2. 
Oncogene. 22:4235-4242, 2003.
98. Laaksonen, D. E., M. Atalay, L. Niskanen, M. Uusitupa, O. Hanninen, and C. K. 
Sen. Blood glutathione homeostasis as a determinant of resting and exercise-
induced oxidative stress in young men. Redox Rep. 4:53-59, 1999.
99. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature. 227:680-685, 1970.
100. Laughlin, M. H., T. Simpson, W. L. Sexton, O. R. Brown, J. K. Smith, and R. J. 
Korthuis. Skeletal muscle oxidative capacity, antioxidant enzymes, and exercise 
training. J Appl Physiol. 68:2337-2343, 1990.
101. Lawler, J. M., S. K. Powers, H. Van Dijk, T. Visser, M. J. Kordus, and L. L. Ji. 
Metabolic and antioxidant enzyme activities in the diaphragm: effects of acute 
exercise. Respir Physiol. 96:139-149, 1994.
102. Lawler, J. M., S. K. Powers, T. Visser, H. Van Dijk, M. J. Kordus, and L. L. Ji. 
Acute exercise and skeletal muscle antioxidant and metabolic enzymes: effects of 
fiber type and age. Am J Physiol. 265:R1344-1350, 1993.
103. Leeuwenburgh, C., J. Hollander, S. Leichtweis, M. Griffiths, M. Gore, and L. L. 
Ji. Adaptations of glutathione antioxidant system to endurance training are tissue 
and muscle fiber specific. Am J Physiol. 272:R363-369, 1997.
117
104. Lengqvist, J., R. Svensson, E. Evergren, R. Morgenstern, and W. J. Griffiths. 
Observation of an intact noncovalent homotrimer of detergent-solubilized rat 
microsomal glutathione transferase-1 by electrospray mass spectrometry. J Biol 
Chem. 279:13311-13316, 2004.
105. Levine, R. L. and E. R. Stadtman. Oxidative modification of proteins during 
aging. Exp Gerontol. 36:1495-1502, 2001.
106. Li, Q. X., N. Ke, R. Sundaram, and F. Wong-Staal. NR4A1, 2, 3--an orphan 
nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. 
Histol Histopathol. 21:533-540, 2006.
107. Li, X. and G. R. Stark. NFkappaB-dependent signaling pathways. Exp Hematol. 
30:285-296, 2002.
108. Li, X., R. Zhang, D. Luo, S. J. Park, Q. Wang, Y. Kim, and W. Min. Tumor 
necrosis factor alpha-induced desumoylation and cytoplasmic translocation of 
homeodomain-interacting protein kinase 1 are critical for apoptosis signal-
regulating kinase 1-JNK/p38 activation. J Biol Chem. 280:15061-15070, 2005.
109. Lindwall, C. and M. Kanje. Retrograde axonal transport of JNK signaling 
molecules influence injury induced nuclear changes in p-c-Jun and ATF3 in adult 
rat sensory neurons. Mol Cell Neurosci. 29:269-282, 2005.
110. Liu, C. H., W. L. Ma, R. Shi, Q. Ouyang, and W. L. Zheng. [Application of 
Agilent 2100 Bioanalyzer in the study of differential gene expression]. Di Yi Jun 
Yi Da Xue Xue Bao. 22:1066-1069, 2002.
111. Liu, J., D. Lei, M. P. Waalkes, R. P. Beliles, and D. L. Morgan. Genomic analysis 
of the rat lung following elemental mercury vapor exposure. Toxicol Sci. 74:174-
181, 2003.
112. Lodovici, M., C. Casalini, R. Cariaggi, L. Michelucci, and P. Dolara. Levels of 8-
hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes. Free 
Radic Biol Med. 28:13-17, 2000.
113. Lovlin, R., W. Cottle, I. Pyke, M. Kavanagh, and A. N. Belcastro. Are indices of 
free radical damage related to exercise intensity. Eur J Appl Physiol Occup 
Physiol. 56:313-316, 1987.
114. Lowe, D. A., G. L. Warren, C. P. Ingalls, D. B. Boorstein, and R. B. Armstrong. 
Muscle function and protein metabolism after initiation of eccentric contraction-
induced injury. J Appl Physiol. 79:1260-1270, 1995.
118
115. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein 
measurement with the Folin phenol reagent. J Biol Chem. 193:265-275, 1951.
116. Maeda, A., J. W. Crabb, and K. Palczewski. Microsomal glutathione S-transferase 
1 in the retinal pigment epithelium: protection against oxidative stress and a 
potential role in aging. Biochemistry. 44:480-489, 2005.
117. Mahoney, D. J., K. Carey, M. H. Fu, R. Snow, D. Cameron-Smith, G. Parise, and 
M. A. Tarnopolsky. Real-time RT-PCR analysis of housekeeping genes in human 
skeletal muscle following acute exercise. Physiol Genomics. 18:226-231, 2004.
118. Mahoney, D. J., G. Parise, S. Melov, A. Safdar, and M. A. Tarnopolsky. Analysis 
of global mRNA expression in human skeletal muscle during recovery from 
endurance exercise. Faseb J. 19:1498-1500, 2005.
119. Malech, H. L. and J. I. Gallin. Current concepts: immunology. Neutrophils in 
human diseases. N Engl J Med. 317:687-694, 1987.
120. Margaritis, I., F. Tessier, M. J. Richard, and P. Marconnet. No evidence of 
oxidative stress after a triathlon race in highly trained competitors. Int J Sports 
Med. 18:186-190, 1997.
121. Marx, G. and M. Chevion. Site-specific modification of albumin by free radicals. 
Reaction with copper(II) and ascorbate. Biochem J. 236:397-400, 1986.
122. Maughan, R. J., A. E. Donnelly, M. Gleeson, P. H. Whiting, K. A. Walker, and P. 
J. Clough. Delayed-onset muscle damage and lipid peroxidation in man after a 
downhill run. Muscle Nerve. 12:332-336, 1989.
123. Maxwell, M. A. and G. E. Muscat. The NR4A subgroup: immediate early 
response genes with pleiotropic physiological roles. Nucl Recept Signal. 4:e002, 
2006.
124. Maxwell, S. R., P. Jakeman, H. Thomason, C. Leguen, and G. H. Thorpe. 
Changes in plasma antioxidant status during eccentric exercise and the effect of 
vitamin supplementation. Free Radic Res Commun. 19:191-202, 1993.
125. McArdle, A., R. H. Edwards, and M. J. Jackson. Accumulation of calcium by 
normal and dystrophin-deficient mouse muscle during contractile activity in vitro. 
Clin Sci (Lond). 82:455-459, 1992.
126. McArdle, A., R. H. Edwards, and M. J. Jackson. Effects of contractile activity on 
muscle damage in the dystrophin-deficient mdx mouse. Clin Sci (Lond). 80:367-
371, 1991.
119
127. McArdle, A., A. Vasilaki, and M. Jackson. Exercise and skeletal muscle ageing: 
cellular and molecular mechanisms. Ageing Res Rev. 1:79-93, 2002.
128. McArdle, A. J., MJ. Intracellular mechanism s involved in damage to skeletal 
muscle. Bacis Appl Myo. 4:43-50, 1994.
129. McDowell, I. Alzheimer's disease: insights from epidemiology. Aging (Milano). 
13:143-162, 2001.
130. McHugh, M. P., D. A. Connolly, R. G. Eston, and G. W. Gleim. Exercise-induced 
muscle damage and potential mechanisms for the repeated bout effect. Sports 
Med. 27:157-170, 1999.
131. Meneshian, A. and G. B. Bulkley. The physiology of endothelial xanthine 
oxidase: from urate catabolism to reperfusion injury to inflammatory signal 
transduction. Microcirculation. 9:161-175, 2002.
132. Metin, G., M. K. Gumustas, E. Uslu, A. Belce, and A. Kayserilioglu. Effect of 
regular training on plasma thiols, malondialdehyde and carnitine concentrations in 
young soccer players. Chin J Physiol. 46:35-39, 2003.
133. Molitor, J. A., D. W. Ballard, and W. C. Greene. Kappa B-specific DNA binding 
proteins are differentially inhibited by enhancer mutations and biological 
oxidation. New Biol. 3:987-996, 1991.
134. Morrow, J. D. The isoprostanes: their quantification as an index of oxidant stress 
status in vivo. Drug Metab Rev. 32:377-385, 2000.
135. Mosialou, E. and R. Morgenstern. Activity of rat liver microsomal glutathione 
transferase toward products of lipid peroxidation and studies of the effect of 
inhibitors on glutathione-dependent protection against lipid peroxidation. Arch 
Biochem Biophys. 275:289-294, 1989.
136. Murphy, R. M., K. K. Watt, D. Cameron-Smith, C. J. Gibbons, and R. J. Snow. 
Effects of creatine supplementation on housekeeping genes in human skeletal 
muscle using real-time RT-PCR. Physiol Genomics. 12:163-174, 2003.
137. Nakagomi, S., Y. Suzuki, K. Namikawa, S. Kiryu-Seo, and H. Kiyama. 
Expression of the activating transcription factor 3 prevents c-Jun N-terminal 
kinase-induced neuronal death by promoting heat shock protein 27 expression and 
Akt activation. J Neurosci. 23:5187-5196, 2003.
120
138. Nawa, T., M. T. Nawa, M. T. Adachi, I. Uchimura, R. Shimokawa, K. Fujisawa, 
A. Tanaka, F. Numano, and S. Kitajima. Expression of transcriptional repressor 
ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in 
cell death of vascular endothelial cells. Atherosclerosis. 161:281-291, 2002.
139. NCBI- Pubmed. 8 June 2006. National Center for Biotechnology Information.
<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=nucleotide&cmd=search&ter
m=>. 
140. Nieman, D. C., D. A. Henson, S. R. McAnulty, L. S. McAnulty, J. D. Morrow, A. 
Ahmed, and C. B. Heward. Vitamin E and immunity after the Kona Triathlon 
World Championship. Med Sci Sports Exerc. 36:1328-1335, 2004.
141. Nohl, H. Generation of superoxide radicals as byproduct of cellular respiration. 
Ann Biol Clin (Paris). 52:199-204, 1994.
142. O'Farrell, P. H. High resolution two-dimensional electrophoresis of proteins. J 
Biol Chem. 250:4007 -4021, 1975.
143. Ohno, H., H. Yamashita, T. Ookawara, D. Saitoh, K. Mimura, and N. Taniguchi. 
Effects of brief physical exercise on the concentrations of immunoreactive 
superoxide dismutase isoenzymes in human plasma. Tohoku J Exp Med. 167:301-
303, 1992.
144. Okamoto, A., Y. Iwamoto, and Y. Maru. Oxidative stress-responsive transcription 
factor ATF3 potentially mediates diabetic angiopathy. Mol Cell Biol. 26:1087-
1097, 2006.
145. Okamura, K., T. Doi, K. Hamada, M. Sakurai, Y. Yoshioka, R. Mitsuzono, T. 
Migita, S. Sumida, and Y. Sugawa-Katayama. Effect of repeated exercise on 
urinary 8-hydroxy-deoxyguanosine excretion in humans. Free Radic Res. 26:507-
514, 1997.
146. Okamura, K., T. Doi, M. Sakurai, K. Hamada, Y. Yoshioka, S. Sumida, and Y. 
Sugawa-Katayama. Effect of endurance exercise on the tissue 8-hydroxy-
deoxyguanosine content in dogs. Free Radic Res. 26:523-528, 1997.
147. Ortenblad, N., K. Madsen, and M. S. Djurhuus. Antioxidant status and lipid 
peroxidation after short-term maximal exercise in trained and untrained humans. 
Am J Physiol. 272:R1258-1263, 1997.
121
148. Pan, Y., H. Chen, F. Siu, and M. S. Kilberg. Amino acid deprivation and 
endoplasmic reticulum stress induce expression of multiple activating 
transcription factor-3 mRNA species that, when overexpressed in HepG2 cells, 
modulate transcription by the human asparagine synthetase promoter. J Biol 
Chem. 278:38402-38412, 2003.
149. Park, J. and A. Y. Liu. JNK phosphorylates the HSF1 transcriptional activation 
domain: role of JNK in the regulation of the heat shock response. J Cell Biochem. 
82:326-338, 2001.
150. Paton, C. M., M. D. Brown, F. M. Ivey, S. M. Roth, and J. M. Hagberg. The 
hemostatic response to postprandial lipemia before and after exercise training. J 
Appl Physiol, 2006.
151. Pattison, J. S., L. C. Folk, R. W. Madsen, and F. W. Booth. Selected Contribution: 
Identification of differentially expressed genes between young and old rat soleus 
muscle during recovery from immobilization-induced atrophy. J Appl Physiol. 
95:2171-2179, 2003.
152. Pattison, J. S., L. C. Folk, R. W. Madsen, T. E. Childs, E. E. Spangenburg, and F. 
W. Booth. Expression profiling identifies dysregulation of myosin heavy chains 
IIb and IIx during limb immobilization in the soleus muscles of old rats. J 
Physiol. 553:357-368, 2003.
153. Peng, J., X. O. Mao, F. F. Stevenson, M. Hsu, and J. K. Andersen. The herbicide 
paraquat induces dopaminergic nigral apoptosis through sustained activation of 
the JNK pathway. J Biol Chem. 279:32626-32632, 2004.
154. Pereira, B., L. F. Costa Rosa, D. A. Safi, M. H. Medeiros, R. Curi, and E. J. 
Bechara. Superoxide dismutase, catalase, and glutathione peroxidase activities in 
muscle and lymphoid organs of sedentary and exercise-trained rats. Physiol 
Behav. 56:1095-1099, 1994.
155. Pilegaard, H., G. A. Ordway, B. Saltin, and P. D. Neufer. Transcriptional 
regulation of gene expression in human skeletal muscle during recovery from 
exercise. Am J Physiol Endocrinol Metab. 279:E806-814, 2000.
156. Poulsen, H. E., S. Loft, and K. Vistisen. Extreme exercise and oxidative DNA 
modification. J Sports Sci. 14:343-346, 1996.
157. Powers, S. K., D. Criswell, J. Lawler, L. L. Ji, D. Martin, R. A. Herb, and G. 
Dudley. Influence of exercise and fiber type on antioxidant enzyme activity in rat 
skeletal muscle. Am J Physiol. 266:R375-380, 1994.
122
158. Powers, S. K., D. Criswell, J. Lawler, D. Martin, L. L. Ji, R. A. Herb, and G. 
Dudley. Regional training-induced alterations in diaphragmatic oxidative and 
antioxidant enzymes. Respir Physiol. 95:227-237, 1994.
159. Powers, S. K., H. A. Demirel, J. S. Coombes, L. Fletcher, C. Calliaud, I. Vrabas, 
and D. Prezant. Myosin phenotype and bioenergetic characteristics of rat 
respiratory muscles. Med Sci Sports Exerc. 29:1573-1579, 1997.
160. Powers, S. K., L. L. Ji, and C. Leeuwenburgh. Exercise training-induced 
alterations in skeletal muscle antioxidant capacity: a brief review. Med Sci Sports 
Exerc. 31:987-997, 1999.
161. Powers, S. K., J. Quindry, and K. Hamilton. Aging, exercise, and 
cardioprotection. Ann N Y Acad Sci. 1019:462-470, 2004.
162. Powers, S. K., R. A. Shanely, J. S. Coombes, T. J. Koesterer, M. McKenzie, D. 
Van Gammeren, M. Cicale, and S. L. Dodd. Mechanical ventilation results in 
progressive contractile dysfunction in the diaphragm. J Appl Physiol. 92:1851-
1858, 2002.
163. Quindry, J. C., W. L. Stone, J. King, and C. E. Broeder. The effects of acute 
exercise on neutrophils and plasma oxidative stress. Med Sci Sports Exerc. 
35:1139-1145, 2003.
164. Radak, Z., H. Y. Chung, H. Naito, R. Takahashi, K. J. Jung, H. J. Kim, and S. 
Goto. Age-associated increase in oxidative stress and nuclear factor kappaB 
activation are attenuated in rat liver by regular exercise. Faseb J. 18:749-750, 
2004.
165. Radak, Z., T. Kaneko, S. Tahara, H. Nakamoto, H. Ohno, M. Sasvari, C. Nyakas, 
and S. Goto. The effect of exercise training on oxidative damage of lipids, 
proteins, and DNA in rat skeletal muscle: evidence for beneficial outcomes. Free 
Radic Biol Med. 27:69-74, 1999.
166. Radak, Z., J. Pucsuk, S. Boros, L. Josfai, and A. W. Taylor. Changes in urine 8-
hydroxydeoxyguanosine levels of super-marathon runners during a four-day race 
period. Life Sci. 66:1763-1767, 2000.
167. Radak, Z., A. W. Taylor, H. Ohno, and S. Goto. Adaptation to exercise-induced 
oxidative stress: from muscle to brain. Exerc Immunol Rev. 7:90-107, 2001.
168. Radom-Aizik, S., S. Hayek, I. Shahar, G. Rechavi, N. Kaminski, and I. Ben-Dov. 
Effects of aerobic training on gene expression in skeletal muscle of elderly men. 
Med Sci Sports Exerc. 37:1680-1696, 2005.
123
169. Rajguru, S. U., G. S. Yeargans, and N. W. Seidler. Exercise causes oxidative 
damage to rat skeletal muscle microsomes while increasing cellular sulfhydryls. 
Life Sci. 54:149-157, 1994.
170. Ran, Q., H. Liang, M. Gu, W. Qi, C. A. Walter, L. J. Roberts, 2nd, B. Herman, A. 
Richardson, and H. Van Remmen. Transgenic mice overexpressing glutathione 
peroxidase 4 are protected against oxidative stress induced apoptosis. J Biol 
Chem, 2004.
171. Rayet, B. and C. Gelinas. Aberrant rel/nfkb genes and activity in human cancer. 
Oncogene. 18:6938-6947, 1999.
172. Reid, M. B., K. E. Haack, K. M. Franchek, P. A. Valberg, L. Kobzik, and M. S. 
West. Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and 
fatigue in vitro. J Appl Physiol. 73:1797-1804, 1992.
173. Reid, M. B., T. Shoji, M. R. Moody, and M. L. Entman. Reactive oxygen in 
skeletal muscle. II. Extracellular release of free radicals. J Appl Physiol. 73:1805-
1809, 1992.
174. Rice-Evans, C. In: Oxygen Radicals: Systemic Events amd Disease Processes. D. 
Dass (Ed.) Basel: Karger, 1990, pp. 1-30.
175. Roberts, C. W., M. M. Leroux, M. D. Fleming, and S. H. Orkin. Highly penetrant, 
rapid tumorigenesis through conditional inversion of the tumor suppressor gene 
Snf5. Cancer Cell. 2:415-425, 2002.
176. Rodemann, H. P. and A. L. Goldberg. Arachidonic acid, prostaglandin E2 and F2 
alpha influence rates of protein turnover in skeletal and cardiac muscle. J Biol 
Chem. 257:1632-1638, 1982.
177. Rokitzki, L., E. Logemann, A. N. Sagredos, M. Murphy, W. Wetzel-Roth, and J. 
Keul. Lipid peroxidation and antioxidative vitamins under extreme endurance 
stress. Acta Physiol Scand. 151:149-158, 1994.
178. Russell, A. P. Lipotoxicity: the obese and endurance-trained paradox. Int J Obes 
Relat Metab Disord. 28 Suppl 4:S66-71, 2004.
179. Sacheck, J. M., E. A. Decker, and P. M. Clarkson. The effect of diet on vitamin E 
intake and oxidative stress in response to acute exercise in female athletes. Eur J 
Appl Physiol. 83:40-46, 2000.
124
180. Sakon, S., X. Xue, M. Takekawa, T. Sasazuki, T. Okazaki, Y. Kojima, J. H. Piao, 
H. Yagita, K. Okumura, T. Doi, and H. Nakano. NF-kappaB inhibits TNF-
induced accumulation of ROS that mediate prolonged MAPK activation and 
necrotic cell death. Embo J. 22:3898-3909, 2003.
181. Sankar, S., H. Chan, W. J. Romanow, J. Li, and R. J. Bates. IKK-i signals through 
IRF3 and NFkappaB to mediate the production of inflammatory cytokines. Cell 
Signal. 18:982-993, 2006.
182. Schena, M., D. Shalon, R. W. Davis, and P. O. Brown. Quantitative monitoring of 
gene expression patterns with a complementary DNA microarray. Science. 
270:467-470, 1995.
183. Schena, M., D. Shalon, R. Heller, A. Chai, P. O. Brown, and R. W. Davis. Parallel 
human genome analysis: microarray-based expression monitoring of 1000 genes. 
Proc Natl Acad Sci U S A. 93:10614-10619, 1996.
184. Scheuermann, B. W., J. H. Tripse McConnell, and T. J. Barstow. EMG and 
oxygen uptake responses during slow and fast ramp exercise in humans. Exp 
Physiol. 87:91-100, 2002.
185. Schmitz, K. H., P. J. Schreiner, D. R. Jacobs, A. S. Leon, K. Liu, B. Howard, and 
B. Sternfeld. Independent and interactive effects of apolipoprotein E phenotype 
and cardiorespiratory fitness on plasma lipids. Ann Epidemiol. 11:94-103, 2001.
186. Schoneich, C. Methionine oxidation by reactive oxygen species: reaction 
mechanisms and relevance to Alzheimer's disease. Biochim Biophys Acta. 
1703:111-119, 2005.
187. Schroeder, A., O. Mueller, S. Stocker, R. Salowsky, M. Leiber, M. Gassmann, S. 
Lightfoot, W. Menzel, M. Granzow, and T. Ragg. The RIN: an RNA integrity 
number for assigning integrity values to RNA measurements. BMC Mol Biol. 7:3, 
2006.
188. Selman, C., J. S. McLaren, A. R. Collins, G. G. Duthie, and J. R. Speakman. 
Antioxidant enzyme activities, lipid peroxidation, and DNA oxidative damage: 
the effects of short-term voluntary wheel running. Arch Biochem Biophys. 
401:255-261, 2002.
189. Sen, C. K. Glutathione homeostasis in response to exercise training and 
nutritional supplements. Mol Cell Biochem. 196:31-42, 1999.
190. Sen, C. K. Update on thiol status and supplements in physical exercise. Can J 
Appl Physiol. 26 Suppl:S4-12, 2001.
125
191. Sen, C. K., M. Atalay, J. Agren, D. E. Laaksonen, S. Roy, and O. Hanninen. Fish 
oil and vitamin E supplementation in oxidative stress at rest and after physical 
exercise. J Appl Physiol. 83:189-195, 1997.
192. Sen, C. K., E. Marin, M. Kretzschmar, and O. Hanninen. Skeletal muscle and 
liver glutathione homeostasis in response to training, exercise, and 
immobilization. J Appl Physiol. 73:1265-1272, 1992.
193. Sen, C. K., L. Packer, and O. H·anninen. Handbook of oxidants and antioxidants 
in exercise. Amsterdam ; Oxford: Elsevier, 2000, x, 1207.
194. Sen, C. K., Packer, L., Hanninen, O., (Ed.). Exercise and oxygen toxicity: 
Amsterdam: Elsevier Science., 1994.
195. Serfling, E., F. Berberich-Siebelt, A. Avots, S. Chuvpilo, S. Klein-Hessling, M. 
K. Jha, E. Kondo, P. Pagel, J. Schulze-Luehrmann, and A. Palmetshofer. NFAT 
and NF-kappaB factors-the distant relatives. Int J Biochem Cell Biol. 36:1166-
1170, 2004.
196. Shanely, R. A., D. Van Gammeren, K. C. Deruisseau, A. M. Zergeroglu, M. J. 
McKenzie, K. E. Yarasheski, and S. K. Powers. Mechanical ventilation depresses 
protein synthesis in the rat diaphragm. Am J Respir Crit Care Med. 170:994-999, 
2004.
197. Shou, Y., L. Li, K. Prabhakaran, J. L. Borowitz, and G. E. Isom. Calcineurin-
mediated Bad translocation regulates cyanide-induced neuronal apoptosis. 
Biochem J. 379:805-813, 2004.
198. Squier, T. C. Oxidative stress and protein aggregation during biological aging. 
Exp Gerontol. 36:1539-1550, 2001.
199. Sriwijitkamol, A., C. Christ-Roberts, R. Berria, P. Eagan, T. Pratipanawatr, R. A. 
DeFronzo, L. J. Mandarino, and N. Musi. Reduced skeletal muscle inhibitor of 
kappaB beta content is associated with insulin resistance in subjects with type 2 
diabetes: reversal by exercise training. Diabetes. 55:760-767, 2006.
200. Stadtman, E. R. Metal ion-catalyzed oxidation of proteins: biochemical 
mechanism and biological consequences. Free Radic Biol Med. 9:315-325, 1990.
201. Strom, C. C., M. Aplin, T. Ploug, T. E. Christoffersen, J. Langfort, M. Viese, H. 
Galbo, S. Haunso, and S. P. Sheikh. Expression profiling reveals differences in 
metabolic gene expression between exercise-induced cardiac effects and 
maladaptive cardiac hypertrophy. Febs J. 272:2684-2695, 2005.
126
202. Sugden, P. H. and A. Clerk. "Stress-responsive" mitogen-activated protein kinases 
(c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the 
myocardium. Circ Res. 83:345-352, 1998.
203. Sumida, S., T. Doi, M. Sakurai, Y. Yoshioka, and K. Okamura. Effect of a single 
bout of exercise and beta-carotene supplementation on the urinary excretion of 8-
hydroxy-deoxyguanosine in humans. Free Radic Res. 27:607-618, 1997.
204. Sumida, S., K. Okamura, T. Doi, M. Sakurai, Y. Yoshioka, and Y. Sugawa-
Katayama. No influence of a single bout of exercise on urinary excretion of 8-
hydroxy-deoxyguanosine in humans. Biochem Mol Biol Int. 42:601-609, 1997.
205. Sung, F. L., T. Y. Zhu, K. K. Au-Yeung, Y. L. Siow, and K. O. Enhanced MCP-1 
expression during ischemia/reperfusion injury is mediated by oxidative stress and 
NF-kappaB. Kidney Int. 62:1160-1170, 2002.
206. Tamura, K., B. Hua, S. Adachi, I. Guney, J. Kawauchi, M. Morioka, M. 
Tamamori-Adachi, Y. Tanaka, Y. Nakabeppu, M. Sunamori, J. M. Sedivy, and S. 
Kitajima. Stress response gene ATF3 is a target of c-myc in serum-induced cell 
proliferation. Embo J. 24:2590-2601, 2005.
207. Tauler, P., A. Aguilo, N. Cases, A. Sureda, F. Gimenez, G. Villa, A. Cordova, and 
A. P. Biescas. Acute phase immune response to exercise coexists with decreased 
neutrophil antioxidant enzyme defences. Free Radic Res. 36:1101-1107, 2002.
208. Teran-Garcia, M., T. Rankinen, R. A. Koza, D. C. Rao, and C. Bouchard. 
Endurance training-induced changes in insulin sensitivity and gene expression. 
Am J Physiol Endocrinol Metab. 288:E1168-1178, 2005.
209. Thomas, M. S., W. Zhang, P. M. Jordan, H. U. Saragovi, and G. Taglialatela. 
Signaling pathways mediating a selective induction of nitric oxide synthase II by 
tumor necrosis factor alpha in nerve growth factor-responsive cells. J 
Neuroinflammation. 2:19, 2005.
210. Timmons, J. A., O. Larsson, E. Jansson, H. Fischer, T. Gustafsson, P. L. 
Greenhaff, J. Ridden, J. Rachman, M. Peyrard-Janvid, C. Wahlestedt, and C. J. 
Sundberg. Human muscle gene expression responses to endurance training 
provide a novel perspective on Duchenne muscular dystrophy. Faseb J. 19:750-
760, 2005.
211. Tsai, S. H., Y. C. Liang, S. Y. Lin-Shiau, and J. K. Lin. Suppression of 
TNFalpha-mediated NFkappaB activity by myricetin and other flavonoids 
through downregulating the activity of IKK in ECV304 cells. J Cell Biochem. 
74:606-615, 1999.
127
212. Urso, M. L. and P. M. Clarkson. Oxidative stress, exercise, and antioxidant 
supplementation. Toxicology. 189:41-54, 2003.
213. Urso, M. L., P. M. Clarkson, D. Hittel, E. P. Hoffman, and P. D. Thompson. 
Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with 
exercise and statins. Arterioscler Thromb Vasc Biol. 25:2560-2566, 2005.
214. Valko, M., M. Izakovic, M. Mazur, C. J. Rhodes, and J. Telser. Role of oxygen 
radicals in DNA damage and cancer incidence. Mol Cell Biochem. 266:37-56, 
2004.
215. Veurink, G., S. J. Fuller, C. S. Atwood, and R. N. Martins. Genetics, lifestyle and 
the roles of amyloid beta and oxidative stress in Alzheimer's disease. Ann Hum 
Biol. 30:639-667, 2003.
216. Vider, J., D. E. Laaksonen, A. Kilk, M. Atalay, J. Lehtmaa, M. Zilmer, and C. K. 
Sen. Physical exercise induces activation of NF-kappaB in human peripheral 
blood lymphocytes. Antioxid Redox Signal. 3:1131-1137, 2001.
217. Viedt, C., R. Dechend, J. Fei, G. M. Hansch, J. Kreuzer, and S. R. Orth. MCP-1 
induces inflammatory activation of human tubular epithelial cells: involvement of 
the transcription factors, nuclear factor-kappaB and activating protein-1. J Am Soc 
Nephrol. 13:1534-1547, 2002.
218. Viguie, C. A., B. Frei, M. K. Shigenaga, B. N. Ames, L. Packer, and G. A. 
Brooks. Antioxidant status and indexes of oxidative stress during consecutive 
days of exercise. J Appl Physiol. 75:566-572, 1993.
219. Vincent, A. M., M. Brownlee, and J. W. Russell. Oxidative stress and 
programmed cell death in diabetic neuropathy. Ann N Y Acad Sci. 959:368-383, 
2002.
220. Welle, S., K. Bhatt, B. Shah, N. Needler, J. M. Delehanty, and C. A. Thornton. 
Reduced amount of mitochondrial DNA in aged human muscle. J Appl Physiol. 
94:1479-1484, 2003.
221. Wilber, R. L., P. L. Holm, D. M. Morris, G. M. Dallam, A. W. Subudhi, D. M. 
Murray, and S. D. Callan. Effect of FIO2 on oxidative stress during interval 
training at moderate altitude. Med Sci Sports Exerc. 36:1888-1894, 2004.
222. Wilson, D. O. and P. Johnson. Exercise modulates antioxidant enzyme gene 
expression in rat myocardium and liver. J Appl Physiol. 88:1791-1796, 2000.
223. Wolff, S., M. Crabbe, and P. Thornalley. The autoxidation of glyceradehydes and 
other simple monosacharides. Experimentia Basel. 40:244 -246, 1984.
128
224. Xu, J., J. Xie, M. Bao, Z. Li, and Z. Yang. NF-kappaB/I-kappaB pathway during 
ischemia reperfusion injury of rat liver. Chin Med J (Engl). 116:1146-1149, 2003.
225. Yan, C. and D. D. Boyd. ATF3 regulates the stability of p53: a link to cancer. Cell 
Cycle. 5:926-929, 2006.
226. Yan, C., D. Lu, T. Hai, and D. D. Boyd. Activating transcription factor 3, a stress 
sensor, activates p53 by blocking its ubiquitination. Embo J. 24:2425-2435, 2005.
227. You, T., A. H. Goldfarb, L. Nguyen, X. Sha, and M. J. McKenzie. Oxidative 
stress response in normal and antioxidant supplemented rats to a downhill run: 
changes in blood and skeletal muscle. Can J Appl Physiol. In Press, 2005.
228. Yu, B. P. Cellular defenses against damage from reactive oxygen species. Physiol 
Rev. 74:139-162, 1994.
229. Zambon, A. C., E. L. McDearmon, N. Salomonis, K. M. Vranizan, K. L. 
Johansen, D. Adey, J. S. Takahashi, M. Schambelan, and B. R. Conklin. Time-
and exercise-dependent gene regulation in human skeletal muscle. Genome Biol. 
4:R61, 2003.
230. Zergeroglu, M. A., M. J. McKenzie, R. A. Shanely, D. Van Gammeren, K. C. 
DeRuisseau, and S. K. Powers. Mechanical ventilation-induced oxidative stress in 
the diaphragm. J Appl Physiol. 95:1116-1124, 2003.
231. Zhang, H. J., L. Xu, V. J. Drake, L. Xie, L. W. Oberley, and K. C. Kregel. Heat-
induced liver injury in old rats is associated with exaggerated oxidative stress and 
altered transcription factor activation. Faseb J. 17:2293-2295, 2003.
232. Zhang, M., Y. J. Xu, H. K. Saini, B. Turan, P. P. Liu, and N. S. Dhalla. TNF-
alpha as a potential mediator of cardiac dysfunction due to intracellular Ca2+-
overload. Biochem Biophys Res Commun. 327:57-63, 2005.
233. Zhang, Y. and F. Chen. Reactive oxygen species (ROS), troublemakers between 
nuclear factor-kappaB (NF-kappaB) and c-Jun NH(2)-terminal kinase (JNK). 
Cancer Res. 64:1902-1905, 2004.
234. Zimmerman, S. D., R. J. McCormick, R. K. Vadlamudi, and D. P. Thomas. Age 
and training alter collagen characteristics in fast- and slow-twitch rat limb muscle. 
J Appl Physiol. 75:1670-1674, 1993.
129
APPENDIX A
DNA MICROARRY RESULTS FOR ALL ARRAYS
GenBank Gene Symbol
Array 
1
Array 
2
Array 
3
Array 
4
NM_012543 Dbp -1.66 -1.65 -1.71 -1.60
XM_215375 LOC294337 -1.96 -1.82 -1.95 -2.05
NM_021989 Timp2 -1.52 -1.59 -1.47 -1.52
AW918612 -1.79 -1.73 -1.95 -1.81
NM_012656 Sparc -1.67 -1.85 -1.71 -1.87
NM_019237 Pcolce -1.44 -1.45 -1.50 -1.57
NM_031628 Nr4a3 15.16 18.09 11.99 24.66
XM_227446 LOC310670 -1.50 -1.72 -1.53 -1.65
NM_012588 Igfbp3 -1.61 -1.74 -1.48 -1.59
NM_012588 Igfbp3 -1.51 -1.54 -1.49 -1.71
XM_223124 Col9a1_predicted -2.09 -2.55 -1.95 -2.22
XM_220752 Rnf135_predicted -1.67 -1.43 -1.49 -1.52
NM_031347 Ppargc1a 2.12 1.80 2.08 2.46
NM_053356 Col1a2 -2.11 -1.98 -2.62 -2.67
NM_024388 Nr4a1 4.48 3.96 4.65 7.93
XM_213440 -2.52 -2.70 -2.03 -3.12
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
XM_346228 1.62 1.57 1.47 1.33
TC495193 1.43 1.52 1.28 1.36
XM_225173 Pfn3_predicted -1.81 -1.72 -2.11 -2.39
NM_012912 Atf3 4.95 5.23 2.89 6.41
NM_022501 RGD:1302959 -1.34 -1.53 -1.46 -1.65
XM_346881 LOC360478 -1.71 -1.93 -2.33 -2.44
NM_053356 Col1a2 -1.96 -2.68 -1.79 -2.13
AF139830 Igfbp5 -1.91 -1.64 -1.88 -1.46
AA964296 2.17 2.07 3.23 2.22
BC061782 Fhl1 -1.29 -1.56 -1.51 -1.38
TC483914 LOC310395 2.65 1.71 2.09 2.16
NM_145669 Fhl1 -1.42 -1.65 -1.76 -1.93
XM_344122 LOC365949 -1.49 -1.28 -1.28 -1.30
NM_021693 Snf1lk 5.24 3.38 2.39 3.66
XM_214443 Ecm2_predicted -1.45 -1.51 -1.45 -1.24
BI282748 -1.38 -1.80 -1.89 -1.73
M12199 -1.96 -1.95 -2.10 -3.06
NM_032085 Col3a1 -1.78 -2.12 -1.98 -1.45
NM_199093 Serping1 -1.23 -1.51 -1.40 -1.31
XM_343169 Adn -2.76 -3.28 -6.80 -5.17
NM_013086 Crem 2.25 2.15 1.89 3.34
XM_226041 1.59 1.33 1.27 1.50
130
NM_134399 RGD:621165 -1.50 -1.31 -1.25 -1.27
BF544403 3.32 4.07 3.53 8.78
NM_031688 Sncg -1.66 -1.43 -1.52 -1.26
AA924335 1.57 1.29 1.70 1.75
XM_218977 Rhog_predicted -1.74 -1.49 -1.44 -1.30
AA858639 -1.76 -1.84 -2.20 -3.02
BE117007 -1.38 -1.88 -1.71 -1.42
AI013671 4.01 2.34 1.92 3.11
XM_341859 Tulp2_predicted -1.30 -1.19 -1.47 -1.27
NM_145669 Fhl1 -1.30 -1.58 -1.82 -1.77
TC487987 3.29 3.05 1.69 3.40
NM_033351 Fcgrt -1.73 -1.61 -1.49 -1.27
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
NM_053326 Enh -1.47 -1.49 -1.29 -1.21
AW920693 -1.56 -1.68 -1.25 -1.43
NM_017151 Rps15 -1.89 -1.54 -2.73 -2.24
XM_346193 LOC363397 1.48 1.25 1.28 1.20
XM_345940 -1.36 -1.83 -2.19 -1.74
BC079462 -1.80 -1.34 -1.56 -1.34
BF549650 3.36 2.30 1.67 3.28
M34136 Tpm1 -1.32 -1.25 -1.54 -1.64
AW917764 -1.25 -1.60 -1.67 -1.37
BQ200408 -1.21 -1.54 -1.55 -1.33
BC079165 -1.25 -1.50 -1.48 -1.79
NM_017240 Myh7 -1.66 -1.86 -2.74 -3.16
U87983 1.68 1.31 1.65 2.08
XM_345834 1.34 1.81 1.33 1.71
NM_001002850 Prm1 -1.74 -1.59 -2.81 -2.72
XM_216335 -1.24 -1.62 -1.87 -1.54
CA512073 Igfbp4 -1.23 -1.81 -1.64 -1.49
XM_237971 Mast3_predicted -1.31 -1.34 -1.83 -1.71
XM_236348 Cilp_predicted -1.26 -1.59 -1.21 -1.35
ENSRNOT00000030063 -1.30 -1.51 -1.81 -1.31
BI275716 -1.81 -1.72 -1.74 -1.20
AW917911 -1.33 -1.58 -1.60 -1.19
NM_145775 Nr1d1 -1.26 -1.42 -1.80 -1.81
NM_017259 Btg2 2.82 1.91 1.69 3.72
NM_138887 Hspb6 -2.24 -1.29 -2.23 -2.32
XM_213911 LOC289155 -1.50 -1.26 -1.96 -1.53
XM_235164 Frs2_predicted 1.60 1.36 1.19 1.27
NM_012595 Ldhb -1.42 -1.54 -2.15 -1.42
AW918768 -1.47 -1.98 -2.45 -1.48
AI409900 1.47 1.30 1.21 1.15
NM_012893 Actg2 -1.49 -1.23 -1.55 -1.20
AY075025 Car11 -1.66 -1.44 -1.19 -1.32
NM_181368 Mustn1 2.64 2.08 4.22 7.25
XM_221952 Ftsj2_predicted -1.93 -1.39 -2.71 -1.76
TC493257 1.47 1.53 1.34 1.14
131
XM_216062 Smarcd3_predicted -1.61 -1.56 -3.00 -2.16
NM_013069 Cd74 -1.32 -1.31 -1.89 -1.81
NM_017239 Myh6 -1.50 -2.04 -1.72 -3.06
XM_227366 LOC310585 1.19 1.25 1.47 1.16
NM_138549 Gpsn2 -1.33 -1.21 -1.40 -1.74
AI574673 -1.60 -1.34 -2.28 -1.55
AW918430 Lpin1_predicted 2.57 1.59 3.41 4.96
NM_001000262 Olr383_predicted 1.62 1.24 1.19 1.48
BG673253 -1.27 -1.65 -1.30 -1.21
AW917657 -1.11 -1.48 -1.34 -1.27
NM_021261 Tmsb10 -1.65 -1.61 -1.45 -1.14
NM_012649 Sdc4 1.97 1.29 1.34 1.58
NM_031675 Actn4 -1.40 -1.11 -1.55 -1.47
XM_231617 1.70 1.19 1.40 1.80
XM_217539 1.60 1.43 1.32 1.14
NM_024156 Anxa6 -1.73 -1.72 -1.31 -1.21
A_44_P708381 1.20 1.92 1.70 2.18
BF408982 Zfpm2_predicted -1.39 -1.96 -1.76 -2.96
XM_216546 RGD1305453_predicted -1.14 -1.55 -1.49 -1.27
XM_216399 Col15a1_predicted -1.70 -2.25 -1.47 -1.29
XM_221348 LOC288019 -1.38 -1.33 -2.10 -1.49
NM_053933 Pcdha4 1.84 1.80 1.16 1.52
NM_031340 Timeless -1.95 -1.27 -1.32 -1.58
XM_347128 1.53 1.50 1.20 1.17
NM_053638 Idh3a 1.42 1.16 1.35 1.70
XM_346252 -1.64 -1.41 -2.95 -2.30
NM_057208 Tpm3 -1.33 -1.60 -1.72 -2.54
ENSRNOT00000034797 -1.22 -1.56 -1.91 -1.35
TC504821 -1.29 -1.40 -1.17 -1.69
XM_219345 LOC308991 -1.45 -1.45 -1.85 -1.18
NM_031509 Gsta5 -1.43 -1.85 -2.12 -1.26
TC489660 -1.45 -1.75 -1.32 -1.17
AI008316 2.09 1.55 2.53 4.39
XM_216850 LOC299625 -1.50 -1.56 -1.15 -1.23
XM_345948 LOC367102 -1.17 -1.48 -1.39 -1.15
NM_212505 RGD:1303321 -1.55 -2.20 -1.78 -3.70
XM_343196 Mybpc1 -1.60 -1.54 -1.29 -1.14
NM_173111 RGD:708368 -1.40 -1.53 -2.76 -1.96
XM_225097 -1.19 -1.75 -1.86 -1.37
BG664147 -1.12 -1.58 -1.30 -1.37
XM_213440 -4.68 -1.89 -2.40 -1.72
XM_230278 RGD1311701_predicted -1.48 -1.33 -1.23 -1.10
AI031053 2.72 1.27 3.07 3.49
NM_134349 Mgst1 -1.57 -1.67 -2.62 -2.07
NM_031841 Scd2 -1.30 -1.85 -1.73 -2.77
NM_053959 Bin1 -1.79 -1.64 -1.21 -1.26
NM_017338 Calca 1.55 1.26 1.11 1.39
XM_215285 Rbp4 -1.49 -1.28 -1.80 -1.20
132
NM_019143 Fn1 -1.50 -1.88 -4.12 -2.81
NM_012604 Myh3 -1.55 -1.62 -3.25 -3.31
BE116572 -1.19 -1.50 -1.28 -1.79
NM_080903 Trim63 2.08 1.46 2.80 4.37
NM_017100 Plk1 1.31 1.16 1.75 1.54
XM_341145 RGD1310442_predicted 1.67 1.19 1.24 1.31
XM_237998 RGD1306643_predicted -1.46 -1.61 -1.19 -1.19
NM_001007678 Mss4 1.49 1.19 1.63 2.08
XM_341875 -1.63 -1.71 -1.77 -1.10
NM_022597 Ctsb -1.64 -1.48 -1.38 -1.10
S43941 -1.83 -1.44 -2.67 -1.40
XM_341642 Dok4_predicted -1.52 -1.56 -2.90 -3.30
NM_175844 Stars 2.04 1.86 2.84 6.20
XM_340759 RGD1307032_predicted -1.29 -1.44 -2.05 -1.34
NM_017184 Tnni1 -1.67 -1.64 -3.78 -3.84
AI638986 2.07 1.75 1.18 1.47
XM_224849 -1.10 -1.50 -1.28 -1.24
AI548750 -1.86 -2.43 -1.51 -1.25
XM_213943 Mgst3_predicted -1.07 -1.33 -1.42 -1.47
XM_216109 Ube2h_predicted 1.50 1.20 1.24 1.13
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
NM_001000739 Olr150_predicted -1.51 -1.30 -1.09 -1.51
NM_130431 Hspb2 -1.43 -1.08 -1.57 -1.32
XM_233606 LOC313641 -1.21 -1.48 -1.85 -2.26
NM_022401 Plec1 -1.42 -1.49 -1.14 -1.16
NM_033539 Eef1a2 -1.09 -1.72 -1.81 -1.60
BC083725 1.58 1.08 1.37 1.56
AF540887 -1.12 -1.29 -1.68 -1.43
XM_237718 Tuba6_predicted -1.66 -1.21 -1.78 -1.22
TC466730 -1.51 -1.52 -1.65 -1.07
AW914778 1.47 1.10 1.62 1.81
AW919109 -1.10 -1.19 -1.47 -1.35
NM_080698 Fmod -1.16 -1.21 -1.62 -1.28
BI286389 1.52 1.47 1.07 1.32
NM_022596 Golga2 1.66 1.18 1.55 1.18
NM_017265 1.62 1.13 1.66 2.16
TC478102 -1.11 -1.77 -1.36 -1.49
NM_080903 Trim63 2.70 1.22 3.93 4.03
BC083721 -1.44 -1.85 -1.11 -1.50
TC504962 Eif4g3_predicted -1.24 -1.19 -1.14 -1.55
NM_053502 Abcg1 -1.63 -1.98 -1.79 -1.09
NM_024129 Dcn -1.18 -1.70 -1.83 -1.26
NM_031825 Fbn1 -1.23 -1.55 -2.49 -1.66
AI232147 1.62 1.15 1.20 1.31
AI317880 1.11 1.47 1.20 1.20
NM_001004080 RGD:1303089 -1.89 -2.15 -1.33 -1.23
NM_031054 Mmp2 -1.09 -1.34 -1.69 -1.54
NM_022634 Lst1 -1.43 -1.18 -2.20 -1.81
133
NM_134388 Tnnt1 -1.36 -1.58 -3.09 -3.06
XM_226680 -1.19 -1.90 -1.69 -1.26
NM_031582 Aoc3 -1.19 -1.39 -1.93 -2.17
A_44_P470892 -1.41 -1.08 -1.67 -1.34
NM_019288 App -1.75 -1.65 -1.98 -1.08
NM_139324 Ehd4 -1.11 -1.37 -1.76 -1.36
NM_024349 Ak1 1.54 1.47 2.02 3.56
NM_053328 Bhlhb2 -1.24 -1.38 -1.92 -1.24
NM_031140 Vim -1.25 -1.92 -1.69 -1.20
NM_017131 Casq2 -1.34 -1.10 -1.30 -1.65
AW919066 -1.36 -1.27 -1.13 -1.74
XM_231103 -1.26 -1.18 -1.49 -1.10
AABR03001498 1.38 1.09 1.65 1.81
XM_228553 LOC317258 -1.67 -1.32 -1.48 -1.08
XM_340817 Myh4 1.48 1.91 4.48 5.28
XM_347347 LOC301596 -1.56 -1.42 -1.05 -1.60
XM_342599 Col9a3_predicted -2.54 -1.68 -2.44 -1.15
AW141699 Tgfbi -1.29 -1.56 -1.79 -1.12
TC476390 2.00 1.17 1.45 1.35
BF411421 -1.37 -1.49 -1.22 -1.07
XM_345482 LOC311710 -1.21 -1.89 -1.63 -2.84
NM_017147 Cfl1 -1.28 -1.54 -1.15 -1.14
BF548976 -1.19 -1.66 -1.53 -1.13
AA859053 -1.20 -1.08 -1.48 -1.51
NM_030826 Gpx1 -1.08 -1.57 -2.08 -1.88
XM_347332 Lamc3_predicted -1.13 -1.71 -2.04 -2.60
NM_181090 Slc38a2 2.06 1.14 1.99 3.04
XM_219933 Cyp2c65_predicted 1.62 1.23 1.30 1.11
XM_342245 Postn_predicted -1.63 -1.46 -3.20 -1.52
NM_175758 Slc1a5 -1.13 -1.51 -1.21 -1.69
XM_238167 LOC293860 -1.10 -1.57 -1.26 -1.23
XM_341958 Eps8l2_predicted -1.37 -1.19 -2.23 -2.06
ENSRNOT00000028943 -1.17 -1.12 -1.35 -1.57
ENSRNOT00000027259 -1.76 -1.90 -1.05 -1.64
AA997829 -1.72 -2.09 -1.35 -1.15
XM_340760 RGD1309385_predicted -1.78 -1.30 -3.22 -1.67
XM_343647 LOC363306 1.43 1.51 1.07 1.20
XM_233107 LOC298169 -1.16 -1.24 -1.84 -1.44
BF567803 Nfe2l1_predicted -1.47 -1.60 -1.26 -1.07
AW917238 1.94 1.51 1.28 1.16
XM_222302 -1.22 -1.70 -1.22 -2.02
NM_001009639 RGD1305061_predicted -1.58 -1.23 -2.84 -1.76
NM_199087 Spint2 -1.61 -2.22 -1.79 -1.09
AW434670 2.56 2.12 1.29 1.32
AW142344 1.13 1.23 1.69 1.30
XM_213835 LOC288925 -1.16 -1.71 -1.21 -1.28
NM_053674 Phyh -1.08 -1.49 -1.21 -1.22
NM_173111 RGD:708368 -1.21 -1.09 -1.52 -1.59
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NM_031832 Lgals3 -1.06 -1.35 -1.54 -1.24
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
XM_223715 1.62 1.65 1.43 1.03
XM_345415 LOC366153 1.49 1.38 1.54 1.02
NM_019143 Fn1 -1.49 -1.79 -3.75 -1.53
NM_139115 Coro6 -1.27 -1.16 -1.83 -2.01
TC489044 -1.38 -1.32 -1.52 -1.03
NM_031796 Galnt5 -1.53 -1.24 -1.74 -1.10
NM_053981 Kcnj12 1.30 1.03 1.42 1.55
XM_220874 LOC303471 -1.42 -1.74 -1.29 -1.08
XM_228900 LOC317454 -1.61 -1.89 -5.68 -7.71
AI103276 -1.57 -1.14 -1.12 -1.32
NM_012848 Fth1 -1.71 -1.39 -1.22 -1.11
TC503900 -2.13 -1.28 -1.34 -1.28
BE103095 1.86 1.03 1.57 1.63
AW143724 -1.34 -1.69 -4.54 -3.11
NM_031035 Gnai2 -1.42 -1.66 -1.23 -1.08
XM_229609 1.47 1.22 1.19 1.06
NM_031686 RGD:61922 -1.40 -1.07 -1.50
AW916908 -1.53 -1.75 -1.53 -1.02
NM_001007678 Mss4 1.30 1.26 1.64 2.43
NM_022514 Rpl27 -1.37 -1.57 -1.35 -1.03
CA338648 -1.43 -2.09 -1.09 -1.65
XM_216577 RGD1306651_predicted 1.67 1.40 1.97 4.23
CB547639 Cpeb4_predicted 1.73 1.33 1.28 2.65
NM_199390 Flcn 1.85 1.05 1.46 1.97
NM_177927 Serpinf1 -1.25 -1.14 -1.93 -1.85
AW913985 -1.10 -1.71 -1.66 -1.23
NM_033234 Hbb 1.58 1.08 1.93 2.38
NM_017149 Meox2 -1.14 -1.86 -1.64 -1.21
XM_341824 -1.65 -1.68 -1.28 -1.06
XM_344015 LOC363767 -1.17 -1.19 -1.77 -1.32
BF550246 -1.31 -1.45 -1.74 -1.06
BE128566 -1.17 -1.07 -1.54 -1.37
NM_023972 Arl6ip5 -1.57 -1.30 -1.17 -1.09
NM_030826 Gpx1 -1.13 -1.34 -2.16 -1.92
TC473838 1.55 1.11 1.12 1.41
NM_031531 Spin2c -1.45 -1.01 -1.54 -1.60
AA996757 -1.23 -1.55 -1.09 -1.75
AW918186 1.59 1.11 1.59 2.44
X52757 1.19 1.11 1.53 1.16
NM_138900 C1s -1.20 -1.57 -1.67 -1.09
AI232783 1.17 1.38 2.00 2.56
XM_215403 Marcks -1.44 -1.33 -2.13 -1.16
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
AW917756 -1.09 -2.03 -2.00 -1.38
BF290649 1.38 1.12 1.66 2.23
NM_022265 Pdcd4 -2.00 -1.38 -1.70 -1.07
135
NM_134402 Bzw2 -1.08 -1.26 -1.68 -1.29
AF053360 -1.42 -1.39 -3.96 -3.29
NM_013057 F3 -1.18 -1.69 -1.97 -1.18
XM_216288 Gabarapl1_predicted 1.60 1.02 1.48 1.85
XM_341671 Tradd -1.92 -1.37 -4.22 -1.65
NM_022582 Lgals7 -1.49 -1.15 -1.09 -1.21
AABR03073563 1.88 1.10 1.31 1.39
XM_341462 LOC361179 1.83 1.12 1.20 1.59
XM_229147 LOC302827 -1.26 -1.08 -1.69 -1.30
NM_012848 Fth1 -1.65 -1.42 -1.22 -1.06
NM_021740 Ptma -1.25 -1.69 -1.26 -1.10
XM_344113 LOC363925 -1.21 -1.86 -2.81 -4.70
NM_022531 Des -1.57 -1.40 -1.15 -1.08
NM_017113 Grn -1.17 -1.17 -1.50 -1.10
XM_236238 LOC315661 -1.01 -1.65 -1.75 -1.46
XM_341158 LOC360883 -1.08 -1.37 -2.01 -1.50
TC486677 1.55 1.36 1.09 1.13
XM_214014 Igfbp7_predicted -1.80 -1.43 -1.85 -1.03
BF291173 -1.31 -1.25 -1.14 -1.86
XM_341238 Hmx1_predicted -1.28 -1.23 -1.17 -1.86
AW918626 -1.97 -1.82 -1.33 -1.07
BF567631 -1.07 -1.49 -1.71 -1.22
TC494356 -1.07 -1.50 -1.68 -1.21
TC478611 -1.21 -1.40 -2.05 -1.20
NM_019292 Ca3 -1.20 -2.06 -4.67 -5.85
NM_019904 Lgals1 -1.25 -1.50 -1.07 -1.15
NM_013036 Sstr4 -1.53 -1.05 -1.26 -1.22
AW142568 -1.19 -1.21 -1.22 -1.82
TC482103 1.56 1.08 1.16 1.57
XM_343674 LOC363336 1.51 1.17 1.44 1.05
XM_341957 Ifitm3 -1.02 -1.23 -1.50 -1.42
NM_012618 S100a4 -1.10 -1.93 -2.38 -1.39
L00382 -1.51 -1.03 -1.50 -1.23
NM_198776 MGC72973 1.80 1.04 2.27 3.09
NM_012935 Cryab -1.16 -1.50 -2.46 -3.28
ENSRNOT00000005403 -1.44 -1.13 -1.54 -2.43
NM_001004238 RGD:1303150 1.36 1.08 1.25 1.77
TC486532 -1.22 -1.50 -2.35 -1.26
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
TC484553 10.88 6.24 1.27 2.41
CB548368 1.16 1.30 2.51 1.95
NM_019230 Slc22a3 1.66 1.58 1.03 1.26
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
AI045171 -1.14 -1.43 -2.92 -2.13
ENSRNOT00000030063 -1.55 -1.46 -2.35 -1.09
CB547615 1.45 1.36 1.90 3.93
NM_019257 Sfrs5 -1.11 -1.79 -1.16 -1.53
XM_343643 -1.19 -1.30 -2.50 -2.61
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XM_213823 -2.22 -2.61 -1.16 -1.31
AW917988 -1.11 -1.28 -1.49 -1.07
AA945152 1.17 1.07 1.36 1.64
NM_013172 Myf6 1.78 1.15 2.26 4.26
XM_214108 1.75 1.16 1.15 2.00
XM_341989 1.99 1.09 1.44 1.27
XM_226390 Arhgap10_predicted 1.63 1.15 1.28 1.09
XM_344825 LOC365122 1.54 1.50 1.05 1.15
AF329828 -1.31 -1.27 -1.84 -1.08
AW507352 1.57 1.24 1.02 1.29
XM_217332 1.60 1.37 1.19 1.04
AW914778 1.18 1.09 1.64 1.81
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
XM_213688 Pex11c_predicted 1.47 1.06 1.14 1.21
TC483382 -1.19 -1.10 -1.68 -1.23
AI548201 1.22 1.09 1.62 1.17
AW914778 1.05 1.24 1.51 1.83
NM_134399 RGD:621165 -1.05 -1.64 -1.21 -1.28
AI171966 -1.01 -1.22 -1.53 -1.47
XM_342274 Hapln2 -1.05 -1.18 -1.63 -1.63
TC496068 1.36 1.04 1.88 1.35
XM_343661 1.82 1.25 1.22 1.12
L33722 -1.39 -1.61 -3.07 -1.24
NM_031345 Dsipi 1.47 1.20 1.28 1.01
XM_345156 Itga2 -1.32 -1.70 -1.01 -1.87
NM_053714 Ank -1.14 -1.08 -1.57 -1.23
TC513661 1.27 1.04 1.49 1.89
XM_344814 Qki -1.33 -1.00 -1.58 -1.26
XM_214977 -1.20 -1.61 -1.39 -1.02
NM_031001 Ube2d2 -1.57 -1.13 -1.31 -1.07
U42627 Dusp6 -1.28 -1.79 -1.84 -1.03
BQ204109 1.10 1.53 1.11 1.19
AI236635 1.49 1.01 1.19 1.28
XM_229650 1.49 1.21 1.11 1.07
TC474582 -1.30 -1.66 -1.82 -1.00
XM_342225 RGD1307747_predicted -1.01 -1.56 -1.25 -1.74
XM_236348 Cilp_predicted -1.61 -1.32 -2.98 -1.24
BQ780215 -1.23 -1.07 -2.06 -1.84
BM386565 1.04 1.47 1.21 1.80
XM_224969 Slc25a15_predicted 1.55 1.09 1.24 1.10
XM_217130 LOC300684 1.03 1.53 1.20 1.22
XM_217218 RGD1311381_predicted -1.49 -1.20 -1.70 -1.03
AA817799 1.50 1.05 1.49 1.11
NM_145677 Slc25a25 1.37 1.15 1.49 2.65
TC464530 -1.76 -2.38 -2.29 1.08
XM_213925 Dpt_predicted -1.28 -1.39 -1.56 1.02
M57728 Pmpca 1.49 1.11 1.42 1.04
BF555415 -1.11 -1.15 -1.08 -1.47
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NM_019243 Ptgfrn -1.22 -2.06 -1.45 -1.09
XM_343174 Ilvbl_predicted -1.59 -1.04 -1.48 -1.13
AW915860 -1.10 -1.89 -1.66 -1.12
XM_228594 LOC317270 1.47 1.00 1.54 1.19
NM_012512 B2m -1.06 -1.39 -1.88 -1.21
NM_012606 Myl3 -1.04 -2.07 -1.93 -4.37
XM_232202 Adamts9_predicted 1.46 1.15 1.82 3.53
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
XM_232671 Chd7_predicted 1.03 1.23 1.54 1.90
XM_216882 Mrpl42_predicted 1.68 1.07 1.13 1.36
XM_216768 Asb2_predicted 1.34 1.07 1.55 2.39
XM_343946 LOC363657 1.09 1.09 1.16 1.47
XM_217446 1.17 1.76 1.33 1.06
XM_344837 LOC365141 1.63 1.31 1.09 1.09
XM_214266 Tncc_predicted -1.01 -1.66 -3.28 -4.05
XM_346178 1.54 1.16 1.20 1.04
AI104924 1.36 1.62 1.03 1.16
XM_236776 -1.38 -1.01 -2.51 -2.12
NM_031975 Ptms -2.00 -1.25 -4.33 -1.41
ENSRNOT00000016811 -1.21 -1.00 -1.23 -1.52
BQ200332 1.53 1.13 1.28 1.03
BQ200807 Gamt 1.03 2.71 1.40 1.91
XM_215692 Myoz2_predicted -1.04 -1.38 -2.89 -2.39
AA866409 1.04 1.54 1.10 1.53
TC473591 1.24 1.02 1.38 1.79
XM_345677 -1.49 -1.00 -1.16 -1.50
XM_342556 LOC362250 1.10 1.08 1.47 1.13
XM_217334 Apobec2_predicted -1.00 -1.32 -1.62 -1.21
XM_221690 Krtap15-1_predicted -3.01 -2.12 -1.00 -1.50
AA891242 -1.02 -1.36 -2.55 -2.40
XM_221937 1.78 1.30 1.09 1.14
NM_031677 Fhl2 -1.25 -1.04 -1.92 -1.37
XM_345970 Chst2_predicted 1.52 1.03 1.47 1.11
NM_013082 Sdc2 -1.16 -1.43 -1.73 -1.03
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APPENDIX B
DNA MICORARRY RESULTS LISTED BY FAMILY
Function/GenBank Symbol Array 1 Array 2 Array 3 Array 4
mitosis
Accession Gene
NM_017100 Plk1 1.31 1.16 1.75 1.54
immune response
Accession Gene
NM_013069 Cd74 -1.32 -1.31 -1.89 -1.81
NM_031975 Ptms -2.00 -1.25 -4.33 -1.41
NM_013057 F3 -1.18 -1.69 -1.97 -1.18
NM_012512 B2m -1.06 -1.39 -1.88 -1.21
NM_033351 Fcgrt -1.73 -1.61 -1.49 -1.27
NM_012848 Fth1 -1.71 -1.39 -1.22 -1.11
dopamine catabolism
Accession Gene
AA858639 Comt -1.76 -1.84 -2.20 -3.02
mRNA splice site selection
Accession Gene
NM_019257 Sfrs5 -1.11 -1.79 -1.16 -1.53
locomotory behavior
Accession Gene
NM_053714 Ank -1.14 -1.08 -1.57 -1.23
positive regulation of transcription
Accession Gene
NM_031347 Ppargc1a 2.12 1.80 2.08 2.46
amino acid metabolism
Accession Gene
XM_224969 Slc25a15_predicted 1.55 1.09 1.24 1.10
actin filament bundle formation
Accession Gene
NM_031675 Actn4 -1.40 -1.11 -1.55 -1.47
positive regulation of fatty acid metabolism
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
negative regulation of transport
Accession Gene
NM_023972 Arl6ip5 -1.57 -1.30 -1.17 -1.09
mitochondrial ornithine transport
Accession Gene
XM_224969 Slc25a15_predicted 1.55 1.09 1.24 1.10
positive regulation of apoptosis
Accession Gene
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NM_012588 Igfbp3 -1.61 -1.74 -1.48 -1.59
cell death
Accession Gene
NM_019288 App -1.75 -1.65 -1.98 -1.08
N-acetylglucosamine metabolism
Accession Gene
XM_345970 Chst2_predicted 1.52 1.03 1.47 1.11
lamellipodium biogenesis
Accession Gene
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
intracellular sequestering of iron ion
Accession Gene
NM_012848 Fth1 -1.71 -1.39 -1.22 -1.11
peroxisome division
Accession Gene
XM_213688 Pex11c_predicted 1.47 1.06 1.14 1.21
acetylcholine receptor signaling, muscarinic pathway
Accession Gene
NM_031035 Gnai2 -1.42 -1.66 -1.23 -1.08
glutathione metabolism
Accession Gene
NM_031509 Gsta5 -1.43 -1.85 -2.12 -1.26
NM_134349 Mgst1 -1.57 -1.67 -2.62 -2.07
metabolism
Accession Gene
NM_053638 Idh3a 1.42 1.16 1.35 1.70
XM_214108 Ugp2_predicted 1.75 1.16 1.15 2.00
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
BF567631 Sulf1 -1.07 -1.49 -1.71 -1.22
NM_019143 Fn1 -1.50 -1.88 -4.12 -2.81
response to wounding
Accession Gene
AF540887 Dmbt1 -1.12 -1.29 -1.68 -1.43
NM_019143 Fn1 -1.50 -1.88 -4.12 -2.81
nucleobase, nucleoside, nucleotide and nucleic acid metabolism
Accession Gene
XM_236348 Cilp_predicted -1.26 -1.59 -1.21 -1.35
protein-nucleus import
Accession Gene
NM_017147 Cfl1 -1.28 -1.54 -1.15 -1.14
focal adhesion formation
Accession Gene
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
protein amino acid phosphorylation
Accession Gene
NM_021693 Snf1lk 5.24 3.38 2.39 3.66
NM_017100 Plk1 1.31 1.16 1.75 1.54
AW917911 Tgfbr2 -1.33 -1.58 -1.60 -1.19
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transcription initiation from RNA polymerase I promoter
Accession Gene
BG664147 Ptrf_predicted -1.12 -1.58 -1.30 -1.37
regulation of transcription from RNA polymerase II promoter
Accession Gene
NM_031677 Fhl2 -1.25 -1.04 -1.92 -1.37
NM_012543 Dbp -1.66 -1.65 -1.71 -1.60
NM_013172 Myf6 1.78 1.15 2.26 4.26
antigen presentation, endogenous antigen
Accession Gene
NM_012512 B2m -1.06 -1.39 -1.88 -1.21
activation of MAPK
Accession Gene
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
circulation
Accession Gene
NM_017149 Meox2 -1.14 -1.86 -1.64 -1.21
NM_032085 Col3a1 -1.78 -2.12 -1.98 -1.45
BI275716 Col3a1 -1.81 -1.72 -1.74 -1.20
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
ER-nuclear signaling pathway
Accession Gene
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
Wnt receptor signaling pathway
Accession Gene
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
response to oxidative stress
Accession Gene
NM_030826 Gpx1 -1.08 -1.57 -2.08 -1.88
NM_019292 Ca3 -1.20 -2.06 -4.67 -5.85
sodium ion transport
Accession Gene
NM_031686 RGD:61922 -1.40 -1.07 -1.50 0.00
smooth muscle contraction
Accession Gene
AA891242 Myl7_predicted -1.02 -1.36 -2.55 -2.40
negative regulation of complement activation
Accession Gene
NM_199093 RGD:735225 -1.23 -1.51 -1.40 -1.31
intermediate filament-based process
Accession Gene
NM_031140 Vim -1.25 -1.92 -1.69 -1.20
apoptosis
Accession Gene
NM_019288 App -1.75 -1.65 -1.98 -1.08
BF567631 Sulf1 -1.07 -1.49 -1.71 -1.22
XM_341671 Tradd -1.92 -1.37 -4.22 -1.65
NM_022265 Pdcd4 -2.00 -1.38 -1.70 -1.07
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NM_022582 Lgals7 -1.49 -1.15 -1.09 -1.21
unknownP
Accession Gene
NM_080903 Trim63 2.08 1.46 2.80 4.37
XM_227366 LOC310585 1.19 1.25 1.47 1.16
XM_233606 LOC313641 -1.21 -1.48 -1.85 -2.26
NM_053933 Pcdha11 1.84 1.80 1.16 1.52
NM_013082 Sdc2 -1.16 -1.43 -1.73 -1.03
XM_346228 LOC367620 1.62 1.57 1.47 1.33
XM_237998 RGD1306643_predicted -1.46 -1.61 -1.19 -1.19
NM_139324 Ehd4 -1.11 -1.37 -1.76 -1.36
XM_344015 LOC363767 -1.17 -1.19 -1.77 -1.32
XM_219345 LOC308991 -1.45 -1.45 -1.85 -1.18
NM_031531 Spin2c -1.45 -1.01 -1.54 -1.60
XM_343674 LOC367576 1.51 1.17 1.44 1.05
NM_177927 Serpinf1 -1.25 -1.14 -1.93 -1.85
AY075025 RGD:735155 -1.66 -1.44 -1.19 -1.32
XM_344825 LOC308198 1.54 1.50 1.05 1.15
AI103276 LOC499691 -1.57 -1.14 -1.12 -1.32
AW142568 LOC500067 -1.19 -1.21 -1.22 -1.82
CA338648 MGC109519 -1.43 -2.09 -1.09 -1.65
NM_134399 RGD:621165 -1.50 -1.31 -1.25 -1.27
BC079165 LOC362934 -1.25 -1.50 -1.48 -1.79
NM_199390 RGD:735088 1.85 1.05 1.46 1.97
XM_346193 LOC367523 1.48 1.25 1.28 1.20
NM_022634 Lst1 -1.43 -1.18 -2.20 -1.81
XM_343647 LOC363306 1.43 1.51 1.07 1.20
XM_217218 RGD1311381_predicted -1.49 -1.20 -1.70 -1.03
AI548750 Ttyh3_predicted -1.86 -2.43 -1.51 -1.25
AW917238 Hint2_predicted 1.94 1.51 1.28 1.16
XM_215375 LOC294337 -1.96 -1.82 -1.95 -2.05
XM_341957 Ifitm2 -1.02 -1.23 -1.50 -1.42
XM_345948 LOC367102 -1.17 -1.48 -1.39 -1.15
NM_022596 Golga2 1.66 1.18 1.55 1.18
XM_217332 LOC301215 1.60 1.37 1.19 1.04
AW918626 LOC361340 -1.97 -1.82 -1.33 -1.07
XM_218977 Rhog -1.74 -1.49 -1.44 -1.30
NM_033539 Eef1a2 -1.09 -1.72 -1.81 -1.60
NM_199087 RGD:735123 -1.61 -2.22 -1.79 -1.09
XM_228594 LOC317270 1.47 1.00 1.54 1.19
XM_213835 LOC288925 -1.16 -1.71 -1.21 -1.28
BQ204109 RGD1306947_predicted 1.10 1.53 1.11 1.19
NM_017265 Hsd3b1 1.62 1.13 1.66 2.16
XM_228553 LOC317258 -1.67 -1.32 -1.48 -1.08
XM_215692 Myoz2_predicted -1.04 -1.38 -2.89 -2.39
NM_031796 Galnt5 -1.53 -1.24 -1.74 -1.10
AI232147 Ggps1 1.62 1.15 1.20 1.31
NM_017259 Btg2 2.82 1.91 1.69 3.72
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XM_341958 Eps8l2_predicted -1.37 -1.19 -2.23 -2.06
AF329828 RGD:620649 -1.31 -1.27 -1.84 -1.08
NM_001009639 RGD1305061_predicted -1.58 -1.23 -2.84 -1.76
NM_145677 Slc25a25 1.37 1.15 1.49 2.65
XM_216850 LOC299625 -1.50 -1.56 -1.15 -1.23
AI574673 LOC317232 -1.60 -1.34 -2.28 -1.55
NM_012618 S100a4 -1.10 -1.93 -2.38 -1.39
XM_231617 RGD1310722_predicted 1.70 1.19 1.40 1.80
XM_345677 LOC366631 -1.49 -1.00 -1.16 -1.50
XM_238167 LOC293860 -1.10 -1.57 -1.26 -1.23
NM_175844 RGD:708493 2.04 1.86 2.84 6.20
NM_139115 RGD:708560 -1.27 -1.16 -1.83 -2.01
AW434670 Cmya1_predicted 2.56 2.12 1.29 1.32
XM_344122 LOC363942 -1.49 -1.28 -1.28 -1.30
XM_340760 RGD1309385_predicted -1.78 -1.30 -3.22 -1.67
NM_138549 Gpsn2 -1.33 -1.21 -1.40 -1.74
XM_346881 LOC360478 -1.71 -1.93 -2.33 -2.44
BI286389 RGD:1303181 1.52 1.47 1.07 1.32
XM_227446 LOC310670 -1.50 -1.72 -1.53 -1.65
AW141699 RGD:620017 -1.29 -1.56 -1.79 -1.12
AI236635 Skp1a 1.49 1.01 1.19 1.28
XM_217130 LOC300684 1.03 1.53 1.20 1.22
BQ200408 Cst3 -1.21 -1.54 -1.55 -1.33
BC079462 Pon2_predicted -1.80 -1.34 -1.56 -1.34
NM_053326 Enh -1.47 -1.49 -1.29 -1.21
XM_345415 LOC366153 1.49 1.38 1.54 1.02
XM_217539 LOC302192 1.60 1.43 1.32 1.14
XM_220752 -1.67 -1.43 -1.49 -1.52
TC495193 1.43 1.52 1.28 1.36
XM_225173 -1.81 -1.72 -2.11 -2.39
AA964296 2.17 2.07 3.23 2.22
TC483914 2.65 1.71 2.09 2.16
M12199 -1.96 -1.95 -2.10 -3.06
XM_226041 1.59 1.33 1.27 1.50
BF544403 3.32 4.07 3.53 8.78
AA924335 1.57 1.29 1.70 1.75
AI013671 4.01 2.34 1.92 3.11
XM_341859 -1.30 -1.19 -1.47 -1.27
TC487987 3.29 3.05 1.69 3.40
AW920693 -1.56 -1.68 -1.25 -1.43
XM_345940 -1.36 -1.83 -2.19 -1.74
BF549650 3.36 2.30 1.67 3.28
U87983 1.68 1.31 1.65 2.08
XM_345834 1.34 1.81 1.33 1.71
NM_001002850 -1.74 -1.59 -2.81 -2.72
XM_216335 -1.24 -1.62 -1.87 -1.54
CA512073 -1.23 -1.81 -1.64 -1.49
XM_237971 -1.31 -1.34 -1.83 -1.71
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ENSRNOT00000030063 -1.30 -1.51 -1.81 -1.31
XM_213911 -1.50 -1.26 -1.96 -1.53
AI409900 1.47 1.30 1.21 1.15
XM_221952 -1.93 -1.39 -2.71 -1.76
TC493257 1.47 1.53 1.34 1.14
XM_216062 -1.61 -1.56 -3.00 -2.16
AW918430 2.57 1.59 3.41 4.96
AW917657 -1.11 -1.48 -1.34 -1.27
A_44_P708381 1.20 1.92 1.70 2.18
BF408982 -1.39 -1.96 -1.76 -2.96
XM_216546 -1.14 -1.55 -1.49 -1.27
XM_221348 -1.38 -1.33 -2.10 -1.49
XM_347128 1.53 1.50 1.20 1.17
XM_346252 -1.64 -1.41 -2.95 -2.30
ENSRNOT00000034797 -1.22 -1.56 -1.91 -1.35
TC504821 -1.29 -1.40 -1.17 -1.69
TC489660 -1.45 -1.75 -1.32 -1.17
AI008316 2.09 1.55 2.53 4.39
XM_225097 -1.19 -1.75 -1.86 -1.37
XM_230278 -1.48 -1.33 -1.23 -1.10
AI031053 2.72 1.27 3.07 3.49
BE116572 -1.19 -1.50 -1.28 -1.79
XM_341145 1.67 1.19 1.24 1.31
NM_001007678 1.49 1.19 1.63 2.08
XM_341875 -1.63 -1.71 -1.77 -1.10
S43941 -1.83 -1.44 -2.67 -1.40
XM_340759 -1.29 -1.44 -2.05 -1.34
AI638986 2.07 1.75 1.18 1.47
XM_224849 -1.10 -1.50 -1.28 -1.24
XM_216109 1.50 1.20 1.24 1.13
XM_237718 -1.66 -1.21 -1.78 -1.22
TC466730 -1.51 -1.52 -1.65 -1.07
AW914778 1.47 1.10 1.62 1.81
TC478102 -1.11 -1.77 -1.36 -1.49
BC083721 -1.44 -1.85 -1.11 -1.50
TC504962 -1.24 -1.19 -1.14 -1.55
AI317880 1.11 1.47 1.20 1.20
XM_226680 -1.19 -1.90 -1.69 -1.26
A_44_P470892 -1.41 -1.08 -1.67 -1.34
AW919066 -1.36 -1.27 -1.13 -1.74
XM_231103 -1.26 -1.18 -1.49 -1.10
AABR03001498 1.38 1.09 1.65 1.81
XM_340817 1.48 1.91 4.48 5.28
XM_347347 -1.56 -1.42 -1.05 -1.60
TC476390 2.00 1.17 1.45 1.35
XM_345482 -1.21 -1.89 -1.63 -2.84
BF548976 -1.19 -1.66 -1.53 -1.13
AA859053 -1.20 -1.08 -1.48 -1.51
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XM_347332 -1.13 -1.71 -2.04 -2.60
ENSRNOT00000028943 -1.17 -1.12 -1.35 -1.57
ENSRNOT00000027259 -1.76 -1.90 -1.05 -1.64
XM_233107 -1.16 -1.24 -1.84 -1.44
XM_222302 -1.22 -1.70 -1.22 -2.02
AW142344 1.13 1.23 1.69 1.30
XM_223715 1.62 1.65 1.43 1.03
TC489044 -1.38 -1.32 -1.52 -1.03
XM_220874 -1.42 -1.74 -1.29 -1.08
XM_228900 -1.61 -1.89 -5.68 -7.71
TC503900 -2.13 -1.28 -1.34 -1.28
BE103095 1.86 1.03 1.57 1.63
AW143724 -1.34 -1.69 -4.54 -3.11
XM_229609 1.47 1.22 1.19 1.06
AW916908 -1.53 -1.75 -1.53 -1.02
XM_216577 1.67 1.40 1.97 4.23
BF550246 -1.31 -1.45 -1.74 -1.06
TC473838 1.55 1.11 1.12 1.41
AW918186 1.59 1.11 1.59 2.44
X52757 1.19 1.11 1.53 1.16
AI232783 1.17 1.38 2.00 2.56
BF290649 1.38 1.12 1.66 2.23
XM_216288 1.60 1.02 1.48 1.85
AABR03073563 1.88 1.10 1.31 1.39
XM_341462 1.83 1.12 1.20 1.59
XM_229147 -1.26 -1.08 -1.69 -1.30
XM_344113 -1.21 -1.86 -2.81 -4.70
XM_236238 -1.01 -1.65 -1.75 -1.46
XM_341158 -1.08 -1.37 -2.01 -1.50
TC486677 1.55 1.36 1.09 1.13
XM_214014 -1.80 -1.43 -1.85 -1.03
BF291173 -1.31 -1.25 -1.14 -1.86
TC494356 -1.07 -1.50 -1.68 -1.21
TC478611 -1.21 -1.40 -2.05 -1.20
TC482103 1.56 1.08 1.16 1.57
L00382 -1.51 -1.03 -1.50 -1.23
ENSRNOT00000005403 -1.44 -1.13 -1.54 -2.43
TC486532 -1.22 -1.50 -2.35 -1.26
TC484553 10.88 6.24 1.27 2.41
CB548368 1.16 1.30 2.51 1.95
CB547615 1.45 1.36 1.90 3.93
AA945152 1.17 1.07 1.36 1.64
XM_226390 1.63 1.15 1.28 1.09
TC483382 -1.19 -1.10 -1.68 -1.23
AI548201 1.22 1.09 1.62 1.17
XM_342274 -1.05 -1.18 -1.63 -1.63
TC496068 1.36 1.04 1.88 1.35
XM_343661 1.82 1.25 1.22 1.12
145
L33722 -1.39 -1.61 -3.07 -1.24
TC513661 1.27 1.04 1.49 1.89
XM_344814 -1.33 -1.00 -1.58 -1.26
XM_214977 -1.20 -1.61 -1.39 -1.02
XM_229650 1.49 1.21 1.11 1.07
TC474582 -1.30 -1.66 -1.82 -1.00
BQ780215 -1.23 -1.07 -2.06 -1.84
AA817799 1.50 1.05 1.49 1.11
TC464530 -1.76 -2.38 -2.29 1.08
XM_232202 1.46 1.15 1.82 3.53
XM_216768 1.34 1.07 1.55 2.39
XM_343946 1.09 1.09 1.16 1.47
XM_217446 1.17 1.76 1.33 1.06
XM_344837 1.63 1.31 1.09 1.09
XM_346178 1.54 1.16 1.20 1.04
XM_236776 -1.38 -1.01 -2.51 -2.12
ENSRNOT00000016811 -1.21 -1.00 -1.23 -1.52
AA866409 1.04 1.54 1.10 1.53
TC473591 1.24 1.02 1.38 1.79
XM_342556 1.10 1.08 1.47 1.13
XM_221690 -3.01 -2.12 -1.00 -1.50
response to stress
Accession Gene
NM_012935 Cryab -1.16 -1.50 -2.46 -3.28
establishment and/or maintenance of cell polarity
Accession Gene
AW919109 Cap2 -1.10 -1.19 -1.47 -1.35
synaptic vesicle endocytosis
Accession Gene
NM_053959 Bin1 -1.79 -1.64 -1.21 -1.26
inactivation of MAPK
Accession Gene
U42627 Dusp6 -1.28 -1.79 -1.84 -1.03
negative regulation of adenylate cyclase activity
Accession Gene
NM_031035 Gnai2 -1.42 -1.66 -1.23 -1.08
positive regulation of I-kappaB kinase/NF-kappaB cascade
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
circadian rhythm
Accession Gene
NM_012543 Dbp -1.66 -1.65 -1.71 -1.60
NM_145775 Nr1d1 -1.26 -1.42 -1.80 -1.81
NM_031340 Timeless -1.95 -1.27 -1.32 -1.58
inner cell mass cell proliferation
Accession Gene
AF540887 Dmbt1 -1.12 -1.29 -1.68 -1.43
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intracellular signaling cascade
Accession Gene
XM_341989 RGD1304930_predicted 1.99 1.09 1.44 1.27
lipid catabolism
Accession Gene
NM_017113 Grn -1.17 -1.17 -1.50 -1.10
visceral muscle development
Accession Gene
NM_017239 Myh6 -1.50 -2.04 -1.72 -3.06
AI104924 Myh6 1.36 1.62 1.03 1.16
regulation of heart contraction rate
Accession Gene
M34136 Tpm1 -1.32 -1.25 -1.54 -1.64
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
NM_053981 Kcnj12 1.30 1.03 1.42 1.55
NM_031035 Gnai2 -1.42 -1.66 -1.23 -1.08
G-protein signaling, adenylate cyclase inhibiting pathway
Accession Gene
NM_013036 Sstr4 -1.53 -1.05 -1.26 -1.22
NM_031035 Gnai2 -1.42 -1.66 -1.23 -1.08
striated muscle contraction
Accession Gene
XM_343196 RGD:735102 -1.60 -1.54 -1.29 -1.14
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
NM_017131 Casq2 -1.34 -1.10 -1.30 -1.65
AI045171 Casq2 -1.14 -1.43 -2.92 -2.13
NM_012604 Myh3 -1.55 -1.62 -3.25 -3.31
NM_017240 Myh7 -1.66 -1.86 -2.74 -3.16
NM_017239 Myh6 -1.50 -2.04 -1.72 -3.06
AI104924 Myh6 1.36 1.62 1.03 1.16
prostaglandin biosynthesis
Accession Gene
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
anti-apoptosis
Accession Gene
NM_021740 Ptma -1.25 -1.69 -1.26 -1.10
NM_031345 Dsipi 1.47 1.20 1.28 1.01
skeletal development
Accession Gene
NM_053714 Ank -1.14 -1.08 -1.57 -1.23
XM_213440 Col1a1 -2.52 -2.70 -2.03 -3.12
NM_031825 Fbn1 -1.23 -1.55 -2.49 -1.66
NM_032085 Col3a1 -1.78 -2.12 -1.98 -1.45
BI275716 Col3a1 -1.81 -1.72 -1.74 -1.20
NM_017338 Calca 1.55 1.26 1.11 1.39
NM_053356 Col1a2 -2.11 -1.98 -2.62 -2.67
BI282748 Col1a2 -1.38 -1.80 -1.89 -1.73
XM_342245 Postn_predicted -1.63 -1.46 -3.20 -1.52
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ossification
Accession Gene
NM_012656 Sparc -1.67 -1.85 -1.71 -1.87
cell communication
Accession Gene
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
positive regulation of epithelial cell differentiation
Accession Gene
AF540887 Dmbt1 -1.12 -1.29 -1.68 -1.43
embryonic heart tube development
Accession Gene
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
glycosaminoglycan metabolism
Accession Gene
BF567631 Sulf1 -1.07 -1.49 -1.71 -1.22
phospholipase C activation
Accession Gene
NM_017338 Calca 1.55 1.26 1.11 1.39
perception of sound
Accession Gene
NM_053714 Ank -1.14 -1.08 -1.57 -1.23
XM_213440 Col1a1 -2.52 -2.70 -2.03 -3.12
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
NM_053356 Col1a2 -2.11 -1.98 -2.62 -2.67
BI282748 Col1a2 -1.38 -1.80 -1.89 -1.73
NM_053674 Phyh -1.08 -1.49 -1.21 -1.22
cell cycle arrest
Accession Gene
NM_024349 Ak1 1.54 1.47 2.02 3.56
mRNA editing
Accession Gene
XM_217334 Apobec2_predicted -1.00 -1.32 -1.62 -1.21
cell proliferation
Accession Gene
NM_053959 Bin1 -1.79 -1.64 -1.21 -1.26
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
NM_012848 Fth1 -1.71 -1.39 -1.22 -1.11
neurotransmitter catabolism
Accession Gene
AA858639 Comt -1.76 -1.84 -2.20 -3.02
positive regulation of myoblast differentiation
Accession Gene
NM_012588 Igfbp3 -1.61 -1.74 -1.48 -1.59
cholesterol transport
Accession Gene
NM_053502 Abcg1 -1.63 -1.98 -1.79 -1.09
innate immune response
Accession Gene
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AF540887 Dmbt1 -1.12 -1.29 -1.68 -1.43
negative regulation of gluconeogenesis
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
endocytosis
Accession Gene
NM_019288 App -1.75 -1.65 -1.98 -1.08
NM_053959 Bin1 -1.79 -1.64 -1.21 -1.26
regulation of body size
Accession Gene
BQ200807 Gamt 1.03 2.71 1.40 1.91
perception of smell, sensory transduction of chemical stimulus
Accession Gene
NM_001000739 Olr150_predicted -1.51 -1.30 -1.09 -1.51
NM_001000262 Olr383_predicted 1.62 1.24 1.19 1.48
myogenesis
Accession Gene
NM_013172 Myf6 1.78 1.15 2.26 4.26
cytoskeleton organization and biogenesis
Accession Gene
AW919109 Cap2 -1.10 -1.19 -1.47 -1.35
AA891242 Myl7_predicted -1.02 -1.36 -2.55 -2.40
XM_343643 Mrlcb -1.19 -1.30 -2.50 -2.61
NM_021261 Tmsb10 -1.65 -1.61 -1.45 -1.14
NM_012893 Actg2 -1.49 -1.23 -1.55 -1.20
NM_012606 Myl3 -1.04 -2.07 -1.93 -4.37
NM_012604 Myh3 -1.55 -1.62 -3.25 -3.31
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
NM_017239 Myh6 -1.50 -2.04 -1.72 -3.06
AI104924 Myh6 1.36 1.62 1.03 1.16
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
regulation of muscle contraction
Accession Gene
NM_138887 Hspb6 -2.24 -1.29 -2.23 -2.32
NM_057208 RGD:621546 -1.33 -1.60 -1.72 -2.54
NM_173111 RGD:621546 -1.40 -1.53 -2.76 -1.96
AF053360 RGD:621546 -1.42 -1.39 -3.96 -3.29
M34136 Tpm1 -1.32 -1.25 -1.54 -1.64
NM_017184 Tnni1 -1.67 -1.64 -3.78 -3.84
XM_214266 Tncc_predicted -1.01 -1.66 -3.28 -4.05
NM_024156 Anxa6 -1.73 -1.72 -1.31 -1.21
NM_134388 Tnnt1 -1.36 -1.58 -3.09 -3.06
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
NM_017131 Casq2 -1.34 -1.10 -1.30 -1.65
AI045171 Casq2 -1.14 -1.43 -2.92 -2.13
cell aging
Accession Gene
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
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phosphoinositide-mediated signaling
Accession Gene
NM_001004080 RGD:1303089 -1.89 -2.15 -1.33 -1.23
fatty acid oxidation
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
angiogenesis
Accession Gene
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
chromatin assembly or disassembly
Accession Gene
XM_232671 Chd7_predicted 1.03 1.23 1.54 1.90
regulated secretory pathway
Accession Gene
AW507352 Gars_predicted 1.57 1.24 1.02 1.29
glucose homeostasis
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
determination of left/right symmetry
Accession Gene
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
transcription
Accession Gene
NM_024388 Nr4a1 4.48 3.96 4.65 7.93
NM_031628 Nr4a3 15.16 18.09 11.99 24.66
XM_221937 Papolb_predicted 1.78 1.30 1.09 1.14
NM_145775 Nr1d1 -1.26 -1.42 -1.80 -1.81
NM_021740 Ptma -1.25 -1.69 -1.26 -1.10
BG664147 Ptrf_predicted -1.12 -1.58 -1.30 -1.37
adenine metabolism
Accession Gene
NM_024349 Ak1 1.54 1.47 2.02 3.56
muscle cell differentiation
Accession Gene
NM_022531 Des -1.57 -1.40 -1.15 -1.08
response to unfolded protein
Accession Gene
NM_130431 Hspb2 -1.43 -1.08 -1.57 -1.32
entrainment of circadian clock
Accession Gene
NM_053328 Bhlhb2 -1.24 -1.38 -1.92 -1.24
plasma membrane repair
Accession Gene
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
sensory organ development
Accession Gene
NM_012935 Cryab -1.16 -1.50 -2.46 -3.28
antimicrobial humoral response (sensu Vertebrata)
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Accession Gene
XM_213943 Mgst3_predicted -1.07 -1.33 -1.42 -1.47
transmembrane receptor protein serine/threonine kinase signaling pathway
Accession Gene
AW917911 Tgfbr2 -1.33 -1.58 -1.60 -1.19
NAD biosynthesis
Accession Gene
BC083725 Nmnat3_predicted 1.58 1.08 1.37 1.56
regulation of cell differentiation
Accession Gene
NM_021693 Snf1lk 5.24 3.38 2.39 3.66
Rho protein signal transduction
Accession Gene
NM_017147 Cfl1 -1.28 -1.54 -1.15 -1.14
negative regulation of axon extension
Accession Gene
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
development
Accession Gene
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
NM_031975 Ptms -2.00 -1.25 -4.33 -1.41
BC061782 Fhl1 -1.29 -1.56 -1.51 -1.38
NM_145669 Fhl1 -1.42 -1.65 -1.76 -1.93
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
NM_031825 Fbn1 -1.23 -1.55 -2.49 -1.66
NM_017149 Meox2 -1.14 -1.86 -1.64 -1.21
NM_021740 Ptma -1.25 -1.69 -1.26 -1.10
NM_019237 Pcolce -1.44 -1.45 -1.50 -1.57
NM_013172 Myf6 1.78 1.15 2.26 4.26
acute-phase response
Accession Gene
NM_019143 Fn1 -1.50 -1.88 -4.12 -2.81
heterophilic cell adhesion
Accession Gene
NM_019904 Lgals1 -1.25 -1.50 -1.07 -1.15
NM_031832 Lgals3 -1.06 -1.35 -1.54 -1.24
NM_022582 Lgals7 -1.49 -1.15 -1.09 -1.21
protein transport
Accession Gene
BE128566 Copz2_predicted -1.17 -1.07 -1.54 -1.37
integrin-mediated signaling pathway
Accession Gene
XM_345156 Itga2 -1.32 -1.70 -1.01 -1.87
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
proton transport
Accession Gene
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
regulation of cell cycle
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Accession Gene
NM_031975 Ptms -2.00 -1.25 -4.33 -1.41
NM_017100 Plk1 1.31 1.16 1.75 1.54
U42627 Dusp6 -1.28 -1.79 -1.84 -1.03
NM_019257 Sfrs5 -1.11 -1.79 -1.16 -1.53
NM_021740 Ptma -1.25 -1.69 -1.26 -1.10
regulation of endocytosis
Accession Gene
NM_053959 Bin1 -1.79 -1.64 -1.21 -1.26
negative regulation of caspase activation
Accession Gene
NM_021740 Ptma -1.25 -1.69 -1.26 -1.10
nuclear mRNA splicing, via spliceosome
Accession Gene
NM_019257 Sfrs5 -1.11 -1.79 -1.16 -1.53
BQ200332 Snrpa_predicted 1.53 1.13 1.28 1.03
CB547639 Cpeb4_predicted 1.73 1.33 1.28 2.65
cellular morphogenesis
Accession Gene
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
chemotaxis
Accession Gene
NM_080698 Fmod -1.16 -1.21 -1.62 -1.28
positive regulation of cell proliferation
Accession Gene
AW917911 Tgfbr2 -1.33 -1.58 -1.60 -1.19
NM_022501 RGD:1302959 -1.34 -1.53 -1.46 -1.65
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
XM_341824 Capns1 -1.65 -1.68 -1.28 -1.06
cell surface receptor linked signal transduction
Accession Gene
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
O-linked glycosylation
Accession Gene
BG673253 Ogt -1.27 -1.65 -1.30 -1.21
pyridine nucleotide biosynthesis
Accession Gene
BC083725 Nmnat3_predicted 1.58 1.08 1.37 1.56
L-glutamate transport
Accession Gene
NM_023972 Arl6ip5 -1.57 -1.30 -1.17 -1.09
induction of apoptosis
Accession Gene
NM_024388 Nr4a1 4.48 3.96 4.65 7.93
NM_019288 App -1.75 -1.65 -1.98 -1.08
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
urea cycle
Accession Gene
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XM_224969 Slc25a15_predicted 1.55 1.09 1.24 1.10
lipid biosynthesis
Accession Gene
NM_031841 Scd2 -1.30 -1.85 -1.73 -2.77
signal complex formation
Accession Gene
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
somite specification
Accession Gene
NM_017149 Meox2 -1.14 -1.86 -1.64 -1.21
inflammatory response
Accession Gene
BF567803 Nfe2l1_predicted -1.47 -1.60 -1.26 -1.07
NM_017338 Calca 1.55 1.26 1.11 1.39
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
spermatogenesis
Accession Gene
BQ200807 Gamt 1.03 2.71 1.40 1.91
NM_013086 Crem 2.25 2.15 1.89 3.34
NM_021989 Timp2 -1.52 -1.59 -1.47 -1.52
AW918612 Timp2 -1.79 -1.73 -1.95 -1.81
response to nutrients
Accession Gene
BG673253 Ogt -1.27 -1.65 -1.30 -1.21
NM_031035 Gnai2 -1.42 -1.66 -1.23 -1.08
regulation of nuclear mRNA splicing, via spliceosome
Accession Gene
NM_019257 Sfrs5 -1.11 -1.79 -1.16 -1.53
blood coagulation
Accession Gene
NM_013057 F3 -1.18 -1.69 -1.97 -1.18
antigen presentation
Accession Gene
AI171966 RGD:735096 -1.01 -1.22 -1.53 -1.47
NM_033351 Fcgrt -1.73 -1.61 -1.49 -1.27
neuron differentiation
Accession Gene
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
eye morphogenesis (sensu Mammalia)
Accession Gene
NM_012935 Cryab -1.16 -1.50 -2.46 -3.28
protein biosynthesis
Accession Gene
NM_022514 Rpl27 -1.37 -1.57 -1.35 -1.03
AW507352 Gars_predicted 1.57 1.24 1.02 1.29
XM_216882 Mrpl42_predicted 1.68 1.07 1.13 1.36
NM_017151 Rps15 -1.89 -1.54 -2.73 -2.24
lung development
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Accession Gene
NM_031340 Timeless -1.95 -1.27 -1.32 -1.58
G-protein signaling, coupled to cAMP nucleotide second messenger
Accession Gene
NM_017338 Calca 1.55 1.26 1.11 1.39
extracellular amino acid transport
Accession Gene
NM_175758 Slc1a5 -1.13 -1.51 -1.21 -1.69
neuron migration
Accession Gene
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
regulation of blood pressure
Accession Gene
NM_017338 Calca 1.55 1.26 1.11 1.39
defense response
Accession Gene
NM_012512 B2m -1.06 -1.39 -1.88 -1.21
regulation of cell migration
Accession Gene
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
rhythmic behavior
Accession Gene
NM_012543 Dbp -1.66 -1.65 -1.71 -1.60
protein kinase cascade
Accession Gene
NM_021693 Snf1lk 5.24 3.38 2.39 3.66
NM_031035 Gnai2 -1.42 -1.66 -1.23 -1.08
cell cycle
Accession Gene
NM_021693 Snf1lk 5.24 3.38 2.39 3.66
NM_017100 Plk1 1.31 1.16 1.75 1.54
AA997829 Calm1 -1.72 -2.09 -1.35 -1.15
negative regulation of cell proliferation
Accession Gene
NM_013036 Sstr4 -1.53 -1.05 -1.26 -1.22
NM_012848 Fth1 -1.71 -1.39 -1.22 -1.11
negative regulation of transcription
Accession Gene
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
cell-substrate junction assembly
Accession Gene
NM_019143 Fn1 -1.50 -1.88 -4.12 -2.81
vascular endothelial growth factor receptor signaling pathway
Accession Gene
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
lipoprotein metabolism
Accession Gene
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
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cell-cell signaling
Accession Gene
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
NM_012649 Sdc4 1.97 1.29 1.34 1.58
NM_017338 Calca 1.55 1.26 1.11 1.39
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
detection of abiotic stimulus
Accession Gene
NM_031340 Timeless -1.95 -1.27 -1.32 -1.58
ion transport
Accession Gene
NM_053981 Kcnj12 1.30 1.03 1.42 1.55
NM_031686 RGD:61922 -1.40 -1.07 -1.50 0.00
NM_019230 Slc22a3 1.66 1.58 1.03 1.26
fluid secretion
Accession Gene
NM_031345 Dsipi 1.47 1.20 1.28 1.01
tricarboxylic acid cycle intermediate metabolism
Accession Gene
NM_012595 Ldhb -1.42 -1.54 -2.15 -1.42
patterning of blood vessels
Accession Gene
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
electron transport
Accession Gene
BC061782 Fhl1 -1.29 -1.56 -1.51 -1.38
NM_145669 Fhl1 -1.42 -1.65 -1.76 -1.93
XM_219933 Cyp2c65_predicted 1.62 1.23 1.30 1.11
AW917988 RGD1305146_predicted -1.11 -1.28 -1.49 -1.07
NM_031347 Ppargc1a 2.12 1.80 2.08 2.46
positive regulation of cytosolic calcium ion concentration
Accession Gene
NM_017338 Calca 1.55 1.26 1.11 1.39
carbohydrate metabolism
Accession Gene
AW913985 Slc3a1 -1.10 -1.71 -1.66 -1.23
NM_053638 Idh3a 1.42 1.16 1.35 1.70
substrate-bound cell migration, cell extension
Accession Gene
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
cytoskeletal anchoring
Accession Gene
NM_022401 Plec1 -1.42 -1.49 -1.14 -1.16
regulation of neuronal synaptic plasticity
Accession Gene
NM_053328 Bhlhb2 -1.24 -1.38 -1.92 -1.24
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
G-protein signaling, coupled to cyclic nucleotide second messenger
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Accession Gene
NM_013036 Sstr4 -1.53 -1.05 -1.26 -1.22
somatic muscle development
Accession Gene
NM_130431 Hspb2 -1.43 -1.08 -1.57 -1.32
humoral immune response
Accession Gene
NM_033351 Fcgrt -1.73 -1.61 -1.49 -1.27
proteolysis and peptidolysis
Accession Gene
XM_343169 Adn -2.76 -3.28 -6.80 -5.17
NM_022597 Ctsb -1.64 -1.48 -1.38 -1.10
M57728 Pmpca 1.49 1.11 1.42 1.04
NM_031054 Mmp2 -1.09 -1.34 -1.69 -1.54
NM_019237 Pcolce -1.44 -1.45 -1.50 -1.57
XM_341824 Capns1 -1.65 -1.68 -1.28 -1.06
one-carbon compound metabolism
Accession Gene
NM_019292 Ca3 -1.20 -2.06 -4.67 -5.85
branched chain family amino acid biosynthesis
Accession Gene
XM_343174 Ilvbl_predicted -1.59 -1.04 -1.48 -1.13
actin filament-based movement
Accession Gene
AA891242 Myl7_predicted -1.02 -1.36 -2.55 -2.40
NM_012604 Myh3 -1.55 -1.62 -3.25 -3.31
tRNA aminoacylation for protein translation
Accession Gene
AW507352 Gars_predicted 1.57 1.24 1.02 1.29
regulation of transcription, DNA-dependent
Accession Gene
NM_013086 Crem 2.25 2.15 1.89 3.34
NM_024388 Nr4a1 4.48 3.96 4.65 7.93
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
XM_214108 Ugp2_predicted 1.75 1.16 1.15 2.00
NM_031628 Nr4a3 15.16 18.09 11.99 24.66
BF567803 Nfe2l1_predicted -1.47 -1.60 -1.26 -1.07
NM_012543 Dbp -1.66 -1.65 -1.71 -1.60
NM_019257 Sfrs5 -1.11 -1.79 -1.16 -1.53
XM_341238 Hmx1_predicted -1.28 -1.23 -1.17 -1.86
NM_017149 Meox2 -1.14 -1.86 -1.64 -1.21
NM_053328 Bhlhb2 -1.24 -1.38 -1.92 -1.24
NM_145775 Nr1d1 -1.26 -1.42 -1.80 -1.81
NM_012912 Atf3 4.95 5.23 2.89 6.41
BG664147 Ptrf_predicted -1.12 -1.58 -1.30 -1.37
XM_232671 Chd7_predicted 1.03 1.23 1.54 1.90
NM_013172 Myf6 1.78 1.15 2.26 4.26
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NM_031347 Ppargc1a 2.12 1.80 2.08 2.46
NM_031345 Dsipi 1.47 1.20 1.28 1.01
NM_031340 Timeless -1.95 -1.27 -1.32 -1.58
transport
Accession Gene
AW913985 Slc3a1 -1.10 -1.71 -1.66 -1.23
NM_053714 Ank -1.14 -1.08 -1.57 -1.23
NM_033234 Hbb 1.58 1.08 1.93 2.38
NM_198776 Hbb 1.80 1.04 2.27 3.09
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
NM_053502 Abcg1 -1.63 -1.98 -1.79 -1.09
NM_053981 Kcnj12 1.30 1.03 1.42 1.55
BE128566 Copz2_predicted -1.17 -1.07 -1.54 -1.37
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
NM_031686 RGD:61922 -1.40 -1.07 -1.50 0.00
XM_224969 Slc25a15_predicted 1.55 1.09 1.24 1.10
AW918768 Sln_predicted -1.47 -1.98 -2.45 -1.48
NM_181090 Slc38a2 2.06 1.14 1.99 3.04
XM_215285 Rbp4 -1.49 -1.28 -1.80 -1.20
NM_019230 Slc22a3 1.66 1.58 1.03 1.26
inhibition of caspase activation
Accession Gene
NM_024388 Nr4a1 4.48 3.96 4.65 7.93
G-protein coupled receptor protein signaling pathway
Accession Gene
NM_013036 Sstr4 -1.53 -1.05 -1.26 -1.22
NM_001000739 Olr150_predicted -1.51 -1.30 -1.09 -1.51
AA997829 Calm1 -1.72 -2.09 -1.35 -1.15
NM_031035 Gnai2 -1.42 -1.66 -1.23 -1.08
NM_001000262 Olr383_predicted 1.62 1.24 1.19 1.48
XM_235164 Frs2_predicted 1.60 1.36 1.19 1.27
chromatin modification
Accession Gene
XM_232671 Chd7_predicted 1.03 1.23 1.54 1.90
biosynthesis
Accession Gene
BC083725 Nmnat3_predicted 1.58 1.08 1.37 1.56
oxygen transport
Accession Gene
NM_033234 Hbb 1.58 1.08 1.93 2.38
NM_198776 Hbb 1.80 1.04 2.27 3.09
cellular defense response
Accession Gene
NM_031975 Ptms -2.00 -1.25 -4.33 -1.41
NM_012512 B2m -1.06 -1.39 -1.88 -1.21
transmembrane receptor protein tyrosine kinase signaling pathway
Accession Gene
XM_341642 Dok4_predicted -1.52 -1.56 -2.90 -3.30
157
XM_235164 Frs2_predicted 1.60 1.36 1.19 1.27
regulation of transcription
Accession Gene
NM_024388 Nr4a1 4.48 3.96 4.65 7.93
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
regulation of axon extension
Accession Gene
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
hemopoiesis
Accession Gene
NM_022501 RGD:1302959 -1.34 -1.53 -1.46 -1.65
response to hypoxia
Accession Gene
AW917911 Tgfbr2 -1.33 -1.58 -1.60 -1.19
catecholamine metabolism
Accession Gene
AA858639 Comt -1.76 -1.84 -2.20 -3.02
spermatid development
Accession Gene
NM_021261 Tmsb10 -1.65 -1.61 -1.45 -1.14
secretion
Accession Gene
NM_024156 Anxa6 -1.73 -1.72 -1.31 -1.21
DNA replication
Accession Gene
NM_031975 Ptms -2.00 -1.25 -4.33 -1.41
tissue regeneration
Accession Gene
NM_181368 Mustn1 2.64 2.08 4.22 7.25
AF540887 Dmbt1 -1.12 -1.29 -1.68 -1.43
heart development
Accession Gene
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
NM_017131 Casq2 -1.34 -1.10 -1.30 -1.65
AI045171 Casq2 -1.14 -1.43 -2.92 -2.13
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
fatty acid beta-oxidation
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
regulation of striated muscle contraction
Accession Gene
NM_017184 Tnni1 -1.67 -1.64 -3.78 -3.84
morphogenesis
Accession Gene
BF567803 Nfe2l1_predicted -1.47 -1.60 -1.26 -1.07
iron ion transport
Accession Gene
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NM_012848 Fth1 -1.71 -1.39 -1.22 -1.11
axon guidance
Accession Gene
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
regulation of macrophage activation
Accession Gene
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
induction of bacterial agglutination
Accession Gene
AF540887 Dmbt1 -1.12 -1.29 -1.68 -1.43
glucose metabolism
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
regulation of cell proliferation
Accession Gene
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
AW917911 Tgfbr2 -1.33 -1.58 -1.60 -1.19
NM_012543 Dbp -1.66 -1.65 -1.71 -1.60
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
regulation of translational initiation
Accession Gene
NM_134402 Bzw2 -1.08 -1.26 -1.68 -1.29
glycyl-tRNA aminoacylation
Accession Gene
AW507352 Gars_predicted 1.57 1.24 1.02 1.29
positive regulation of glucose import
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
cell adhesion
Accession Gene
NM_031582 Aoc3 -1.19 -1.39 -1.93 -2.17
XM_342599 Col9a3_predicted -2.54 -1.68 -2.44 -1.15
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
XM_213440 Col1a1 -2.52 -2.70 -2.03 -3.12
NM_012649 Sdc4 1.97 1.29 1.34 1.58
XM_223124 Col9a1_predicted -2.09 -2.55 -1.95 -2.22
NM_019288 App -1.75 -1.65 -1.98 -1.08
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
AA996757 Cldn10_predicted -1.23 -1.55 -1.09 -1.75
XM_343196 RGD:735102 -1.60 -1.54 -1.29 -1.14
NM_032085 Col3a1 -1.78 -2.12 -1.98 -1.45
BI275716 Col3a1 -1.81 -1.72 -1.74 -1.20
XM_345156 Itga2 -1.32 -1.70 -1.01 -1.87
XM_216399 Col15a1_predicted -1.70 -2.25 -1.47 -1.29
NM_053356 Col1a2 -2.11 -1.98 -2.62 -2.67
BI282748 Col1a2 -1.38 -1.80 -1.89 -1.73
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
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XM_213925 Dpt_predicted -1.28 -1.39 -1.56 1.02
XM_342245 Postn_predicted -1.63 -1.46 -3.20 -1.52
NM_019143 Fn1 -1.50 -1.88 -4.12 -2.81
amino acid transport
Accession Gene
AW913985 Slc3a1 -1.10 -1.71 -1.66 -1.23
NM_181090 Slc38a2 2.06 1.14 1.99 3.04
blastocyst development
Accession Gene
AF540887 Dmbt1 -1.12 -1.29 -1.68 -1.43
regulation of translation
Accession Gene
XM_213823 Rbms2_predicted -2.22 -2.61 -1.16 -1.31
embryonic limb morphogenesis
Accession Gene
NM_181368 Mustn1 2.64 2.08 4.22 7.25
synaptic transmission
Accession Gene
NM_053959 Bin1 -1.79 -1.64 -1.21 -1.26
pregnancy
Accession Gene
NM_033351 Fcgrt -1.73 -1.61 -1.49 -1.27
negative regulation of neuron differentiation
Accession Gene
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
transmembrane receptor protein tyrosine phosphatase signaling pathway
Accession Gene
XM_235164 Frs2_predicted 1.60 1.36 1.19 1.27
epithelial cell differentiation
Accession Gene
AF540887 Dmbt1 -1.12 -1.29 -1.68 -1.43
epidermis development
Accession Gene
XM_213440 Col1a1 -2.52 -2.70 -2.03 -3.12
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
cell migration
Accession Gene
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
NM_019143 Fn1 -1.50 -1.88 -4.12 -2.81
ubiquitin cycle
Accession Gene
BF411421 Herc4_predicted -1.37 -1.49 -1.22 -1.07
NM_031001 Ube2d2 -1.57 -1.13 -1.31 -1.07
negative regulation of smooth muscle contraction
Accession Gene
NM_017338 Calca 1.55 1.26 1.11 1.39
organic cation transport
Accession Gene
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NM_019230 Slc22a3 1.66 1.58 1.03 1.26
cell fate commitment
Accession Gene
AW917911 Tgfbr2 -1.33 -1.58 -1.60 -1.19
learning and/or memory
Accession Gene
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
glial cell differentiation
Accession Gene
NM_138900 C1s -1.20 -1.57 -1.67 -1.09
positive regulation of signal transduction
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
RNA processing
Accession Gene
XM_213823 Rbms2_predicted -2.22 -2.61 -1.16 -1.31
neurogenesis
Accession Gene
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
XM_341642 Dok4_predicted -1.52 -1.56 -2.90 -3.30
NM_053328 Bhlhb2 -1.24 -1.38 -1.92 -1.24
NM_053674 Phyh -1.08 -1.49 -1.21 -1.22
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
negative regulation of signal transduction
Accession Gene
NM_012588 Igfbp3 -1.61 -1.74 -1.48 -1.59
protein amino acid dephosphorylation
Accession Gene
BM386565 Ptpn18_predicted 1.04 1.47 1.21 1.80
U42627 Dusp6 -1.28 -1.79 -1.84 -1.03
negative regulation of cell cycle
Accession Gene
NM_053959 Bin1 -1.79 -1.64 -1.21 -1.26
intracellular transport
Accession Gene
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
visual perception
Accession Gene
NM_031825 Fbn1 -1.23 -1.55 -2.49 -1.66
NM_012935 Cryab -1.16 -1.50 -2.46 -3.28
NM_053674 Phyh -1.08 -1.49 -1.21 -1.22
XM_215285 Rbp4 -1.49 -1.28 -1.80 -1.20
antigen processing, endogenous antigen via MHC class I
Accession Gene
NM_012512 B2m -1.06 -1.39 -1.88 -1.21
negative regulation of transcription from RNA polymerase II promoter
Accession Gene
NM_021693 Snf1lk 5.24 3.38 2.39 3.66
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branching morphogenesis
Accession Gene
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
NM_031340 Timeless -1.95 -1.27 -1.32 -1.58
regulation of cell growth
Accession Gene
NM_012588 Igfbp3 -1.61 -1.74 -1.48 -1.59
AF139830 Igfbp5 -1.91 -1.64 -1.88 -1.46
AW917764 Igfbp5 -1.25 -1.60 -1.67 -1.37
transforming growth factor beta receptor signaling pathway
Accession Gene
AW917911 Tgfbr2 -1.33 -1.58 -1.60 -1.19
potassium ion transport
Accession Gene
NM_053981 Kcnj12 1.30 1.03 1.42 1.55
pattern specification
Accession Gene
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
negative regulation of apoptosis
Accession Gene
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
protein modification
Accession Gene
NM_031001 Ube2d2 -1.57 -1.13 -1.31 -1.07
fatty acid alpha-oxidation
Accession Gene
NM_053674 Phyh -1.08 -1.49 -1.21 -1.22
protein homooligomerization
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
actin cytoskeleton organization and biogenesis
Accession Gene
AW919109 Cap2 -1.10 -1.19 -1.47 -1.35
NM_017147 Cfl1 -1.28 -1.54 -1.15 -1.14
NM_021261 Tmsb10 -1.65 -1.61 -1.45 -1.14
induction of apoptosis by oxidative stress
Accession Gene
NM_030826 Gpx1 -1.08 -1.57 -2.08 -1.88
intracellular protein transport
Accession Gene
BE128566 Copz2_predicted -1.17 -1.07 -1.54 -1.37
regulation of mitotic cell cycle
Accession Gene
NM_021693 Snf1lk 5.24 3.38 2.39 3.66
vesicle-mediated transport
Accession Gene
NM_001004238 RGD:1303150 1.36 1.08 1.25 1.77
response to heat
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Accession Gene
NM_130431 Hspb2 -1.43 -1.08 -1.57 -1.32
NM_012935 Cryab -1.16 -1.50 -2.46 -3.28
synaptic transmission, cholinergic
Accession Gene
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
mRNA processing
Accession Gene
XM_221937 Papolb_predicted 1.78 1.30 1.09 1.14
XM_217334 Apobec2_predicted -1.00 -1.32 -1.62 -1.21
NM_019257 Sfrs5 -1.11 -1.79 -1.16 -1.53
BQ200332 Snrpa_predicted 1.53 1.13 1.28 1.03
CB547639 Cpeb4_predicted 1.73 1.33 1.28 2.65
muscle development
Accession Gene
NM_057208 RGD:621546 -1.33 -1.60 -1.72 -2.54
NM_173111 RGD:621546 -1.40 -1.53 -2.76 -1.96
AF053360 RGD:621546 -1.42 -1.39 -3.96 -3.29
M34136 Tpm1 -1.32 -1.25 -1.54 -1.64
BC061782 Fhl1 -1.29 -1.56 -1.51 -1.38
NM_145669 Fhl1 -1.42 -1.65 -1.76 -1.93
NM_017184 Tnni1 -1.67 -1.64 -3.78 -3.84
XM_214266 Tncc_predicted -1.01 -1.66 -3.28 -4.05
AA891242 Myl7_predicted -1.02 -1.36 -2.55 -2.40
NM_134388 Tnnt1 -1.36 -1.58 -3.09 -3.06
XM_343196 RGD:735102 -1.60 -1.54 -1.29 -1.14
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
NM_012935 Cryab -1.16 -1.50 -2.46 -3.28
XM_343643 Mrlcb -1.19 -1.30 -2.50 -2.61
NM_017131 Casq2 -1.34 -1.10 -1.30 -1.65
AI045171 Casq2 -1.14 -1.43 -2.92 -2.13
NM_012893 Actg2 -1.49 -1.23 -1.55 -1.20
NM_012606 Myl3 -1.04 -2.07 -1.93 -4.37
NM_012604 Myh3 -1.55 -1.62 -3.25 -3.31
NM_017240 Myh7 -1.66 -1.86 -2.74 -3.16
NM_017239 Myh6 -1.50 -2.04 -1.72 -3.06
AI104924 Myh6 1.36 1.62 1.03 1.16
NM_013172 Myf6 1.78 1.15 2.26 4.26
NM_022531 Des -1.57 -1.40 -1.15 -1.08
ubiquitin-dependent protein catabolism
Accession Gene
NM_031001 Ube2d2 -1.57 -1.13 -1.31 -1.07
signal transduction
Accession Gene
NM_013086 Crem 2.25 2.15 1.89 3.34
NM_024388 Nr4a1 4.48 3.96 4.65 7.93
BG673253 Ogt -1.27 -1.65 -1.30 -1.21
NM_019288 App -1.75 -1.65 -1.98 -1.08
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AW919109 Cap2 -1.10 -1.19 -1.47 -1.35
BF555415 Gfra3 -1.11 -1.15 -1.08 -1.47
NM_031035 Gnai2 -1.42 -1.66 -1.23 -1.08
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
XM_213943 Mgst3_predicted -1.07 -1.33 -1.42 -1.47
AF139830 Igfbp5 -1.91 -1.64 -1.88 -1.46
AW917764 Igfbp5 -1.25 -1.60 -1.67 -1.37
protein folding
Accession Gene
NM_013069 Cd74 -1.32 -1.31 -1.89 -1.81
NM_130431 Hspb2 -1.43 -1.08 -1.57 -1.32
NM_012935 Cryab -1.16 -1.50 -2.46 -3.28
cell growth
Accession Gene
BC061782 Fhl1 -1.29 -1.56 -1.51 -1.38
NM_145669 Fhl1 -1.42 -1.65 -1.76 -1.93
myoblast differentiation
Accession Gene
NM_019904 Lgals1 -1.25 -1.50 -1.07 -1.15
complement activation, alternative pathway
Accession Gene
XM_343169 Adn -2.76 -3.28 -6.80 -5.17
cell maturation
Accession Gene
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
wound healing
Accession Gene
NM_181368 Mustn1 2.64 2.08 4.22 7.25
NM_019143 Fn1 -1.50 -1.88 -4.12 -2.81
cell differentiation
Accession Gene
BC061782 Fhl1 -1.29 -1.56 -1.51 -1.38
NM_145669 Fhl1 -1.42 -1.65 -1.76 -1.93
U42627 Dusp6 -1.28 -1.79 -1.84 -1.03
NM_053959 Bin1 -1.79 -1.64 -1.21 -1.26
AF540887 Dmbt1 -1.12 -1.29 -1.68 -1.43
NM_013172 Myf6 1.78 1.15 2.26 4.26
dendrite morphogenesis
Accession Gene
AW917756 Nrp1 -1.09 -2.03 -2.00 -1.38
peripheral nervous system development
Accession Gene
BF555415 Gfra3 -1.11 -1.15 -1.08 -1.47
NM_031688 Sncg -1.66 -1.43 -1.52 -1.26
rhythmic process
Accession Gene
NM_012543 Dbp -1.66 -1.65 -1.71 -1.60
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transcription from RNA polymerase II promoter
Accession Gene
BF567803 Nfe2l1_predicted -1.47 -1.60 -1.26 -1.07
muscle contraction
Accession Gene
BQ200807 Gamt 1.03 2.71 1.40 1.91
M34136 Tpm1 -1.32 -1.25 -1.54 -1.64
NM_012567 Gja1 -1.42 -1.99 -1.24 -1.35
NM_053981 Kcnj12 1.30 1.03 1.42 1.55
NM_031686 RGD:61922 -1.40 -1.07 -1.50
XM_343196 RGD:735102 -1.60 -1.54 -1.29 -1.14
NM_012935 Cryab -1.16 -1.50 -2.46 -3.28
NM_012606 Myl3 -1.04 -2.07 -1.93 -4.37
collagen catabolism
Accession Gene
NM_031054 Mmp2 -1.09 -1.34 -1.69 -1.54
UDP-glucose metabolism
Accession Gene
XM_214108 Ugp2_predicted 1.75 1.16 1.15 2.00
actin filament severing
Accession Gene
NM_001004080 RGD:1303089 -1.89 -2.15 -1.33 -1.23
extracellular matrix organization and biogenesis
Accession Gene
NM_019288 App -1.75 -1.65 -1.98 -1.08
XM_345156 Itga2 -1.32 -1.70 -1.01 -1.87
NM_024129 Dcn -1.18 -1.70 -1.83 -1.26
protein amino acid alkylation
Accession Gene
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
DNA damage response, signal transduction by p53 class mediator
Accession Gene
NM_031051 Mif -1.32 -1.27 -1.00 -1.53
exocytosis
Accession Gene
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
fibroblast growth factor receptor signaling pathway
Accession Gene
XM_235164 Frs2_predicted 1.60 1.36 1.19 1.27
cell-matrix adhesion
Accession Gene
XM_214443 Ecm2_predicted -1.45 -1.51 -1.45 -1.24
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
regulation of T cell proliferation
Accession Gene
NM_212505 RGD:1303321 -1.55 -2.20 -1.78 -3.70
chromatin remodeling
Accession Gene
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XM_342225 RGD1307747_predicted -1.01 -1.56 -1.25 -1.74
heme biosynthesis
Accession Gene
BF567803 Nfe2l1_predicted -1.47 -1.60 -1.26 -1.07
negative regulation of transcription, DNA-dependent
Accession Gene
NM_024383 Hes5 -1.29 -1.15 -2.36 -2.23
NM_053328 Bhlhb2 -1.24 -1.38 -1.92 -1.24
feeding behavior
Accession Gene
NM_017338 Calca 1.55 1.26 1.11 1.39
MAPKKK cascade
Accession Gene
XM_341642 Dok4_predicted -1.52 -1.56 -2.90 -3.30
response to drug
Accession Gene
NM_031509 Gsta5 -1.43 -1.85 -2.12 -1.26
ATP metabolism
Accession Gene
NM_024349 Ak1 1.54 1.47 2.02 3.56
lipid transport
Accession Gene
NM_053502 Abcg1 -1.63 -1.98 -1.79 -1.09
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
cholesterol homeostasis
Accession Gene
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
lipid metabolism
Accession Gene
NM_053674 Phyh -1.08 -1.49 -1.21 -1.22
XM_213943 Mgst3_predicted -1.07 -1.33 -1.42 -1.47
transcription termination
Accession Gene
BG664147 Ptrf_predicted -1.12 -1.58 -1.30 -1.37
regulation of bone mineralization
Accession Gene
NM_053714 Ank -1.14 -1.08 -1.57 -1.23
response to reactive oxygen species
Accession Gene
NM_030826 Gpx1 -1.08 -1.57 -2.08 -1.88
NM_138828 Apoe -2.37 -2.38 -2.00 -1.74
phosphate transport
Accession Gene
NM_053714 Ank -1.14 -1.08 -1.57 -1.23
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
XM_342599 Col9a3_predicted -2.54 -1.68 -2.44 -1.15
XM_213440 Col1a1 -2.52 -2.70 -2.03 -3.12
XM_223124 Col9a1_predicted -2.09 -2.55 -1.95 -2.22
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NM_032085 Col3a1 -1.78 -2.12 -1.98 -1.45
BI275716 Col3a1 -1.81 -1.72 -1.74 -1.20
XM_216399 Col15a1_predicted -1.70 -2.25 -1.47 -1.29
NM_053356 Col1a2 -2.11 -1.98 -2.62 -2.67
BI282748 Col1a2 -1.38 -1.80 -1.89 -1.73
neuropeptide signaling pathway
Accession Gene
NM_017338 Calca 1.55 1.26 1.11 1.39
cation transport
Accession Gene
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
NM_031686 RGD:61922 -1.40 -1.07 -1.50
NM_019230 Slc22a3 1.66 1.58 1.03 1.26
copper ion homeostasis
Accession Gene
NM_019288 App -1.75 -1.65 -1.98 -1.08
negative regulation of protein biosynthesis
Accession Gene
NM_019243 Ptgfrn -1.22 -2.06 -1.45 -1.09
adenylate cyclase activation
Accession Gene
AW919109 Cap2 -1.10 -1.19 -1.47 -1.35
NM_017338 Calca 1.55 1.26 1.11 1.39
gluconeogenesis
Accession Gene
NM_012912 Atf3 4.95 5.23 2.89 6.41
glycolysis
Accession Gene
NM_012595 Ldhb -1.42 -1.54 -2.15 -1.42
regulation of cell adhesion
Accession Gene
NM_001004080 RGD:1303089 -1.89 -2.15 -1.33 -1.23
calcium ion transport
Accession Gene
NM_024156 Anxa6 -1.73 -1.72 -1.31 -1.21
NM_017290 Atp2a2 -1.06 -1.86 -2.72 -2.88
organogenesis
Accession Gene
BQ200807 Gamt 1.03 2.71 1.40 1.91
NM_019334 Pitx2 -1.61 -1.77 -3.77 -1.46
XM_223124 Col9a1_predicted -2.09 -2.55 -1.95 -2.22
NM_032085 Col3a1 -1.78 -2.12 -1.98 -1.45
BI275716 Col3a1 -1.81 -1.72 -1.74 -1.20
iron ion homeostasis
Accession Gene
NM_012848 Fth1 -1.71 -1.39 -1.22 -1.11
tricarboxylic acid cycle
Accession Gene
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NM_053638 Idh3a 1.42 1.16 1.35 1.70
fatty acid biosynthesis
Accession Gene
NM_031841 Scd2 -1.30 -1.85 -1.73 -2.77
creatine biosynthesis
Accession Gene
BQ200807 Gamt 1.03 2.71 1.40 1.91
response to glucose stimulus
Accession Gene
NM_144744 Acdc -1.87 -2.17 -3.18 -3.66
mesoderm formation
Accession Gene
NM_031628 Nr4a3 15.16 18.09 11.99 24.66
cell motility
Accession Gene
BE117007 Marcks -1.38 -1.88 -1.71 -1.42
XM_215403 Marcks -1.44 -1.33 -2.13 -1.16
AW915860 Marcks -1.10 -1.89 -1.66 -1.12
NM_031675 Actn4 -1.40 -1.11 -1.55 -1.47
NM_031520 Myh10 -1.18 -1.37 -3.16 -1.67
BC081984 Pxn_predicted 1.25 1.07 1.15 1.51
heparan sulfate proteoglycan metabolism
Accession Gene
BF567631 Sulf1 -1.07 -1.49 -1.71 -1.22
ribosome biogenesis
Accession Gene
NM_022514 Rpl27 -1.37 -1.57 -1.35 -1.03
NM_017151 Rps15 -1.89 -1.54 -2.73 -2.24
